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Abstract
Hearing loss is the most common form of congenital birth defect, affecting an estimated
35 million children worldwide. To date, nearly 100 genes have been identified which
contribute to a deafness phenotype in humans, however, many cases remain in which a
causative mutation has yet to be found. In addition, the exact mechanism by which
hearing loss occurs in the presence of many of these mutations is still not understood.
This is due, in part, to the complex nature of the development and function of the
cochlear duct, the organ of hearing. The cochlea undergoes an intricate morphogenetic
development and requires the proper specification and maintenance of dozens of
different cell types in order to function correctly. In the mature duct, an interplay between
mechanotransducing sensory hair cells, supporting pillar and Dieters' cells, and
generation of electrochemical potential by the stria vascularis are necessary to respond
to sound stimuli. We utilized exome and RNA-sequencing experiments combined with
mouse genetics in order to discover novel genes that play roles in cochlear
development and function. Exome sequencing of families with profound hearing loss
uncovered mutations in Epithelial Splicing Regulatory Protein 1 (ESRP1), a critical
regulator of alternative mRNA splicing. Analysis of Esrp1 mutant mice revealed a
shortened cochlear duct, delay in hair cell differentiation and maturation, and loss of the
stria vascularis due to inappropriate Fgf ligand usage, stemming from an alternatively
spliced receptor, in these cells. To identify additional regulators of inner ear development
we performed an RNA-seq experiment comparing the gene expression profiles of control
and Smoecko otic vesicles, which lack a cochlear duct. This generated a dataset of
hundreds of cochlear enriched transcripts including Growth Arrest Specific 2 (Gas2) a
cytoskeletal binding protein with the potential to act as a regulator of cochlear
development. We generated a Gas2 null mouse line and discovered that these animals
have severe hearing impairment likely due to defects in microtubule organization in the
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pillar cells. Taken together, these studies implicate Esrp1 and Gas2 as novel hearing
loss genes that regulate aspects of cochlear development and function.
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ABSTRACT 
DISCOVERING NOVEL HEARING LOSS GENES: ROLES FOR ESRP1 AND GAS2 IN 
INNER EAR DEVELOPMENT AND AUDITORY FUNCTION 
Alex M Rohacek 
Douglas J Epstein 
Hearing loss is the most common form of congenital birth defect, affecting an estimated 
35 million children worldwide. To date, nearly 100 genes have been identified which 
contribute to a deafness phenotype in humans, however, many cases remain in which a 
causative mutation has yet to be found. In addition, the exact mechanism by which 
hearing loss occurs in the presence of many of these mutations is still not understood. 
This is due, in part, to the complex nature of the development and function of the 
cochlear duct, the organ of hearing. The cochlea undergoes an intricate morphogenetic 
development and requires the proper specification and maintenance of dozens of 
different cell types in order to function correctly. In the mature duct, an interplay between 
mechanotransducing sensory hair cells, supporting pillar and Dieters’ cells, and 
generation of electrochemical potential by the stria vascularis are necessary to respond 
to sound stimuli. We utilized exome and RNA-sequencing experiments combined with 
mouse genetics in order to discover novel genes that play roles in cochlear development 
and function. Exome sequencing of families with profound hearing loss uncovered 
mutations in Epithelial Splicing Regulatory Protein 1 (ESRP1), a critical regulator of 
alternative mRNA splicing. Analysis of Esrp1 mutant mice revealed a shortened cochlear 
duct, delay in hair cell differentiation and maturation, and loss of the stria vascularis due 
to inappropriate Fgf ligand usage, stemming from an alternatively spliced receptor, in 
these cells. To identify additional regulators of inner ear development we performed an 
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RNA-seq experiment comparing the gene expression profiles of control and Smoecko otic 
vesicles, which lack a cochlear duct. This generated a dataset of hundreds of cochlear 
enriched transcripts including Growth Arrest Specific 2 (Gas2) a cytoskeletal binding 
protein with the potential to act as a regulator of cochlear development. We generated a 
Gas2 null mouse line and discovered that these animals have severe hearing 
impairment likely due to defects in microtubule organization in the pillar cells. Taken 
together, these studies implicate Esrp1 and Gas2 as novel hearing loss genes that 
regulate aspects of cochlear development and function. 
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Chapter 1: Introduction 
The inner ear 
 The inner ear is a multifunctional organ embedded in the temporal bone of the 
skull (Fig. 1.1A). The dorsal structures of the inner ear comprise the vestibular 
apparatus, a set of three semicircular canals (SCCs) and associated crista ampullaris 
that function in the detection of three-dimensional orientation of the head, while the 
utricle and saccule sense horizontal and vertical linear acceleration respectively 
(Fig.1.1B). The ventral structure of the inner ear is the coiled cochlear duct which 
functions in the sensing and translation of sound (Fig. 1.1B).  
Induction and patterning of the inner ear 
 The intricate structures of the inner ear arise from a simple, common otic 
precursor and undergo a complex series of morphological changes throughout 
embryogenesis (Cantos et al., 2000; Kopecky et al., 2012). Inner ear development 
begins with the specification of a pair of ectodermally derived placodes that form on 
either side of the neural tube at the level of the hindbrain between rhombomeres 4 and 6 
(Kopecky et al., 2012; Noramly and Grainger, 2002; Solomon and Fritz, 2002; Fig. 1.2A). 
Induction of otic placodes is first observed at Carnegie stage 9 (CS9; ~20 days post 
fertilization) in humans and embryonic day 8 (E8.0) in the mouse (Arnold and Lang, 
2001; Kikuchi and Hilding, 1965; Morsli et al., 1998; Toyoda et al., 2015). Experiments in 
the mouse and chicken have implicated members of the fibroblast growth factor (Fgf) 
signaling family as the initiators of otic development. Mouse knockouts of Fgf3 and 10 or 
Fgf3 and 8 demonstrate a complete failure in otic development, a phenotype 
recapitulated by loss of hindbrain Fgf3 in the chick (Alvarez et al., 2003; Ladher et al., 
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2005; Urness et al., 2010; Wright and Mansour, 2003; Yang et al., 2013; Zelarayan et 
al., 2007). An arrest of early inner ear morphogenesis is also seen in mouse mutants for 
Fgfr2, the receptor for Fgf3 and 10 (Pirvola et al., 2000). Conversely, ectopic expression 
of FGF ligands 3 and 10 in transgenic mice, or with Fgf8 and 19 soaked beads in 
chicken, leads to formation of additional, ectopic, otic placodes (Alvarez et al., 2003; 
Ladher et al., 2005). These findings reveal that FGF ligands 3, 8 and 10 (mouse) or 19 
(chick) emanating from the underlying mesenchyme and neural tube are critically 
required for otic placode formation. Induction of an otic fate causes the ectoderm to alter 
its gene expression profile. The activation of a number of transcription factors such as 
Eya1, Gata3, and Pax2 as well as signaling factors including Bmp7 have been observed 
to be some of the earliest definitive markers of otic identity (Lawoko-Kerali et al., 2002; 
Oh et al., 1996; Xu et al., 1999).  
After induction, the otic placodes form as epithelial sheets. These sheets then 
invaginate to form a cup shape and finally close at the dorsal surface to become a 
spherical vesicle, termed the otic vesicle, by CS13 in humans and E9.5 in mice (Arnold 
and Lang, 2001; Morsli et al., 1998; Toyoda et al., 2015; Fig. 1.2B). The otic vesicle is 
subsequently patterned across its dorsal-ventral (DV) and medial-lateral (ML) axes to 
create gene expression territories that will specify the adult structures of the inner ear 
(Fig. 1.2C-D).  
A multitude of experiments in mouse and chick have implicated signals 
emanating from the developing hindbrain as the primary effectors of DV pattering. The 
dorsal neural tube expresses ligands of the Wnt family while Sonic hedgehog (Shh) 
emanates from the ventral neural tube and notochord. The position of these morphogens 
medially to the otic vesicle places them in optimal range to function as patterning 
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mediators. In chick embryos in which the hindbrain has been ablated after otic induction, 
the final inner ear structure resembles a simple vesicle with no apparent patterning, 
revealing the critical requirement for the hindbrain in inner ear morphogenesis (Bok et 
al., 2005; Fig. 1.2C-D). Mice lacking both Wnt1 and Wnt3a demonstrate a lack of 
expression of dorsally restricted genes such as Dlx5 and 6 and Gbx2 (Riccomagno et 
al., 2005). Subsequently these mice fail to form any recognizable dorsal structures and 
lack a defined vestibular apparatus. A similar phenotype is observed in mouse mutants 
for these transcription factors with Dlx5, Dlx5/6 double, and Gbx2 mutants all displaying 
SCC morphogenesis defects (Acampora et al., 1999; Lin et al., 2005; Merlo et al., 2002; 
Robledo and Lufkin, 2006). Taken together, these results demonstrate the critical 
requirement of Wnt signaling in vestibular specification.  
In explant experiments in chick, excision and dorsal rotation of the hindbrain 
abolishes the expression of dorsal otic genes while simultaneously promoting expansion 
of ventrally restricted genes, such as Six1, into dorsal territories (Bok et al., 2005). A 
similar phenomenon is seen in transgenic mouse (ShhP1) and chick embryos where 
Shh is ectopically expressed in the dorsal otic vesicle. In ShhP1 embryos the inner ear is 
malformed, lacking most vestibular structures, and, in both these and Shh transfected 
chick embryos, ventrally restricted genes become expressed in the dorsal otic vesicle 
(Ohta et al., 2016; Riccomagno et al., 2002). This suggests that the ventral hindbrain 
specifies ventral fates, likely through Shh signaling, and that the otocyst at the vesicle 
stage is still largely plastic and not yet committed to its final patterning. 
Shh null mice demonstrate a nearly complete failure of otic development beyond 
the vesicle stage with the inner ear lacking most of its defining structure or gene 
expression profiles (Riccomagno et al., 2002). This extreme phenotype is thought to 
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largely be due to the combinatorial effects of Shh loss and an expansion of the Wnt 
signaling domain, which is normally restricted by Shh signaling within the neural tube. 
More sophisticated genetic approaches have revealed further roles for Shh signaling in 
inner ear development. Combinatorial deletion of the Gli family transcription factors, the 
downstream mediators of Shh signaling, results in shortened cochlear ducts with 
reduced expression of ventrally restricted genes such as Pax2 and Otx1 and 2 (Bok et 
al., 2007). Conditional deletion of the obligate Shh transducer Smoothened (Smo) within 
the otic vesicle leads to a complete failure in cochlear morphogenesis and loss of 
expression for almost all ventrally expressed genes (Brown and Epstein, 2011). This is 
phenocopied in chick experiments in which hybridoma cells expressing Shh neutralizing 
antibodies are injected near the hindbrain (Bok et al., 2005). Of note, in both of these 
cases the dorsal vestibular structures are largely normal and suffer no direct 
consequences from the loss of Shh signaling. These studies confirm that Shh signaling 
is required for the specification of the ventral otic vesicle and subsequent development 
of the cochlear duct. 
Morphogenesis of the vestibular apparatus and cochlear duct 
Following its initial patterning, the inner ear undergoes a complex series of 
morphogenetic events to arrive at the adult structure. The vestibular apparatus develops 
rapidly beginning at mouse E10.5 and human CS14 with the expansion and evagination 
of the dorsal otic epithelium to form the vertical and horizontal canal pouches. The three 
SCCs are sculpted from these pouches, the anterior and posterior SCCs from the 
vertical pouch and the lateral SCC from the horizontal, by a process of cell movements, 
apoptosis and resorption (Martin and Swanson, 1993). Proliferation of the surrounding 
mesenchyme forces the epithelium at the center of the pouch together where the cells 
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intercalate to form a single layered fusion plate (Haddon and Lewis, 1991; Pirvola et al., 
2004). The cells of the fusion plate then undergo apoptosis or are integrated into the 
lateral rim of remaining epithelium to form the final canal structure (Fekete et al., 1997; 
Martin and Swanson, 1993; Rakowiecki and Epstein, 2013). The resulting vestibular 
structure will undergo many days or weeks of refinement but is recognizably in its 
complete morphology by E14.5 or CS19. 
The formation of the SCCs is governed by a host of intrinsic and extrinsic factors. 
Expression of the laminin-related protein netrin 1 (Ntn1) at the fusion plate instructs 
these cells to undergo apoptosis and be resorbed. Ntn1 mutant mice demonstrate an 
excess of dorsal otic epithelium and an inability to form SCCs (Nishitani et al., 2017; 
Salminen et al., 2000). Wnt signaling has been implicated in canal morphogenesis 
through the regulation of Dlx5 and Ntn1 (Rakowiecki and Epstein, 2013). Inactivating 
canonical Wnt signaling in the ear through conditional deletion of the downstream 
transcriptional effecter β-catenin, after initial patterning, results in loss of Dlx5 expression 
and an expansion of Ntn1 throughout the canal epithelium. The expansion of Ntn1 leads 
to a loss of the anterior and posterior SCCs due to complete resorption of the vestibular 
epithelium. This implicates Wnt signaling maintaining Dlx5 as the instructive cue for cell 
maintenance in the presumptive horizontal and vertical SCCs. Mutants for the 
transmembrane protein Lrig3 show a complete resorption of the horizontal pouch and, 
thus, loss of the lateral SCC (Abraira et al., 2008). As Lrig3 expression in this canal is 
complementary to Ntn1, similar to Dlx5 in the horizontal and vertical pouches, it can be 
concluded that this factor is acting to maintain the cells that will give rise to the final 
SCC. 
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Extracellular signaling molecules of the bone morphogenic protein (Bmp), and 
Fgf families have also been shown to be critical for SCC morphogenesis. A number of 
Bmp ligands are expressed in the developing cristae of the SCCs including Bmp2, 4 and 
7. In experiments in chicken embryos, expression of exogenous Noggin, a potent Bmp 
antagonist, results in a failure of SCC formation (Chang et al., 2004a). Mice with inner 
ear specific deletion of Bmp4 also present with absent vestibular organs, demonstrating 
that Bmps are required for canal development (Chang et al., 2008). Fgfs have also been 
shown to influence canal morphogenesis through signaling to the surrounding 
mesenchyme. Mouse knockouts for Fgf9 display expanded vestibular pouches that fail 
to resorb into SCCs (Pirvola et al., 2004). This is due in large part to a defect in 
proliferation of the surrounding mesenchymal cells which leads to a failure to form a 
fusion plate. This failure to resorb phenotype is also seen in chick embryos treated with 
the Fgfr inhibitor SU5402, demonstrating the critical role for Fgf signaling in the canal 
sculpting process (Chang et al., 2004b). 
The morphogenesis of the cochlear duct is more prolonged than its vestibular 
counterpart, completing postnatally in mouse and by gestational week 18-20 in humans. 
The duct arises from a ventral evagination of the otic vesicle at E10.5 or CS14. The 
initiation and outgrowth of the cochlea is dependent on Shh signaling emanated from the 
ventral hindbrain, as described previously, as well as the expression of Eya1, Six1, and 
Pax2 within the otic epithelium (Brown and Epstein, 2011; Ozaki et al., 2004; 
Riccomagno et al., 2002; Xu et al., 1999; Zheng et al., 2003; Zou et al., 2006). Eya1 and 
Six1 function cooperatively as a transcriptional coactivator complex required for 
maintaining patterning and cell survival within the otic vesicle. Mouse mutants for these 
genes display strikingly similar phenotypes with arrest of otic development at the vesicle 
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stage and large-scale apoptosis of the inner ear epithelium (Ozaki et al., 2004; Xu et al., 
1999; Zheng et al., 2003). Pax2 is required for maintenance of cochlear outgrowth post-
initiation as evidenced by mouse knockouts that present with dramatically shortened 
cochleae due to apoptosis of Pax2 expressing cells during elongation (Burton et al., 
2004). Interestingly, experiments in which compound Eya1/Six1/Pax2 heterozygous 
animals were generated demonstrate that these factors function cooperatively in 
cochlear outgrowth with increasingly severe phenotypes seen with decreasing gene 
dosage (Zou et al., 2006). It remains unclear, however, if these interactions are direct or 
how they might interplay with other regulators of cochlear outgrowth, such as Shh 
signaling. 
The mature cochlear duct contains one and one-half turns in the mouse and two 
and one-half turns in the human. Following its initial outgrowth from the otic vesicle the 
developing cochlea extends medially, towards the neural tube, then loops in the anterior 
direction and begins to coil around the central spiral ganglia neurons between E12.5 and 
E18.5 (Cantos et al., 2000; Kopecky et al., 2012). These stages of cochlear elongation 
are dependent on convergent extension movements of sensory cells within the 
epithelium and will be discussed in detail in following sections.  
The structures of hearing 
 The internal organization of the cochlear duct is highly complex and specialized 
to allow for the sensation and transmission of sound information. In cross section, the 
duct is a hollow tube divided into three fluid filled chambers, from lateral to medial: the 
scala vestibuli, scala media and scala tympani, separated by epithelial membranes. The 
scala vestibuli and tympani contain perilymph, a fluid of low ionic concentration that 
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buffers the scala media. Within the scala media are the primary structures and cell 
types, as well as endolymph fluid, required for hearing (Fig. 1.3A).  
 Lining the medial wall of the scala media is the organ of Corti which contains the 
mechanosensory hair and underlying support cells which sit upon the basilar membrane 
and function in the transduction of sound (Pritchard, 1878; Fig. 1.3B). The hair cells 
develop from epithelial progenitors and take on neuronal properties allowing them to act 
as the sensors of sound. In mammals, the hair cells are organized into 4 stereotyped 
rows along the length of the cochlear duct. At the interior of the spiral a single row of 
inner hair cells (IHCs) act as the primary sound transducers while the more 
circumferentially located rows of outer hair cells (OHCs) function to intensify reception of 
low amplitude sound. A number of actin based microvilli like projections, referred to as 
stereocilia, coat the luminal surface of each hair cell in a chevron pattern. The stereocilia 
are connected to each other by specialized proteins at their tips and link to mechanically 
gated ion channels that open upon sound stimulation (Kachar et al., 2000; Fig. 1.5D).  
 Underlying and adjacent to the hair cells are a set of specialized cells, collectively 
called support cells, that have additional, likely indirect, roles in hearing (Fig. 1.3A-B). 
Sitting between the inner and first row of outer hair cells are a pair of pillar cells. The 
pillar cells are large, column shaped, microtubule rich, cells that form the sides of an 
open triangle, called the tunnel of Corti, that runs the length of the cochlea. The inner 
pillar cell (IPC) sits immediately adjacent to the row of IHCs and extends a “head” across 
the tunnel to connect to OHC row one. The outer pillar cell body lies adjacent to OHC 
row one, while its head underlies and supports that of the IPC and extends a process to 
connect with OHC row two. In the adult, the pillar cells are thought to act as structural 
supports for the tunnel of Corti given that the movement of the basilar membrane and 
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outer hair cells occurs at this point. Supporting this idea, the pillar cells are known to be 
rich in acetylated- and detyrosinated-tubulin, signs of highly stable microtubules, and 
display increased cellular stiffness when compared to neighboring hair cells (Arima et 
al., 1986; Slepecky et al., 1995; Szarama et al., 2012a; Tannenbaum and Slepecky, 
1997; Tolomeo and Holley, 1997). Experiments in gerbil cochlear explants and 
mechanical modeling have shown that the pillar cells move dynamically upon sound 
stimulation, likely placing these cells under shear and torsion stresses that must be 
endured for proper functioning (Chan and Hudspeth, 2005; Karavitaki and Mountain, 
2007; Nam and Fettiplace, 2010; Ni et al., 2016). 
Sitting below the OHCs are three rows of Deiters’ cells, morphologically complex 
cells that cup each OHC and send a long projection towards the luminal surface to 
create a barrier between the OHCs, preventing the diffusion of ions from the endolymph. 
Laterally to the OHCs and Deiters’ cells are the Hensen’s and Claudius cells. These 
simple, cuboidal epithelial cells function to recycle cations from the hair cells during 
mechanotransduction and preserve the ionic concentration of the endolymph. The entire 
organ of Corti sits between two acellular, gel-like, membranes, the basilar and tectorial 
membranes, which are comprised primarily of collagen and glycoproteins. The basilar 
membrane underlies the organ of Corti and bends in response to sound waves. The 
tectorial membrane extends from the greater epithelial ridge and lays on top of the hair 
cells providing the surface on which the stereocilia are deflected. 
 The lateral wall of the cochlear duct is comprised of Reissner's membrane, an 
epithelial sheet separating the scala media and vestibuli, and the stria vascularis (sv), a 
multilayered wall of cells responsible for generating the ionic concentrations in the 
endolymph (Locher et al., 2015; Patuzzi, 2011; Salt et al., 1987; Smith, 1957; Tasaki and 
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Spyropoulos, 1959; Fig. 1.3A,C). The stria vascularis is comprised of three layers, the 
outermost basal layer interacts with cells of the spiral ligament, sharing gap junctions 
claudin 11 (Cldn11) and Connexin 26 (Cx26), which bring potassium ions (K+) from the 
Hensen’s and Claudius cells back into the epithelium (Kitajiri et al., 2004; Xia et al., 
1999). The central, intermediate layer, contains capillaries surrounded by specialized 
melanocytes and the intrastitial fluid rich in chloride, potassium, and sodium ions. Cl- and 
Na+ diffuse from the blood while K+ is pumped in from the melanocytes through Kir4.1 
channels (Hibino et al., 1997). The inner most marginal layer lines the lumen of the 
cochlea and contains the rectifying ion channels, Barttin (Bsnd), sodium-potassium co-
transporter (Atp1A1), and sodium–potassium–chloride co-transporter (Nkcc1) on their 
basal and potassium voltage-gated channel subfamily Q member 1 (Kcnq1) on their 
luminal surface (Birkenhäger et al., 2001; Flagella et al., 1999; Neyroud et al., 1997; Xia 
et al., 1999; Fig. 1.3C). Atp1A1 and Nkcc1 draw K+, Na+ and Cl- from the intrastitial fluid 
into the cells. Atp1A1 and Barttin then balance and remove Na+ and Cl- from the 
marginal cells while Kcnq1 pumps K+ into the endolymph. This complicated orchestra of 
ion movements ultimately maintains the positive potential charge within the cochlear 
duct required for hearing (Fig. 1.3C). 
Development of cochlear sensory structures 
 The complex sensory and nonsensory structures of the cochlear duct arise from 
simple epithelial progenitors in the otic vesicle. The organ of Corti arises from the medial 
wall of the vesicle. Early sensory progenitors can be described as early as E10.5 as a 
buildup of cells in the medial wall epithelium that express the transcription factor Sox2 
and notch signaling components jagged (Jag1) and lunatic fringe (Lfng) (Kiernan et al., 
2005, 2006; Morsli et al., 1998; Pan et al., 2010; Fig. 1.4A). Mouse knockouts for Jag1 
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display a dramatic reduction in sensory cells while loss of Sox2 results in a complete 
absence of the organ of Corti (Kiernan et al., 2005, 2006). Furthermore, ectopic 
activation of these factors, particularly Sox2, has been shown to drive otic progenitors 
into a sensory fate (Liu et al., 2012a; Pan et al., 2013; Savoy-Burke et al., 2014). These 
experiments demonstrate both the necessity and requirement of these genes in sensory 
specification.  
 Following their specification and expansion, prosensory progenitors must exit the 
cell cycle in order to differentiate. Starting around E12.5, expression of p27kip1 beings in 
the sensory cells at the apical most extent of the cochlea and progresses towards the 
base, finishing around E14.5 (Chen and Segil, 1999; Kanzaki et al., 2006; Lee et al., 
2006; Fig. 1.4A). Timely initiation of p27kip1 expression is required for proper patterning 
of the organ of Corti as mouse knockouts demonstrate an overabundance of hair and 
support cells, as expected for the loss of a regulator of mitosis. Interestingly, hair and 
support cells do arise in these mutants and do appear to exit the cell cycle, albeit much 
delayed from WT counterparts, suggesting that timely expression of p27kip1 is required 
for generating proper cell numbers but not the ultimate differentiation of these cells. The 
factors governing the timing of cell cycle exit remain elusive, however, recent work has 
identified the RNA-binding protein Lin28b and microRNA (miRNA) let-7 as regulators of 
p27kip1 expression (Golden et al., 2015). In transgenic mice, overexpression of Lin28b 
results in a failure to express p27kip1 in a timely manner. The opposing phenotype, a 
more rapid cell cycle exit, is seen when let-7, a target for Lin28b repression, is 
overexpressed. This suggests that a critical timing window of expression for Lin28b and 
let-7 plays a key role in governing cell cycle exit in the cochlea, however, additional 
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factors must also be contributing as these models do not completely abrogate p27kip1 
expression or sensory differentiation. 
 Once the sensory progenitors have exited the cell cycle they rapidly begin to 
express differentiation markers and become specified as hair and support cells (Fig. 
1.4A). The expression of the basic helix-loop-helix (bHLH) transcription factor Atonal1 
Atoh1 (Math1) is the earliest marker of sensory differentiation and also progresses in a 
wave like manner along the length of the cochlear duct (Bermingham et al., 1999; Chen 
and Segil, 1999). Fascinatingly, this expression follows in inverse pattern to cell cycle 
exit, beginning in cells at the base around E14.5 and progressing apically until E16.5. 
Similarly to Sox2, Atoh1 knockout animals lack an organ of Corti as sensory cells fails to 
differentiate (Bermingham et al., 1999; Pan et al., 2011). Further, overexpression of 
Atoh1 is sufficient to drive presumptive support cells and cells expressing Sox2, such as 
in the greater epithelial ridge, into a hair cell fate (Kawamoto et al., 2003; Woods et al., 
2004; Zheng and Gao, 2000). 
 How Atoh1 expression is activated in a graded fashion in the cochlea has been a 
widely researched topic given its critical role in hair cell development (Fig. 1.4B). 
Experiments with inactivation and ectopic expression of Sox2 have shown that it is both 
necessary and sufficient for Atoh1 expression (Ahmed et al., 2012; Dabdoub et al., 
2008; Kempfle et al., 2016; Kiernan et al., 2005; Neves et al., 2012; Pan et al., 2013; 
Puligilla and Kelley, 2016). After its initial activation, Atoh1 becomes autoregulatory, 
binding its own promoter and activating its own transcription while becoming inhibitory to 
Sox2 (Helms et al., 2000). This incoherent feedback loop is required to generate a 
proper compliment of hair cells as it has been found that continued expression of Sox2 
also negatively regulates Atoh1. In a number of transgenic overexpression studies, Sox2 
13 
 
must be inactivated in order for hair cells to terminally differentiate as it inactivates 
downstream factors, such as Pou4F3, and prevents Atoh1 autoregulation (Ahmed et al., 
2012; Dabdoub et al., 2008; Kempfle et al., 2016; Puligilla and Kelley, 2016). The 
inhibitory role of Sox2 on Atoh1 is thought to be through the activation of Hey family 
transcription factors Hey1 and 2, which negatively regulate Atoh1. Mouse double 
knockouts for Hey1 and 2 exhibit a premature hair cell differentiation phenotype and 
recent work has shown these factors bind directly to the Atoh1 promoter element, 
repressing its transcriptional activity (Abdolazimi et al., 2016; Benito-Gonzalez and 
Doetzlhofer, 2014).  
Additional experiments have also implicated extracellular signaling from Shh and 
insulin-like growth factor (Igf) in Atoh1 regulation (Fig. 1.4B). Inactivation of Shh 
signaling after otic patterning, through deletion of Shh in the spiral ganglia neurons or 
Smo in the cochlear duct at E12.5, leads to premature hair cell differentiation (Bok et al., 
2013; Tateya et al., 2013). A similar phenotype is observed in animals that express a 
truncated, repressor form, of Gli3 which present with an expanded sensory epithelium 
and ectopic hair cells (Driver et al., 2008). Ectopic activation of Shh signaling through the 
use of a constitutively active Smoothened allele (SmoM2) or treating explants with Shh 
ligand results in the reverse phenotype of delayed differentiation (Driver et al., 2008; 
Tateya et al., 2013). In these transgenic experiments, as well as cochlear explants 
treated with Shh, activation of Hey1 and 2 was found, suggesting that Shh signaling is 
acting to repress Atoh1 by maintaining expression of its antagonists (Benito-Gonzalez 
and Doetzlhofer, 2014; Tateya et al., 2013). In addition to Shh, inhibition of Igf signaling, 
through deletion of its receptor, Igfr1, or pharmacological inhibition, also results in 
delayed hair cell differentiation and Atoh1 expression (Okano et al., 2011). In these 
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studies, it was discovered that Sox2 was significantly upregulated, likely impairing Atoh1 
expression, however a direct link between the Igf signaling pathway and Sox2 has yet to 
be described. 
Downstream of Atoh1, additional transcription factors, such as Brn3C/Pou4F1 
and Gfi1 are activated specifically in the hair cells to further their differentiation, 
maturation and are required for their survival (Erkman et al., 1996; Wallis et al., 2003; 
Xiang et al., 1997). Mature hair cells express a number of specialized proteins such as 
the non-muscle myosins, Myosin VI (Myo6) and Myosin VIIa (Myo7a), and tip link 
proteins connecting the stereocilia, protocadherin 15 and cadherin 23 (Avraham et al., 
1995, 1997; Hasson et al., 1995; Kazmierczak et al., 2007; Siemens et al., 2004). The 
timing of hair cell maturation in humans is estimated to complete by gestational week 20, 
coinciding with onset of hearing function, and postnatally in mice, which begin to hear at 
approximately 2 weeks of age.  
Support cells are specified from a subset of the Atoh1 expressing sensory cells 
and begin a separate developmental trajectory starting around E15.5. Future hair cells 
will begin to express notch signaling ligands Jag2 and Delta 1 (Dll1) which activates 
Notch 1 and downstream targets Hes1 and 5 in the neighboring cells (Lanford et al., 
1999; Zine et al., 2000; Fig. 1.4A). Deletion of Jag2, Dll1, Notch1, Hes1, and Hes5 lead 
to varying degrees, depending on the combination of factors, of hair cell overproduction 
at the expense of the support cells (Lanford et al., 1999; Tateya et al., 2011; Zheng et 
al., 2000; Zine and de Ribaupierre, 2002; Zine et al., 2000, 2001). This process of lateral 
inhibition, through Notch signaling, generates an alternating, “checkerboard”, pattern of 
presumptive hair and support cells. The Notch activated support cells then begin to 
express the transcription factor Prospero Homeobox 1 (Prox1) (Bermingham-McDonogh 
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et al., 2006). Interestingly, Prox1 mutants display only mild disruption of hair cell 
organization and support cell development, suggesting it is not absolutely required for 
their development (Fritzsch et al., 2010). Evidence from viral transduction experiments in 
cochlear explants revealed that ectopic expression of Prox1 led to a repression of Atoh1 
and Gfi1 and subsequent degeneration of OHCs (Kirjavainen et al., 2008). These data 
support a role for Prox1 as a repressor of hair cell fate rather than as an activator of the 
support cell lineage. 
Differentiation of support cell progenitors into pillar and Deiters’ cells has been 
shown to be dependent on Fgf signaling. Mouse knockouts for Fgf8, normally expressed 
in the IHC, and Fgfr3, expressed in the support cells, demonstrate similar phenotypes 
with a lack of support cell differentiation (Hayashi et al., 2007; Jacques et al., 2007a; 
Mueller et al., 2002). Interestingly, the Fgfr3 knockout animals also show a fate switch of 
the outer pillar cell into a Deiters’ cell, likely due to loss of responsiveness to additional 
Fgf ligands, such as Fgf10 expressed from the greater epithelial ridge, and 
demonstrates the strict requirement for exacting levels of Fgf signaling in support cell 
fate determination (Hayashi et al., 2007; Mueller et al., 2002). Further support for this is 
seen in mutants for Sprouty 2 (Spry2), an antagonist of Fgf signaling, and Fgfr3P224R, 
an activating mutation in Fgfr3 that renders it responsive to additional ligands (Mansour 
et al., 2009, 2013; Shim et al., 2005). These mutants result in an increased response to 
Fgf signaling and the transformation of Deiters’ cells into ectopic pillar cells. Strikingly, 
these phenotypes can be rescued by simply decreasing the amount of Fgf signaling 
through deletion of specific ligands, Fgf8 and Spry2 or Fgf10 and Fgfr3P224R in 
combination. Pillar cells continue to develop and mature until just before hearing onset, 
reaching their final morphology postnatally in mouse at approximately P7-10. The 
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complex arrays of microtubules that provide structural support for these cells begin to 
form early postnatally and extend in dynamic fashion from organizing centers at the 
apical and basal surfaces of the cells (Henderson et al., 1994, 1995; Mogensen et al., 
1997; Tucker et al., 1992, 1995). The acquisition of this microtubule network is 
associated with alterations in the mechanical properties of these cells, such that, their 
stiffness is increased over time (Szarama et al., 2012a, 2012b; Tolomeo and Holley, 
1997; Zetes et al., 2012). Finally, the tunnel of Corti opens between P10 and P12, just 
before hearing onset, and the pillar cells achieve their final morphology (Ito et al., 1995; 
Kraus and Aulbach-Kraus, 1981). 
Concomitant with their differentiation, hair and support cells undergo complex 
movements to arrive at their final positions and influence the extension of the cochlear 
duct. The most well studied of these movements require components of the planar cell 
polarity (PCP) pathway which polarizes cells and orients them against the plane of tissue 
extension. PCP components localize to the membrane of hair cells, Van Gogh-Like 2 
(Vangl2) is found on the proximal side of the cell while Cadherin EGF LAG Seven-Pass 
G-Type Receptor 1 (Celsr1) and Disheveled (Dvl) line the distal wall, and function to 
orient the stereociliary bundles (Etheridge et al., 2008; Montcouquiol et al., 2003, 2006; 
Torban et al., 2008; Wang et al., 2005, 2006). Recent work has also implicated an 
interaction between G-protein coupled signaling and orientation of the kinocilium 
regulated by the actions of Lgn, Bbs8, Itf29, and Daple to localize the cilium, as well as 
PCP and other signaling components (Bhonker et al., 2016; May-Simera et al., 2015; 
Siletti et al., 2017). Mutants for these genes exhibit similar phenotypes with misoriented 
hair cells and a shortened cochlear duct that contains a buildup of hair cells at the apical 
turn. This buildup of hair cells has long been attributed to defects in convergent 
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extension, a process by which cells migrate and reconfigure their junctions within the 
plane of elongation to drive the outgrowth of a tissue. Prosensory cells initially form as a 
multilayered, pseudostratified epithelium which resolves over time into the bilayered 
organ of Corti. Recent work has described how prosensory cells remodel their cell 
junctions into rosettes that resolve along the axis of elongation and that cell adhesion 
proteins of the cadherin family, E-cadherin, N-cadherin and P120-Catenin, are involved 
in both convergent extension and PCP (Chacon-Heszele et al., 2012; Driver et al., 
2017). Live cell imaging techniques have also found that hair and support cells undergo 
dynamic movements, extending long processes and crawling along the basement 
membrane, and that their apical migration is dependent on the cellular myosin motor, 
Myosin II (Driver et al., 2017). These results paint a complex picture of sensory 
development and cochlear elongation where PCP and convergent extension interact, 
and potentially regulate each other, to generate the adult structure. 
Development of the cochlear lateral wall 
Despite the critical requirement of the stria vascularis and Reissner’s membrane 
to hearing function, much less is known about their development when compared to the 
organ of Corti. Proper maintenance of endocochlear potential through sv function has 
been shown to be critical for both the sense of hearing as well as hair cell survival, with 
nearly all the sv mutants described here demonstrating degeneration of the organ of 
Corti (Ohlemiller et al., 2016; Neyroud et al., 1997; Rickheit et al., 2008; Tasaki and 
Spyropoulos, 1959; Salt et al., 1987). The three layers of the sv arise from unique origins 
and come together to form this complex tissue (Locher et al., 2015; Smith, 1957). The 
marginal layer is derived from otic epithelium along the lateral cochlear duct and is 
marked at around E15.5 by the expression of the nuclear receptor, Estrogen-related 
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receptor β (ERR-β; Nr3b2) (Chen and Nathans, 2007). Nr3b2 ear specific knockouts 
display defects in marginal cell differentiation and abnormal intermediate layers that fail 
to express critical ion channels, demonstrating that this factor is required for sv 
development but not its early specification. The intermediate cell layer is comprised 
primarily of neural crest derived melanocytes that interdigitate with the marginal cells 
and surround the intermingled capillaries to form an osmotic barrier (Freyer et al., 2011; 
Hilding and Ginzberg, 1977; Locher et al., 2015; Steel and Barkway, 1989). The exact 
timing of melanocyte recruitment has not been described but is known to be dependent 
on hepatocyte growth factor (Hgf) signaling through receptor tyrosine kinase, c-MET 
(Shibata et al., 2016). Loss of Hgf expression from the presumptive sv results in a failure 
to incorporate melanocytes into the intermediate cell layer. Mouse mutants for genes 
that regulate melanocyte development, such as Melanogenesis Associated Transcription 
Factor (MITF) and Pax3, as well as naturally occurring albino animals, also demonstrate 
breakdown in sv development and function from a lack of melanocytes (Tachibana, 
2001; Cable et al., 1992; Steel and Barkway, 1989; Tachibana et al., 1992; Kim et al., 
2014; Steel and Barkway, 1989). Finally, the basal cell layer develops from the 
surrounding periotic mesenchyme which condenses and takes on epithelial properties, 
eventually expressing gap junction proteins shared with the spiral ligament and ion 
transporters of the intermediate layer.  
Reissner’s membrane develops from a thin layer of epithelial cells on the 
cochlear lateral wall, immediately adjacent and lying between the organ of Corti and the 
sv. Mouse knockouts for Fgf10 display a complete absence of Reissner’s membrane 
with little effects on other regions of the cochlea, demonstrating a critical requirement for 
signaling from this Fgf ligand in Reissner’s development (Urness et al., 2015). A similar 
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failure to develop Reissner’s membrane is found in inner ear specific knockouts for the 
transcription factor Otx2, one of the earliest expressed genes on the cochlear lateral wall 
(Vendrell et al., 2015). Interestingly, ear specific Otx2 mutants also display profound 
defects in cochlear duct patterning with a duplicated, mirror image, organ of Corti and an 
expanded sv in the domain once occupied by Reissner’s membrane. Based on these 
data, it remains uncertain if Otx2 is required to specify Reissner’s membrane or if the 
loss of Reissner’s in these mutants is secondary to the failure to repress the domains of 
the sv and sensory cells. 
The sense of hearing and hearing loss 
 Sounds, at their core, are simply pressure waves that the ear detects and 
translates into electrical information that is transmitted to the brain. We measure sound 
by its amplitude, or loudness, in decibels (dB) and its frequency, or tone, in hertz (Hz). 
Humans can hear over a wide range of frequencies and intensities, from soft breathing 
at ~10Hz and 0dB to a loud siren at ~10kHz and 120dB. Interestingly, the hair cells at 
each region of the cochlear duct respond only to specific frequencies, with low frequency 
sound detected by cells at the apex and high frequency sound at the base, creating a 
tonotopic map along the length of the duct (Fig. 1.5B). The establishment of tonotopy is 
not entirely understood but is thought to arise from a combination of the properties of the 
sound waves themselves, with lower frequency sound traveling further along the 
cochlea, as well as increases in the length of OHC stereocilia and in the thickness and 
width of the basilar membrane towards the apex of the duct.   
Sound waves are collected by the outer ear and vibrate the tympanic membrane, 
colloquially called the ear drum, which translates the sound mechanically through the 
three middle ear bones, the incus, malleus, and stapes (Fig. 1.5A). The vibration of the 
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tympanic membrane moves the stapes in and out of the oval window, a small opening at 
the base of the cochlear duct, and causes pressure waves to resonate through the 
perilymph fluid, transmitting the sound into the cochlea. As the sound waves travel 
through the cochlea they displace the perilymph fluid and cause the basilar membrane to 
oscillate into the scala media (Fig. 1.5C). The oscillation of the basement membrane 
causes the hair cell stereocilia to push against the tectorial membrane, deflecting them 
and opening mechanically gated ion channels (Kazmierczak and Müller, 2012; Fig. 
1.5D). This results in an influx of K+ into the hair cell, depolarizing it and stimulating the 
release of neurotransmitter that signals to connecting neurons of the 8th cranial nerve.  
Hearing impairment and deafness are the most common forms of sensory deficit 
in the developed world. Loss of hearing function can arise in a multitude of ways. 
Exposure to loud noise, above 120dB, direct damage and infection, normal aging and 
genetic perturbations can all result in hearing loss (Furness, 2015; Venkatesh et al., 
2015). Congenital hearing impairment affects 1 in 500 newborns with approximately half 
of all cases in developed countries having a genetic etiology. Single gene mutations in 
over 100 different loci have been identified thus far (http://hereditaryhearingloss.org). 
Mutations in the majority of these genes result in nonsyndromic sensorineural hearing 
loss (SNHL), where abnormal inner ear function is the only diagnostic feature. These 
mutations affect nearly every aspect of hearing function from development of sensory 
cells (EYA1, POU4F3), hair cell function (MYO6, MYO7A), to maintenance of 
endocochlear potential (BSND, GJB2) (Atik et al., 2015; Raviv et al., 2010; Shearer et 
al., 1993; Weil et al., 1995). However, despite the large number of identified hearing loss 
genes, the cause of inherited SNHL remains uncertain in many cases (Mehta et al., 
2016; Sloan-Heggen and Smith, 2016). Thus, it is critical to continue to expand our 
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knowledge of inner ear development to better understand the factors that contribute to 
hearing and how their dysfunction may impact the form and function of this structure. 
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Figures 
 
Figure 1.1. The structures of the inner ear. (A) Paint fill of an E14.5 mouse embryo 
displaying the anatomy and location of the inner ear within the temporal bone of the 
skull. (B) Diagram of an inner ear as viewed from the posterior side with the anatomical 
structures labeled. Abbreviations: D (dorsal), V (ventral), P (posterior), A (anterior). 
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Figure 1.2. Inner ear morphogenesis and patterning. (A-D) Diagrams of mouse inner 
ear development as seen on transverse section through the hindbrain at indicated 
stages. (A) At E8.0 Fgf signals from the hindbrain and mesenchyme induce otic placode 
formation. (B) By E8.5 the placode invaginates to form an otic cup. (C) By E10.5, the otic 
cup closes at its dorsal surface and pinches off from the ectoderm to form an otic 
vesicle. Hindbrain Wnt and Shh signals pattern the vesicle into dorsal and ventral gene 
expression domains respectively. (D) Between E10.5 and E11.5 the otic vesicle begins 
to undergo a complex series of morphogenetic changes and alterations in gene 
expression that will give rise to the final, mature, inner ear structures. 
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Figure 1.3. The structure and cell types of the cochlear duct. (A) Diagram of a 
representative transverse view of an adult cochlear duct. (B). Schematic of the organ of 
Corti. (C) Schematic representation of the stria vascularis. Abbreviations: L (lateral), M 
(medial), Bv (blood vessel) and included Key.  
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Figure 1.4. Timing and regulation of factors critical for the development of the 
organ of Corti. (A) Diagrams of sensory development represented on an apical view of 
the cochlear duct and in transverse section. Colored circles represent sensory cells at 
the indicated time points along with genetic interactions. (B) Schematic of the gene 
regulatory network controlling hair cell differentiation. Dashed lines represent potentially 
indirect or unclear regulation. Abbreviations: inner hair cell (ihc), outer hair cells (ohc).
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Figure 1.5. The structures and mechanisms of hearing. (A) Diagram of the human 
external and internal auditory system. (B) Representative schematic of the cochlear duct 
displaying the range and localization of human hearing response. Changes in cell 
morphology and physiology that correlate with sound frequency response are indicated 
below. (C) Transverse view of the organ of Corti at rest and during movement of the 
basilar membrane by sound transduction. (D) Schematic of hair cell stereocilia before 
and during mechanical stimulation. Tip link proteins attached to the actin cytoskeleton 
(blue spheres) of the taller stereocilia connect to the MET channels and force them open 
upon deflection. Abbreviations: Hz (hertz), IHC (inner hair cell), OHC (outer hair cell), 
MET (mechanoelectrical transducer). 
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Chapter 2: ESRP1 mutations cause hearing loss due to defects 
in alternative splicing that disrupt cochlear development 
Introduction 
Alternative Splicing  
 While the genomic DNA encodes nearly all of the information required for the 
function of an organism it must be transcribed into a messenger RNA (mRNA) and 
subsequently translated into a protein in order to enact its coded function. The direct 
product of transcription is a pre-mRNA transcript which contains not only the protein 
coding information, exons, but also additional stretches of intervening base pairs, 
introns. To form a mature mRNA that can be translated into protein the introns must be 
removed via splicing and the exons joined. Alternative splicing is an additional 
posttranscriptional process that alters the exons which are retained between the pre- 
and mature mRNA. The multiple types of alternative splicing events can be roughly 
categorized as: cassette exons, where one or more exons are included or skipped, 
mutually exclusive exons, where neighboring exons are unique to separate transcripts, 
alternative 5’ or 3’ splice sites which extend the length of exons, and retained introns 
(Fig. 2.1B). These events allow for a single locus to encode for multiple RNAs and 
proteins, vastly increasing the complexity of a finite genome (Chen and Manley, 2009; 
Fu and Ares, 2014). Recent work has discovered that ~95% of all human multi-exon 
genes are alternatively spliced in a regulated manner, demonstrating that this is a nearly 
ubiquitous property of protein coding genes (Pan et al., 2008; Wang et al., 2008). 
 The process of alternative splicing revolves around the formation of the 
spliceosome, a large complex of small nuclear ribonucleoprotein particles (snRNPs) and 
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proteins that bind the pre-mRNA transcript at specific sequences and catalyze the 
splicing reaction (Barabino et al., 1990; Berglund et al., 1997; Bindereif and Green, 
1987; Black, 2003; Matlin and Moore, 2007; Zamore and Green, 1989). The reaction 
begins with the binding of the U1 snRNP to the 5’ splice site, splicing factor 1 (SF1) to 
the nucleotide which will provide the free hydroxyl group for the reaction and U2AF to 
the 3’ splice site. SF1 is then replaced by U2 and the U4/U6–U5 tri-snRNP complex is 
recruited to complete the spliceosome (Fig. 2.1A). Due to the relatively small size of 
exons compared to introns, ~150-200bp versus thousands respectively, the binding of 
these factors results in creating an exon definition where the sequence between U1 and 
U2 is the intron to be spliced out (Wang et al., 2012). Long distance interaction between 
the 5’ and 3’ splice site brings them into close proximity and the spliceosome complex 
catalyzes the splicing reaction to remove the intervening sequence and join the exons. 
 Alternative splicing generally occurs when factors enhance or interfere with the 
binding of U1 or U2 to their splice sites. Specialized RNA binding proteins are thought to 
be the primary mediators of the inclusion or exclusion of alternatively spliced exons 
based on their recruitment to cis acting elements in target transcripts (Bourgeois et al., 
1999; Chen and Manley, 2009; Fu and Ares, 2014). Alternative splicing regulators 
commonly contain at least one RNA recognition motif (RRM) that binds to specific 
sequences in the exons or flanking introns of target pre-mRNA transcripts. The binding 
of these factors can both enhance and inhibit splicing in a context dependent manner. 
Inhibition can occur through the binding of RRM containing proteins to the splice 
recognition site, hampering the spliceosome complex by steric hindrance of U1 or U2 or 
by direct inhibition its formation or function (Tange et al., 2001; Zhou and Lou, 2008). 
Enhancing splicing can be accomplished in a similar fashion, RNA binding proteins can 
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direct the spliceosome to specific sites or facilitate formation and function of the complex 
(Graveley et al., 2001; Wu and Maniatis, 1993). Additionally, binding of splice regulators 
can have position dependent effects where binding upstream of an exon represses its 
inclusion and binding downstream enhances inclusion.  
Epithelial Splicing Regulatory Proteins 
 Epithelial Splicing Regulatory Proteins (Esrp) are a family of RNA binding 
proteins, containing 3 RRMs, that are conserved from humans to C. elegans (Fig. 2.1C). 
Mammals possess two highly homologous Esrp genes, Esrp1 and Esrp2, which share 
80-90% sequence similarity in their RRM domains. The Esrps were originally 
characterized in a cell-based screen for regulators of an FGFR2 splicing event 
(Warzecha et al., 2009a, 2009b). FGFR2 has two primary isoforms, driven by the 
inclusion of the mutually exclusive IIIB or IIIC exons, which are expressed in a cell type 
specific manner and confer ligand binding preferences to the extracellular domain. 
Expression of ESRP1 or 2 cDNA in mesenchymal cells drove a switch from the IIIC to 
IIIB isoform of FGFR2, demonstrating the requirement for these genes in alternative 
splicing (Fig. 2.1D; Warzecha et al., 2009a, 2009b). Since their initial identification, 
additional genome wide studies in cell lines and mice have identified hundreds of Esrp 
dependent splicing targets (Bebee et al., 2015, 2016; Cieply et al., 2016; Dittmar et al., 
2012; Fagoonee et al., 2013). Esrp1 and 2 have been found to be partially functionally 
redundant, with many splicing events show a dose dependent response to loss of 
individual alleles of each gene (Bebee et al., 2015). These proteins bind to 6-mers of GU 
rich sequences in their target RNAs and both promote and repress splicing of all known 
event types in a position dependent manner (Bebee et al., 2015; Dittmar et al., 2012). 
Interestingly, the Esrps have also become a model for cell type specific splicing events 
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as their expression is restricted to epithelial tissues throughout development and 
adulthood (Bebee et al., 2015; Warzecha et al., 2009a, 2009b). 
 Due to their restricted expression, the Esrps have been heavily studied in the 
context of epithelial-to-mesenchymal (EMT) transition. Cells undergoing EMT drastically 
alter their morphology and gene expression profiles to accommodate their new identity. 
Recent work has found that Esrps are downregulated during EMT which promotes a 
switch to mesenchymal isoforms of alternatively spliced transcripts. In cell lines, 
knockdown of Esrps results in a mesenchymal like expression pattern but not a 
complete EMT and overexpression drives only a partial epithelial isoform splicing pattern 
(Göttgens et al., 2016; Warzecha and Carstens, 2012; Yang et al., 2016). Thus, it 
remains unclear if Esrps are drivers of EMT or an accessory pathway to assist in the 
transition. Esrp function has also been studied in the context of cancer given the 
contribution of an EMT component to tumor metastasis. ESRP1 was found to be 
downregulated in colorectal cancer samples and mutations have been found in patients 
with colitis and inflammatory bowel disease (Deloria et al., 2016; Jeong et al., 2017; 
Mager et al., 2017). Several studies have also suggested that ESRP1 can act as a tumor 
suppressor by inhibiting EMT and metastasis in pancreatic cancer, oral squamous cell 
and non-small cell lung carcinomas (Hayakawa et al., 2017; Ishii et al., 2014; Shapiro et 
al., 2011). The level of ESRPs must be tightly regulated, however, as overexpression of 
this gene has also been reported to increase the metastatic properties of breast and 
colorectal cancer cell lines and correlates with poor survival of breast and gastric cancer 
patients (Hayakawa et al., 2017). 
 Esrps, and the splicing programs they regulate, are also required during 
development. Loss of Esrp1 in mouse results in a fully penetrant cleft-lip and palate 
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phenotype and defects in kidney development that manifest as a spectrum from 
decreases in uretic branching and nephrons to complete kidney aplasia (Bebee et al., 
2015, 2016). Esrp2 is dispensable for development on its own, likely due to functional 
redundancy with Esrp1 (Bebee et al., 2015). Double knockouts for Esrp1 and 2 present 
with developmental defects in multiple organ systems in addition to the cleft-lip, palate 
and kidney defects seen in the single mutants (Bebee et al., 2015). These mice are 
severely reduced in size and weight and various epithelial organs are aplastic, including 
the lungs and salivary glands, and the thymus is severely reduced in size. Additionally, 
Esrp1/2 knockouts display forelimb agenesis with loss of multiple digits, the humerus 
and radius and a skin specific deletion shows barrier defects associated with reduced 
epidermal thickness and developmental defects. 
Rationale 
 Many mammalian tissues show cell type and stage specific expression of 
alternatively spliced transcripts that often fit into biologically coherent pathways (Bebee 
et al., 2015; Fu and Ares, 2014; Raj and Blencowe, 2015; Traunmüller et al., 2016; Ule 
et al., 2005; Vuong et al., 2016; Yang et al., 2016; Zhang et al., 2016). Consequently, 
mutations that disrupt either the cis or trans regulators of alternative splicing contribute 
significantly to human disease (Cieply and Carstens, 2015; Xiong et al., 2015), as well 
as hearing loss in mice (Moayedi et al., 2014; Nakano et al., 2012). While many of the 
key transcriptional regulators of cochlear development are known, the role that 
posttranscriptional events play in the formation of inner ear structures and cell types is 
less clear. A more comprehensive approach to the study of gene expression dynamics 
that integrates transcriptional and posttranscriptional mechanisms is likely to improve our 
fundamental understanding of inner ear biology and hearing loss. 
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 In the current study, we performed whole exome sequencing in individuals with 
profound bilateral SNHL and identified biallelic pathogenic mutations in ESRP1. Patient 
derived induced pluripotent stem cells (iPSCs) showed alterations in alternative splicing, 
consistent with a loss of ESRP1 function. To understand how mutations in ESRP1 might 
cause hearing loss we evaluated Esrp1-/- mouse embryos and uncovered defects in 
inner ear morphogenesis, auditory hair cell differentiation and cell fate specification 
along the lateral wall of the cochlear epithelium. RNA-seq analysis revealed impaired 
expression and splicing of genes associated with cochlear development and auditory 
function that explain several aspects of the inner ear phenotypes in Esrp1-/- embryos. In 
particular, aberrant splicing of Fgfr2 from the IIIb (epithelial) to IIIc (mesenchymal) 
isoforms compromised the identity of cells along the cochlear lateral wall due to 
improper Fgf9 ligand usage. Surprisingly, ectopic Fgf9/Fgfr2-IIIc signaling also 
compensated for the loss of Fgfr2-IIIB to promote cochlear duct morphogenesis in 
Esrp1-/- mutants. These findings implicate mutations in ESRP1 as a novel cause of 
SNHL and demonstrate the complex interplay between alternative splicing, inner ear 
development, and auditory function. 
Results 
Exome sequencing reveals ESRP1 mutations in a family with SNHL 
 An eight-year-old female with congenital profound bilateral SNHL, born to healthy 
non-consanguineous parents, was evaluated at the Division of Otolaryngology at the 
Children’s Hospital of Philadelphia (Fig. 2.2A). A temporal bone CT scan of the proband 
showed no abnormalities in cochlear morphology. However, an unusual vestibular 
dysplasia was revealed, consisting of a rudimentary lateral semicircular canal deficient in 
its central bony island that took on a cystic appearance (Fig. 2.3A-D). A 14-year-old 
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brother was also diagnosed with severe to profound bilateral SNHL from birth, and 
showed the same vestibular dysplasia as his sister (Fig. 2.3E-F). Despite the abnormal 
vestibular findings, neither child presented with balance or movement disorders. Four 
other healthy siblings, including the proband’s twin brother, have normal hearing (Fig. 
2.2A). No other family history of hearing loss was reported. 
 To identify damaging mutations associated with the inner ear phenotypes in this 
pedigree we performed whole exome sequencing on DNA isolated from peripheral blood 
of the parents, proband, affected brother and unaffected siblings. Coding region and 
splice site variants that segregated in an autosomal recessive inheritance pattern and 
that occurred with a population frequency less than 3% in the 1000 Genomes Project 
Database and Exome Sequencing Project Exome Variant Server were selected for 
further analysis. No pathogenic mutations in known SNHL genes were found using this 
approach. However, compound heterozygous mutations were identified in a novel 
candidate hearing loss gene, ESRP1, that segregated with SNHL in this family (Fig. 2.2A 
and Fig. 2.3G). The two children with SNHL inherited different ESRP1 mutations from 
each parent, while the unaffected siblings had either one or no mutations (Fig. 2.2A, Fig. 
2.3G). The paternal ESRP1 mutation harbors a 19 bp deletion in exon 7 (c.665_683 del) 
that is predicted to cause a frame shift at codon Asp222 resulting in premature 
termination of translation 31 amino acids downstream (p.Asp222Glyfs*32). The maternal 
ESRP1 mutation contains a missense variant in exon 8 (c.775C>G) that results in the 
substitution of leucine for valine (p.Leu259Val) at a highly conserved residue within the 
principle RNA recognition motif (Fig. 2.3G,H). An additional cohort of 144 probands with 
bilateral SNHL was screened for mutations in ESRP1 and ESRP2 by Sanger 
sequencing. While no homozygous or compound heterozygous variants were identified 
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in these genes, rare heterozygous missense substitutions in ESRP1 were found in three 
samples (Fig. 2.3I).  
 To determine the impact of ESRP1 mutations on alternative splicing we derived 
three independent iPSC lines from lymphoblastoid cells obtained from the parents and 
affected children in the pedigree (Fig. 2.2A). We first assessed the abundance of ESRP1 
and found it to be reduced by 50% at both the transcript and protein level in the father 
and affected children, compared to the mother (Fig. 2.2B,D). No differences in ESRP2 
expression were observed across individuals (Fig. 2.2B). The ESRP1 mRNA encoded 
by the mutant paternal allele is likely subject to nonsense-mediated decay due to the 
presence of a premature stop codon, accounting for its reduced expression. The 
paternal ESRP1 mutation is also predicted to be non-functional since it would lead to 
out-of-frame translation prior to the essential RRM domains (Fig. 2.2A). 
 We interrogated the effects of the paternal ESRP1 (c.665_683 del) allele in 
iPSCs from the proband by genetically repairing the mutation with the CRISPR-Cas9 
system.  A guide RNA specific to the mutant paternal ESRP1 allele was cloned into the 
pX330 expression vector and electroporated into iPSCs from the proband along with a 
single-stranded oligodeoxynucleotide (ssODN) template that was used to correct the 
paternal mutation by homology directed repair (Fig. 2.2C). Three independent iPSC 
clones were identified with the corrected ESRP1 paternal allele as assessed by Sanger 
sequencing (Fig. 2.2C). ESRP1 mRNA and protein levels were significantly increased in 
the genetically repaired iPSCs from the proband compared to the uncorrected iPSCs, 
and were similar to the unaffected mother (Fig. 2.2D,E). These results confirm the 
damaging effect of the paternal ESRP1 (c.665_683 del) mutation on its expression in 
iPSCs. 
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 The alternative splicing patterns of several known ESRP dependent events were 
evaluated in patient derived iPSCs by RT-PCR. The level of exon inclusion, quantified as 
percent spliced in (PSI), was significantly reduced for ENAH, NF2 and RALGPS2 and 
increased for ARHGEF11 in iPSCs from both affected children, compared to either 
parent (Fig. 2.2F-I). These alterations in alternative splicing were restored in the 
genetically repaired iPSCs from the proband, indicating their dependency on ESRP1. 
Not all ESRP dependent exons showed significant differences in splicing (e.g. SCRIB, 
MACF1, GRHL1), implying that some events are less sensitive to the loss of ESRP1 
than others (data not shown). The presence of ESRP2 in iPSCs is likely to explain the 
partial, and in some cases nonexistent, splicing switches in the affected children, 
consistent with the recent finding in mice that Esrp2 is able to compensate for the loss of 
Esrp1 in the splicing of some, but not all, regulated transcripts (Bebee et al., 2015). In 
support of this premise, we observed similar splicing switches in mouse embryonic stem 
cells with a targeted disruption in Esrp1 compared to iPSCs from the affected children 
(Fig. 2.2J). 
 To investigate the nature of the maternal ESRP1 (c.775C>G) mutation, we 
performed retroviral transduction of wild type and mutant cDNAs into the MDA-MB 231 
breast cancer cell line that does not express endogenous ESRP1 or ESRP2.  Inclusion 
of the epithelial ENAH exon and skipping of the OSBPL3 exon was significantly 
increased in the presence of wild type ESRP1 compared to the maternal missense allele 
(Fig. 2.2K,L). These findings further support the hypomorphic nature of the ESRP1 
(c.775C>G) mutation. 
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Defects in inner ear morphogenesis and auditory hair cell differentiation in  
Esrp1-/- mouse mutants 
 Our finding that human mutations in ESRP1 segregate with congenital hearing 
loss prompted us to investigate the role of Esrp1 during mouse inner ear development.  
Esrp1 is broadly expressed throughout the epithelium of the otic vesicle (E10.5) and is 
notably absent from the surrounding mesenchyme (Fig. 2.4A). Esrp1 continues to show 
unrestricted expression in sensory and nonsensory epithelial progenitors during cochlear 
and vestibular morphogenesis, although the level is weaker at later stages of inner ear 
development (Fig. 2.4B-E).  
 We evaluated Esrp1-/- embryos for defects in inner ear morphology using the 
paint fill technique. Alterations in the formation of cochlear and vestibular structures were 
observed in Esrp1-/- embryos compared to control littermates at E14.5, including a 
significant shortening and widening of the cochlear duct, as well as dysgenesis of the 
lateral semicircular canal and common crus due to incomplete resorption of the 
vestibular epithelium (Fig. 2.5A-D). This vestibular defect is similar to that described in 
children with ESRP1 mutations (Fig. 2.3A-F). A more severe inner ear phenotype 
consisting of fluid filled cysts with no vestibular or cochlear outgrowth was also observed 
at low penetrance in Esrp1-/- embryos (16%, 23/138) and will be discussed further below 
(Fig. 2.15A,B). 
 We next determined whether the loss of Esrp1 affects sensory development 
within the inner ear. The cochlear sensory epithelium was isolated from Esrp1-/- and 
control embryos at E18.5 and co-stained by whole mount for actin (phalloidin) to 
visualize stereocilliary bundles, and Myosin VIIa (Myo7a), a hair cell marker. Esrp1-/- 
embryos displayed a 25% decrease in total hair cell number that was primarily 
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accounted for by a near complete absence of hair cells at the apex of the cochlear duct 
(Fig. 2.5E-M and Fig. 2.6A,B,E-G). Prosensory progenitors marked by Sox2 were 
present in the requisite number at the apex of the cochlear duct of Esrp1-/- embryos at 
E18.5, indicating that the missing hair cells in this region are not explained by an 
absence of sensory progenitors (Fig. 2.7A-C).  
 Hair cells at the base and middle turn of Esrp1-/- embryos showed an immature 
morphology compared to control littermates as seen by the reduced complexity of 
stereociliary bundles (Fig. 2.4E-H). Support cells marked by Sox2 and Prox1 revealed a 
normal compliment of pillar and Dieter cells at the basal turn of Esrp1-/- embryos (Fig. 
2.5D-I). Moreover, vestibular sensory structures (maculae and cristae) were less 
affected by the loss of Esrp1 with only slight alterations in size, organization and 
innervation at E18.5 (Fig. 2.5J,K). These data reveal an intriguing cochlear phenotype in 
Esrp1-/- mutants consisting of a truncated cochlear duct with immature or absent hair 
cells. 
 We evaluated Esrp1-/- embryos one day later at postnatal day 0 (P0) to determine 
whether the hair cell phenotype was due to an arrest or delay in sensory development 
(Fig. 2.5N-V and Fig. 2.6C,D). Hair cell morphology at the base and middle turns of  
Esrp1-/- mutants appeared more advanced at P0 than at E18.5, with a notable 
improvement in stereocilia bundle morphology that was comparable to control pups at 
this stage (Fig. 2.5N-Q). Whereas the total number of hair cells was reduced in Esrp1-/- 
compared to control embryos after normalizing for cochlear duct length at E18.5, this 
difference was no longer apparent at P0 (Fig. 2.6H). This finding may be explained by 
the continued differentiation of Myosin VIIa positive hair cells at the apex of the cochlear 
duct of Esrp1-/- mutants between E18.5 and P0 (Fig. 2.5I,J,M,R,S,V), which occurred in 
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the absence of further elongation of the cochlear duct (Fig. 2.6C-H). Unfortunately, 
Esrp1-/- mutants die soon after birth due to complications from cleft lip and palate 
defects, preventing their analysis at later postnatal ages (Bebee et al., 2015). These 
data suggest that the sensory phenotype in Esrp1-/- mutants is due, in part, to a temporal 
delay in auditory hair cell development. 
Esrp1 regulates the timing of hair cell differentiation  
 To identify gene expression networks that are disrupted in Esrp1-/- mutants we 
performed RNA-seq from purified cochlear epithelium at E16.5. Three biological 
replicates from Esrp1-/- and control littermates were sequenced to a depth of  
40-60 million reads and mapped to the mouse genome. Our analysis revealed 751 
genes (341 upregulated, 410 downregulated) that were differentially expressed between 
control and Esrp1-/- mutants (fold change ≥0.4, p<0.05, Fig. 2.8A). Gene ontology terms 
associated with inner ear morphogenesis, ion transport, sensory perception of sound, 
and auditory receptor cell differentiation showed a significant enrichment of differentially 
expressed genes as revealed by the DAVID 6.8 analysis tool (Fig. 2.8B; Huang et al., 
2009).  
 We further grouped the list of differentially expressed genes into sensory and 
nonsensory categories based on their published expression patterns (Fig. 2.8C). Two of 
the sensory genes that were downregulated in Esrp1-/- embryos, Atoh1 and Pou4f3, 
stood out because of their essential roles in regulating hair cell differentiation and 
maturation (Bermingham et al., 1999; Erkman et al., 1996; Xiang et al., 1997). Atoh1 
transcription initiated properly at the base and mid-base levels of the cochlea in Esrp1-/- 
embryos, but was delayed by approximately 48 hours at the apex (Fig. 2.9A-F; Fig. 
2.10A-X; Table S2). On the other hand, Pou4f3 expression was delayed at all levels of 
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the cochlear duct in Esrp1-/- embryos by approximately 24 hours (Fig. 2.9G-L; Fig. 
2.10Y-AP; and Table S2). No differences were observed in the expression of Sox2 or 
P27kip1 in prosensory progenitors along the cochlear duct of Esrp1-/- and control 
embryos, suggesting that the delay in hair cell differentiation was not associated with 
alterations in the specification or cell-cycle exit of sensory progenitors at earlier stages 
(Fig. 2.7L-O).  
 A previous study implicated the Hey family of bHLH transcription factors as 
negative regulators of Atoh1 (Benito-Gonzalez and Doetzlhofer, 2014). We examined 
Hey1 and Hey2 in sensory progenitors by in situ hybridization and observed a consistent 
upregulation in Hey2 at the mid and apex regions of the cochlear duct of Esrp1-/- 
embryos at E16.5, a stage when Hey2 transcription is typically downregulated (Fig. 
2.9M-R).  No obvious change in Hey1 expression was detected (Fig. 2.10AQ and data 
not shown). Attempts to validate these results by qRT-PCR revealed a trend for 
increased expression of Hey2 that did not reach statistical significance (Fig. 2.10AQ, 
Table S2). The discrepancy in these results might be explained by the dynamic and 
graded nature of Hey2 expression along the developing cochlear duct at this stage. 
Hey2 has also been shown to be modulated by Shh signaling (Benito-Gonzalez and 
Doetzlhofer, 2014). However, we found no changes in Gli1 expression between Esrp1-/- 
and control embryos by in situ hybridization or qRT-PCR at E14.5 or E16.5, suggesting 
that elevated Shh signaling is unlikely to account for the increase in Hey2 expression in 
Esrp1-/- embryos (Fig. 2.10AQ, Table S2, and data not shown). 
 We also observed a failure to downregulate Sox2 in Esrp1-/- hair cells at P0 (Fig. 
2.9S-X), which is known to be associated with delays in sensory maturation (Puligilla 
and Kelley, 2016). These data suggest that an imbalance in the expression of negative 
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regulators of sensory development (Hey2 and Sox2) may underlie the delay in hair cell 
differentiation in Esrp1-/- embryos (Fig. 2.9Y). Although, the possibility also exists that the 
upregulation of Sox2 and Hey2 is a consequence rather than a cause of the sensory 
delay.  
Esrp1 regulates the fate of nonsensory cells along the lateral cochlear wall  
 Genes in the nonsensory category displayed greater fold changes in expression 
between Esrp1-/- and control embryos than did the sensory genes (Fig. 2.8C). The most 
downregulated transcripts in the cochlea of Esrp1-/- mutants encode for ion channel 
subunits (Bsnd, Kcnq1) and the Estrogen related receptor beta (Nr3b2/Esrrβ) 
transcription factor that regulates their expression (Fig. 2.8C and Table S2). Each of 
these genes is expressed in marginal cells of the stria vascularis and cause hearing loss 
when mutated in humans and mice due to altered ion homeostasis in the endolymph  
(Chen and Nathans, 2007; Collin et al., 2008; Lee et al., 2000; Neyroud et al., 1997; 
Rickheit et al., 2008; Schlingmann et al., 2004). Of note, hearing loss genes were 
significantly enriched in the overall set of differentially expressed transcripts between 
Esrp1-/- and control embryos (Fig. 2.8D). These findings prompted us to investigate the 
integrity of the stria vascularis in Esrp1-/- embryos. 
 We stained the lateral wall of the cochlear epithelium with E-cadherin and 
observed a pronounced expansion of cells with a flattened epithelial morphology 
characteristic of Reissner’s membrane, and a complete absence of cuboidal shaped 
marginal cells in Esrp1-/- compared to control embryos at E16.5 (Fig. 2.11A,D). 
Consistent with this change in epithelial morphology, we observed a three-fold increase 
in the number of cells expressing Otx2, a marker of Reissner’s membrane, and a 
dramatic reduction of Nr3b2 positive marginal cells in Esrp1-/- compared to control 
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embryos (Fig. 2.11B,C,E-G).  This phenotype resulted in a two-fold net gain in the 
number of cells within the lateral wall of the cochlear epithelium and likely explains the 
widened cochlear duct in Esrp1-/- embryos.  
 At E18.5, the lateral cochlear epithelium of Esrp1-/- embryos was highly 
dysmorphic compared to controls with an expanded and partially collapsed Reissner’s 
membrane and no morphological evidence of marginal cells (Fig. 2.11H,O). Several key 
proteins marking distinct cell layers of the stria vascularis, including marginal cells 
(Kcnq1, Barttin), intermediate cells (Atp1a1, CD44), basal cells and fibrocytes (Atp1a1, 
Claudin-11, Connexin-26/GJB2) were reduced or absent in Esrp1-/- embryos (Fig. 2.11I-
N,P-V). Taken together, these data suggest that the identity of cells along the lateral wall 
of the cochlear epithelium has been altered in Esrp1-/- mutants resulting in a gain in 
Reissner’s membrane at the expense of marginal cells. 
Altered splicing of Fgfr2 is responsible for the lateral cochlear wall defects in 
Esrp1 mutants 
 To define and quantify the differential splicing events between Esrp1-/- and 
control embryos that might explain unique aspects of the cochlear phenotype we 
analyzed the RNA-seq dataset from E16.5 cochlear epithelium using the MAJIQ 
algorithm (Vaquero-Garcia et al., 2016). This analysis uncovered 518 splicing alterations 
in mRNA transcripts from 490 different genes with a change in percent spliced in (ΔPSI) 
value of at least 10% (Fig. 2.12A and Table S1). Several of the genes that are 
dependent on Esrp1 for proper splicing have known roles in inner ear development and 
in some cases cause hearing loss in humans when mutated (Fig. 2.12B,C).   
 A switch in the epithelial to mesenchymal splicing pattern was confirmed by 
semi-quantitative RT-PCR analysis for 20 of these altered transcripts, consistent with the 
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premise that Esrp1 regulates an epithelial specific splicing program (Fig. 2.12D,E). Fgfr2 
exhibited the most dramatic change in PSI from 78% in control embryos to 7% in Esrp1-/- 
mutants (ΔPSI=71, Fig. 2.12B,C,F). Instead of expressing the Fgfr2-IIIb isoform typical 
of control cochlear epithelial cells, Esrp1 mutants inappropriately expressed the 
mesenchymal Fgfr2-IIIc isoform. This aberrant splicing switch in Fgfr2 is predicted to 
alter its binding specificity to Fgf ligands (Zhang et al., 2006).  
 The formation of Reissner’s membrane is dependent on Fgf10, which normally 
signals through Fgfr2-IIIb (Urness et al., 2015). This raises the question of how 
Reissner’s membrane might be expanded in Esrp1-/- mutants given the near complete 
replacement of Fgfr2-IIIb with Fgfr2-IIIc, an isoform that does not respond to Fgf10 
(Zhang et al., 2006). It is unlikely that another Fgfr is compensating for the loss of Fgfr2-
IIIb, since Fgfr1 and Fgfr3 predominantly express the IIIc isoform in the cochlear 
epithelium of wild type and Esrp1-/- embryos (Fig. 2.12F). Instead, we propose that 
ectopic signaling through a different Fgf ligand with affinity for Fgfr2-IIIc is mediating the 
expansion of Reissner’s membrane and subsequent loss of the stria vascularis in  
Esrp1-/- mutants. Fgf9 is an excellent candidate to be fulfilling this role given its 
expression in lateral cochlear wall progenitors and its ability to signal through Fgfr2-IIIc 
in the periotic mesenchyme (Fig. 2.13A,B,E,F; Pirvola et al., 2004; Zhang et al., 2006). 
In support of this model, ectopic expression of Fgf signaling effectors, Etv4 and Etv5, 
was observed along the lateral cochlear epithelium in Esrp1-/- embryos, concomitant with 
the expansion of Otx2 positive Reissner’s membrane (Fig. 2.13C-N). 
 To test the hypothesis that aberrant expression of Fgfr2-IIIc in Esrp1-/- embryos 
causes a gain in Fgf9 signaling within the lateral cochlear epithelium, we generated 
Esrp1-/-; Fgf9+/- compound mutants and observed a significant retraction of Reissner’s 
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membrane (Otx2) and recovery of marginal (Nr3b2, Kcnq1, Barttin), intermediate (Cd44) 
and basal (Atp1a1) cell identities at E18.5 (Fig. 2.14A-V). Esrp1-/-; Fgf9+/- compound 
mutants also showed a reduction in the ectopic expression of Etv4 and Etv5 (Fig. 2.13O-
T). These results support our model that ectopic Fgf9 signaling through an aberrantly 
spliced Fgfr2-IIIc isoform is responsible for the cell fate switch between Reissner’s 
membrane and marginal cells in Esrp1-/- mutants (Fig. 2.14W). 
Ectopic Fgf9/Fgfr2-IIIc signaling compensates for the loss of Fgfr2-IIIb to promote 
cochlear morphogenesis in Esrp1-/- mutants 
 Surprisingly, 46% (6/13) of Esrp1-/-; Fgf9+/- embryos also exhibited a cystic inner 
ear with no obvious vestibular or cochlear outgrowth (Fig. 2.15C). This phenotype is 
remarkably similar to that observed in 16% of Esrp1-/- mutants, as well as mouse 
embryos that specifically lack the Fgfr2-IIIb (epithelial) isoform (Fig. 2.15A-C; Pirvola et 
al., 2000). An important distinction between the Fgfr2-IIIb deletion line (De Moerlooze et 
al., 2000; Pirvola et al 2000) and Esrp1-/- mutants is that Fgfr2 expression is altogether 
absent in the otic epithelium of Fgfr2-IIIb mutants, but is present in the otic epithelium of 
Esrp1-/- embryos, albeit as the Fgfr2-IIIc (mesenchymal) isoform. This finding raises the 
intriguing possibility that Fgf9/Fgfr2-IIIc signaling is also compensating for other Fgfr2-
IIIb dependent functions at earlier stages of inner ear morphogenesis. Consistent with 
this premise, all Esrp1-/-; Fgf9-/- double mutants examined (n=3) displayed cystic inner 
ears (Fig. 2.15D). Given that Fgf9 is normally dispensable for cochlear duct outgrowth 
(Pirvola et al., 2004), we attribute the fully penetrant cystic inner ear phenotype in  
Esrp1-/-; Fgf9-/- mutants to the loss of ectopic Fgf9/Fgfr2-IIIc signaling at early stages of 
inner ear development. 
 
44 
 
Discussion 
 We performed whole exome sequencing and identified mutations in ESRP1 that 
segregate with SNHL in a human pedigree. This finding represents the first known 
instance of mutations in a tissue specific regulator of alternative splicing being implicated 
in human deafness. Our analysis of inner ear phenotypes in Esrp1-/- mouse embryos 
revealed possible pathogenic mechanisms for hearing loss, including defects in cochlear 
duct morphogenesis, auditory hair cell differentiation and marginal cell fate specification. 
However, the phenotypes observed in Esrp1-/- mouse embryos may not all occur with the 
same severity in affected children from the pedigree given that one of their mutant 
ESRP1 alleles (p.Leu259Val) is hypomorphic, as indicated by its reduced, but not 
absent, alternative splicing activity in patient derived iPSCs and other cell based assays. 
This residual ESRP1 function may have protected the affected children from cleft-lip and 
palate, which occurs in all Esrp1-/- newborn pups (Bebee et al., 2015). We therefore 
recommend that cases of congenital SNHL that are co-morbid with cleft-lip and palate be 
screened for mutations in ESRP1. 
 The most pronounced changes in gene expression within the cochlear duct of 
Esrp1-/- and control embryos were detected in nonsensory cells of the lateral cochlear 
epithelium. The expanded expression of Otx2 within Reissner’s membrane, and the 
absence of Nr3b2 expression in marginal cells of the stria vascularis suggested that the 
identity of these cells had been severely compromised in Esrp1-/- embryos. This 
represents a unique phenotype in the inner ear as no other mutation has been described 
that completely abrogates formation of the stria vascularis. Nr3b2 is required for the 
expression of many ion channels and transporters that generate the high concentration 
of potassium ions in the endolymph, which is critical for hair cell mechanotransduction 
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(Chen and Nathans, 2007). Several of these Nr3b2 dependent genes cause hearing loss 
when mutated and are downregulated in Esrp1-/- embryos.  Thus, the reduced 
expression of Nr3b2, or any one of its essential transcriptional targets, is expected to 
cause severe hearing impairment in humans with mutations in ESRP1.  
 Alterations in marginal cell identity may also explain some of the non-cell 
autonomous phenotypes observed in Esrp1 mutants. Release of the Hepatocyte growth 
factor (Hgf) signal from marginal cells to its c-Met receptor on neural crest cell derived 
melanocytes is required for their recruitment to the intermediate cell layer of the stria 
vascularis (Shibata et al., 2016). Consequently, the loss of Hgf expression in Esrp1-/- 
embryos is likely responsible for the reduced number of intermediate cells. 
 Marginal cells are more severely affected in Esrp1-/- compared to Nr3b2-/- 
mutants, suggesting that other important determinants of their identity must also be 
misregulated in Esrp1-/- mutants. The expansion of Otx2 into the presumptive marginal 
cell territory in Esrp1-/- embryos represents the best explanation for why these cells failed 
to form. In wild type embryos, Otx2 is initially broadly expressed along the lateral wall of 
the cochlear duct at E13.5, including precursors of marginal cells and Reissner’s 
membrane. Otx2 expression is then downregulated from the marginal cell territory by 
E15.5, coincident with the onset of Nr3b2, but continues to be expressed in Reissner’s 
membrane. We propose that Otx2 regulates the timing of marginal cell development 
through a de-repression mechanism, whereby Otx2 expression must be extinguished 
from marginal cell progenitors in order for their development to proceed. In agreement 
with this model, a recent study demonstrated that mice lacking Otx2 in the inner ear 
showed ectopic expression of marginal cell markers along the entire lateral wall of the 
cochlear duct (Vendrell et al., 2015). Moreover, reduction of ectopic Otx2 expression in 
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the marginal cell territory of Esrp1-/-;Fgf9+/- embryos coincided with the recovery of the 
stria vascularis. These data indicate that the dynamic expression of Otx2 along the 
cochlear lateral wall is important for regulating the developmental fates of marginal cells 
and Reissner’s membrane.  
 Reissner’s membrane does not form in Fgf10-/- embryos (Urness et al. 2015). A 
similar phenotype might have been expected in Esrp1-/- mutants given the aberrant 
splicing of Fgfr2, which reduces the abundance of Fgfr2-IIIb, the high affinity Fgf10 
receptor (Zhang et al., 2006). Surprisingly, Reissner’s membrane still developed in 
Esrp1-/- embryos, albeit through an alternative signaling mechanism that benefitted from 
the ectopic expression of Fgfr2-IIIc in the cochlear epithelium and Fgf9, a ligand that 
normally signals to the otic mesenchyme and is mostly dispensable for cochlear but not 
vestibular development (Pirvola et al., 2004). However, a major consequence of utilizing 
Fgf9/Fgfr2-IIIc to compensate for Fgf10/Fgfr2-IIIb is the gain in signaling strength that 
results in expansion of Reissner’s membrane at the expense of marginal cells. Our study 
adds to the list of genetic disorders (e.g. Apert syndrome, Muenke syndrome) caused by 
a gain in Fgf signaling that results from alterations in Fgfr ligand-binding interactions 
(Mansour et al., 2013; Yu et al., 2000). 
 Fgfr2-IIIb is also required at early stages of inner ear morphogenesis as 
evidenced by the cystic inner ear phenotype displayed by embryos in which the Fgfr2-
IIIb isoform was selectively deleted (Pirvola et al., 2000).  Fgf3 and Fgf10 are the ligands 
that signal predominantly through Fgfr2-IIIb to promote early aspects of inner ear 
development (Alvarez et al., 2003; Wright and Mansour, 2003). One might expect cystic 
inner ears to be more prevalent in Esrp1-/- mutants given the depletion of Fgfr2-IIIb, 
however, only 16% of these embryos showed this phenotype. This observation raised 
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the possibility that Fgf9/Fgfr2-IIIc signaling is also compensating for other Fgfr2-IIIb 
dependent functions at earlier stages of inner ear development in Esrp1 mutants. In 
support of this hypothesis, the removal of an allele of Fgf9 from the Esrp1-/- background 
(Esrp1-/-; Fgf9+/-) increased the penetrance of the cystic inner ear phenotype to almost 
50%, whereas, 100% of Esrp1-/-; Fgf9-/- double mutants displayed cystic inner ears. 
These results indicate that dose dependent signaling through Fgf9/Fgfr2-IIIc is able to 
compensate for the loss of Fgfr2-IIIb to promote inner ear morphogenesis in Esrp1-/- 
mutants. This remarkable example of genetic compensation highlights the tremendous 
flexibility in Fgf signaling activity brought about by alternative splicing of receptor 
isoforms and the numerous genetically encoded ligands that bind to them.  
 Esrp1-/- embryos also displayed a marked decrease in the number of 
differentiated hair cells at the apex of the cochlear duct. This phenotype was attributed to 
a 48-hour delay in the onset of Atoh1 at the apical turn. Hair cell maturation was also 
delayed at the base and mid-base levels of the cochlear duct of Esrp1-/- embryos, but at 
a step downstream of Atoh1, as indicated by the 24-hour lag in Pou4f3 expression.  
Sensory progenitors depend on the input of multiple signaling pathways to coordinate 
the expression of a set of transcriptional activators and repressors, the balance of which 
dictates the timing of Atoh1 transcription along the cochlear duct (Cai and Groves, 2015; 
Neves et al., 2013; Okano et al., 2011). The prevailing model stipulates that Sox2 
functions through an incoherent feed forward loop to both directly activate Atoh1 
transcription but also to promote the expression of Atoh1 repressors, including Hey1, 
Hey2 and Id1-3 (Neves et al., 2013; Benito-Gonzalez and Doetzlhofer, 2014). Once 
Atoh1 accumulates to a point where it can maintain its own expression, Sox2 is 
downregulated, so that its blockade on Atoh1 and other downstream components of the 
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hair cell differentiation program can be released (Ahmed et al., 2012; Dabdoub et al., 
2008; Neves et al., 2013; Puligilla and Kelley, 2016). Based on this model (Fig. 2.9Y), it 
is likely that the upregulation in Hey2 mRNA and Sox2 protein that we observed in 
sensory progenitors and hair cells, respectively, impedes Atoh1 expression and 
transcriptional activity, causing the delay in hair cell differentiation in Esrp1-/- embryos. 
Alternatively, the altered expression of Hey2 and Sox2 may be a secondary 
consequence of the delayed sensory development in Esrp1-/- embryos. 
 The aberrant splicing of one or more transcripts expressed within the sensory 
epithelium of the cochlear duct may contribute to the misregulation of Hey2 and Sox2 in 
Esrp1-/- embryos, although the identity of these transcripts remains to be determined. 
Esrp1 has also been shown to antagonize Sox2 translation by limiting the available pool 
of Sox2 transcripts for loading onto polysomes (Fagoonee et al., 2013). Future 
experiments will determine the precise mechanism responsible for the delay in hair cell 
differentiation in Esrp1-/- embryos and the consequence that this phenotype has on 
auditory function.  
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Figures 
 
Figure 2.1. Alternative splicing and epithelial splice regulatory proteins. (A) 
Schematic of spliceosome assembly on an mRNA transcript. (B) Representations of 
possible alternative splicing events. (C) Diagrams of Esrp proteins in selected species, 
amino acid conservation of RNA recognition motifs (RRM) are listed below the 
respective domains. (D) Schematic of the Fgfr2 splicing event directed by Esrp and 
resulting receptor-ligand interactions. 
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Figure 2.2. ESRP1 mutations segregate with SNHL and disrupt alternative splicing.  
(A) Pedigree with SNHL showing segregation of maternal (blue) and paternal (red) 
ESRP1 mutations to affected (compound heterozygous) and unaffected offspring. The 
position of the ESRP1 frameshift (p.Asp222Glyfs*32) and missense (p.Leu259Val) 
mutations is indicated. (B) Quantitative RT-PCR of ESRP1 and ESRP2 mRNAs from 
iPSCs derived from parents and affected children. (C) Schematic and sequencing tracks 
for CRISPR-Cas9 gene editing strategy to repair the paternal ESRP1 (c.665_683 del) 
mutation. (D) Bar graph and gel image of western blot for ESRP1 from patient derived 
iPSCs and corrected proband (cP). (E) Quantitative RT-PCR of ESRP1 mRNA from 
iPSCs comparing corrected to uncorrected proband and mother. (F-I) Bar graphs and 
gel images of radioactive RT-PCR results showing PSI values for ESRP1 dependent 
alternative splicing events in patient-derived iPSCs and corrected proband. (J) Graph of 
RT-PCR dependent alternative splicing events in mouse ESCs (Bar represents average 
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for two independent clones). (K,L) Bar graphs and gel images of radioactive RT-PCR 
results showing PSI values for ESRP1 dependent splicing events in MDA-MB-231 cells 
transduced with ESRP1 wild type (WT), ESRP1 mutant (p.Leu259Val) and EGFP 
cDNAs at three different titers. Abbreviations: Mother (M), Father (F), Proband (P), 
Affected brother (AB), CRISPR-Cas9 corrected Proband (cP), Percent Spliced In (PSI), 
epi (epithelial isoform), mes (mesenchymal isoform), ns (not significant). Graphs for B 
and E represent mean ± SE, D and F-I,K,L represent mean ± SD (* P<0.05, **P<0.001; 
***P<0.0001, (B,D-I) one-way ANOVA with Tukey’s test, (K,L) 2-way ANOVA with 
Dunnet’s test; n=3). 
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Figure 2.3. ESRP1 mutations in individuals with SNHL. (A-F) Axial CT scans of the 
lateral vestibule from control and affected children in pedigree with SNHL showing 
absence of bony island (bi) in (C-F). (G) Sanger sequencing tracks of ESRP1 from 
individuals in pedigree with SNHL showing position of paternally inherited 19 bp deletion 
(arrowhead) corresponding to underlined sequence, and maternally inherited point 
mutation (asterisk). (H) Cross-species comparison of the first RNA recognition motif 
(RRM) in ESRP1 showing amino acid conservation at site of ESRP1 mutation 
(Leu259Val). (I) Sanger sequencing tracks of ESRP1 from three isolated cases of SNHL 
showing position of point mutations (asterisk).  
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Figure 2.4. Esrp1 expression in the developing mouse cochlea. (A-E) Transverse 
sections through the otic vesicle (A,B) and cochlear duct (C-E) of wild type embryos over 
several developmental stages showing broad Esrp1 expression in the otic epithelium. 
Scale bar = 100µm (A,B) and 50µm (C-E). Abbreviations: cochlear duct (cd), dorsal (D), 
endolymphatic duct (ed), horizontal vestibular outpouch (hvo), Kolliker’s organ (Ko), 
lateral (L), lateral cochlear epithelium (lce), medial (M), medial cochlear epithelium 
(mce), , prosensory domain (psd), organ of Corti (oC), otic vesicle (ov), outer sulcus (os), 
Reissner’s membrane (Rm), stria vascularis (sv), ventral (V), vertical vestibular outpouch 
(vvo). 
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Figure 2.5. Inner ear morphogenesis and auditory hair cell differentiation are 
disrupted in Esrp1-/- mouse embryos. (A-B) Inner ear paint fills of control and Esrp1-/- 
embryos at E14.5. The lateral semicircular canal and apex of the cochlear duct are 
magnified in adjacent panels to reveal their dysmorphic features. Scale bar = 100µm. (C-
D) Quantification of cochlear length and width from control and Esrp1-/- mutant embryos 
represented as mean ± SD (***P<0.001, unpaired t-test; n=8). (E-J, N-S) Whole mount 
preparations of control and Esrp1-/- cochlear sensory epithelium stained with markers of 
hair cells (Myosin VIIa) and actin/stereocilia (Phalloidin) at E18.5 (E-J) and P0 (N-S) at 
defined regions (base, mid and apex) of the cochlear duct. Scale bar = 10µm. (K-M, T-V) 
Quantification of inner and outer hair cells in control and Esrp1-/- embryos at E18.5 (K-M) 
and P0 (T-V) within a 150µm area from defined regions (base, mid and apex) of the 
cochlear duct represented as mean ± SD (*P<0.0001, one-way ANOVA with Tukey’s 
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test; n=10). Abbreviations: anterior, posterior and lateral semicircular canals (asc, psc, 
lsc, respectively), cochlear duct (cd), common crus (cc), endolymphatic duct (ed), inner 
hair cell (ihc), outer hair cell (ohc), saccule (s), utricle (u). 
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Figure 2.6. Hair cell differentiation is delayed at the apex of the cochlear duct in 
Esrp1-/- mutants. (A-D) Whole mount cochlear preparations from control and Esrp1-/- 
embryos immunostained for Myosin VIIa at E18.5 (A-B) and P0 (C-D). Scale bar = 
100µm. (E-F) Quantification of cochlear length (E), total number of hair cells (F), percent 
of cochlea without hair cells (G), and ratio of hair cells per cochlear length (H) presented 
as mean ± SD (*P<0.05; ***P<0.0001, one-way ANOVA with Tukey’s test, n=10). 
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Figure 2.7. Specification of prosensory progenitors, support cells, vestibular hair 
cells and neurons is not compromised in Esrp1-/- embryos. (A-C) Sox2 staining 
reveals a normal pool of sensory progenitors at the apex of the cochlear duct of Esrp1 
mutants. (D-F) Sox2 and (G-I) Prox1 positive support cells are present in similar number 
and organization at the base of Esrp1 mutants. Myo7a labels hair cells. All 
quantifications are presented as mean ± SD (ns, unpaired t-test). (J,K) Vestibular hair 
cells and neurons labeled with Myo7a and neurofilament (NF), respectively, are 
unaffected in Esrp1 mutants. (L-O) The expression of Sox2 and P27kip1 in prosensory 
progenitors is not compromised in Esrp1-/- embryos. Scale bar = 10µm (A,B,D,E,G,H) 
and 50µm (J-O). n=5 for all panels. Abbreviations: L (lateral), M (medial). 
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Figure 2.8. Sensory and nonsensory gene expression profiles are disrupted in the 
cochlear epithelium of Esrp1-/- embryos. (A) Plot of differentially expressed genes 
between wild type and Esrp1-/- cochlear epithelium at E16.5 with a fold change (FC) > 
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0.4 (n=3 replicates, P<0.05). (B) Gene Ontology term enrichment for differentially 
expressed genes between wild type and Esrp1-/- cochlear epithelium. (C) Heatmap of 
differentially expressed genes separated into sensory and nonsensory categories. (D) 
Hearing loss genes are significantly enriched in the set of differentially expressed 
transcripts between control and Esrp1-/- mutants. Genes expressed in the stria vascularis 
are marked with an asterisk. 
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Figure 2.9. Hair cell differentiation is delayed in Esrp1-/- embryos. (A-X) Transverse 
sections through defined regions of the cochlear duct (Base, Mid, Apex) from control and 
Esrp1-/- embryos stained for Atoh1 mRNA (A-F), Pou4F3 protein (G-L) and Hey2 mRNA 
(M-R) at E16.5 (n=5 or 6). Staining in prosensory domain is marked with a bracket. 
Weak Atoh1 expression at the apex of the cochlear duct in control embryos (C) is 
consistently absent in Esrp1-/- embryos at this stage. (S-X) Transverse sections through 
the organ of Corti of control and Esrp1-/- newborn pups (P0) stained for MyoVIIa and 
Sox2. Sox2 staining persists in hair cell nuclei of Esrp1-/- embryos (arrow heads in W). 
Scale bar = 100µm (A-F, M-R), 10µm (G-L) and 5µm (S-X). (Y) Schematic of the gene 
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regulatory network controlling hair cell differentiation. Abbreviations: inner hair cell (ihc), 
outer hair cells (ohc), medial (M), lateral (L). 
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Figure 2.10. Hair cell differentiation and maturation is delayed in Esrp1-/- embryos. 
(A-X) Transverse sections through the cochlear duct of control and Esrp1-/- embryos 
stained for Atoh1 mRNA at progressively later stages of hair cell development. (Y-AP) 
Transverse sections through the cochlear duct of control and Esrp1-/- embryos 
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immunostained for Pou4F3 at progressively later stages of hair cell development. Scale 
bar = 100µm (A-X) and 10µm (Y-AP). (AQ) qRT-PCR of sensory markers on E16.5 
cochlear epithelium represented as mean ± SD (ns, unpaired t-test). (A-AP) n=5, (AQ) 
n=6. Abbreviations: L (lateral), M (medial). 
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Figure 2.11. Esrp1 regulates the identity of nonsensory cells along the lateral 
cochlear wall. (A-F) Transverse sections through the cochlear duct of control (n=8) and 
Esrp1-/- (n=6) embryos at E16.5 immunostained for E-cadherin (A,D), Otx2 (B,E) and 
Nr3b2 (C,F). (G) Quantification of cells expressing Otx2, Nr3b2, as well as the total 
number of cells in the lateral cochlear epithelium represented as mean ± SD  
(***P<0.0001, Student’s t-test). (H-U) Transverse sections through the cochlear duct of 
control (n=5) and Esrp1-/- (n=5) embryos at E18.5 immunostained for E-cadherin (H,O), 
and indicated cell type specific markers of the stria vascularis (I-N, P-U). Scale bar = 
50µm (A-F, H,O) and 25µm (I-N, P-U). (V) Schematic of the stria vascularis displaying 
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cell types and markers analyzed in (H-U). Abbreviations: blood vessel (bv), outer hair 
cells (ohc), outer sulcus (os), Reissner’s membrane (Rm) and stria vascularis (sv).  
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Figure 2.12. Alternative splicing is impaired in the cochlear epithelium of Esrp1-/- 
embryos.  (A) Number and type of alternative splicing switches identified by MAJIQ 
between Esrp1-/- and control embryos in the cochlear epithelium at E16.5 ( PSI > 10%). 
(B) PSI (percent spliced in) values for selected genes with significant splicing differences 
between Esrp1-/- and control embryos determined by MAJIQ and subsequently validated 
by RT-PCR. The highlighted genes have known roles in inner ear development and/or 
auditory function. (C) Voila views (Vaquero-Garcia et al., 2016) of Esrp1 dependent 
alternative splicing events for four genes associated with hearing loss showing examples 
of mutually exclusive (Fgfr2, Eya4), complex (Col11a2) and single (Scrib) exon 
cassettes.  Numbered exons for each gene are represented as rectangles. Numbers 
above splicing events indicate RNA-seq read counts. Violin plots represent PSI 
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estimates. (D) Correlation plot of alternative splicing switches predicted by MAJIQ and 
validated by RT-PCR.  The Pearson's product-moment correlation and the line of best fit 
(least squares polynomial) were computed in R (P<0.0001).  (E) Radioactive RT-PCR 
validation of differential splicing events in the cochlear epithelium of Esrp1-/- and control 
littermates at E16.5. (F) Comparison of PSI values for Fgfr1-3, exon III-b (epithelial) and 
exon III-c (mesenchymal) in cochlear epithelium from Esrp1-/- and control embryos as 
determined by RT-PCR (multiple t-test comparison, P<0.0001). 
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Figure 2.13. Fgf signaling is ectopically activated in the lateral cochlear epithelium 
of Esrp1 mutants. (A-H) Transverse sections through the cochlear duct of control and 
Esrp1-/- mutants at E14.5 stained with markers of Fgf signaling. Ectopic expression of 
Fgf9, Etv4 and Etv5 along the lateral cochlear epithelium is highlighted (red-bracket). (I-
N) Otx2 is progressively restricted to Reissner’s membrane in control embryos but 
remains broadly expressed throughout the lateral cochlear epithelium in Esrp1 mutants. 
Otx2 repression from the stria vascularis is indicated (dashed line). (O-T) Transverse 
sections through the cochlear duct of control, Esrp1-/-, and Esrp1-/-;Fgf9+/-  embryos at 
E16.5 stained for Etv4 and Etv5. Ectopic expression of Etv4 and Etv5 along the lateral 
cochlear epithelium (red-bracket) and normal sensory expression (arrowhead) are 
highlighted. Scale bar = 50µm. n=4 for all panels. Abbreviations: L (lateral), M (medial). 
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Figure 2.14. Ectopic signaling through Fgf9/Fgfr2-IIIc is responsible for the lateral 
cochlear wall defects in Esrp1 mutants. (A-U) Transverse sections through the 
cochlear duct of control (n=15), Esrp1-/- (n=7) and Esrp1-/-;Fgf9+/- (n=6) embryos at E18.5 
immunostained for E-cadherin (A,H,O), Otx2 (B,I,P) and cell type specific markers of the 
stria vascularis (C-G, J-N, Q-U). Scale bars = 50µm. (V) Quantification of cells 
expressing Otx2 and Nr3b2 represented as mean ± SD (***P<0.0001, ANOVA with 
Tukey’s test). (W) Schematic representation of the lateral cochlear wall phenotypes 
manifesting from altered Fgf signaling in Fgf10-/- and Esrp1-/- mutants compared to a 
control embryo. 
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Figure 2.15. The cystic otic phenotype in Esrp1-/- embryos is exacerbated by the 
dose dependent loss of Fgf9. (A-D) Transverse sections through the cochlear ducts of 
control (n=6), Esrp1-/- (n=4), Esrp1-/-; Fgf9+/- (n=4) and Esrp1-/-; Fgf9-/- (n=3) embryos at 
E18.5 immunostained for E-cadherin. Scale bar=100µm. Abbreviations: apical turn (a), 
basal turn (b), medial turn (m). 
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Materials and Methods 
Mice 
Generation of Esrp1+/- mutant mice was described previously (Bebee et. al. 2015). Fgf9 
mutant mice were procured from Jackson Laboratories (0224362; B6N(Cg)-
Fgf9tm1b(KOMP)Wtsi/J; presented in text as Fgf9+/-). For all experiments control littermates 
have at least one wild-type allele of Esrp1. Pregnant dames were euthanized by carbon 
dioxide, and embryos were isolated and euthanized by decapitation in 4ºC PBS. All 
animal procedures and experiments were approved by the Institutional Animal Care and 
Use Committee (IACUC) at the University of Pennsylvania.  
Exome sequencing 
Family members were enrolled under an IRB approved protocol of informed consent at 
the Children’s Hospital of Philadelphia (CHOP). Blood was obtained from all eight family 
members and genomic DNA was extracted from whole blood using standard 
procedures. Exomes were captured using Agilent SureSelect V4 and sequenced at 
100X coverage using Illumina HiSeq 2000. Only coding regions and splice site variants 
at >4x coverage were analyzed, and the results were further filtered using a population 
frequency <3% in the 1000 Genomes and Exome Sequencing Project servers. Mutations 
that did not segregate in an autosomal recessive inheritance pattern were then filtered 
out. All putative causative mutations were validated with Sanger sequencing. 
ESRP1 mutation screening 
An additional cohort of 144 pediatric probands with bilateral SNHL of unknown molecular 
etiology was screened for mutations in ESRP1 and in the closely related gene ESRP2. 
These patients were all enrolled under an IRB approved protocol of informed consent at 
CHOP. PCR primers were designed for specific intronic sequences in ESRP1 and 
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ESRP2 (Supplemental Table S2). DNA sequence analysis was performed using an ABI 
3730XL automated DNA sequencer. 
Generation of iPSCs  
Peripheral blood mononuclear cells (PBMCs) were isolated from family members, 
transduced with EBV and transformed to lymphoblastoid cell lines (LCLs).  The LCLs 
were maintained in RPMI media supplemented with 10% FBS, 1X Penn/Strep, 1X 
glutatmine in a 5% CO2 incubator.  For iPSC generation, 2 million LCLs from the 
mother, father and 2 affected probands were transfected with nonintegrating, 
nontransmissible episomal plasmids expressing OCT4, SOX2, KLF4, MYCL, LIN28A, a 
p53 short hairpin (sh)RNA, and a green fluorescent protein (eGFP) via a single 
nucleofection (Hubbard et al., 2014). Transfected cells are then cultured in human 
embryonic stem cell (HES) media (DMEM/F12, 15% KOSR, 1X NEAA, 1X P/S, 1X 
glutamine, 2ME, 20ng/mL bFGF) in not adherent conditions for 6 days.  Cells were then 
plated onto irradiated mouse embryonic fibroblasts (iMEFs) on day 6 in HES with the 
addition of 0.5mM sodium butyrate, and media was changed daily for a 14-17 days post-
plating. iPSC-like colonies appeared between day 21-28 after nucleofection, colonies 
were isolated (~10/patient), and expanded on iMEFs using standard ES/IPSC culture 
conditions (Mills et al., 2013; Sullivan et al., 2014). 
Repair of ESRP1 (c.665_683 del) allele in patient derived iPSCs 
Patient derived iPSCs were maintained in feeder-free Geltrex (Life Technologies)-coated 
plastics and mTesr1 media (Stem Cell Technologies). For transfection, cells were 
dispersed with Accutase (Life Technologies) and re-suspended in P4 solution (Lonza) 
containing an ESRP1 sgRNA-expressing pX330-mCherry plasmid and the cognate 
repair ssODN (see Key Resources table), and electroporated using a 4D Nucleofector 
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(Lonza). The repair template included a silent Cla I site which was used to test for 
integration (described below). Three days post-transfection, mCherry positive cells were 
recovered using a BD FACSJazz cell sorter and seeded onto a Geltrex-coated 10cm 
dish. One week post-seeding, colonies were manually picked for clonal expansion and 
genotyping. The site of potential repair was amplified and incubated with Cla I (see Key 
Resources table). Unmodified DNA was refractory to Cla I whilst repaired DNA was 
cleaved, yielding 235bp and 231bp fragments. Positive clones were expanded and 
Sanger sequenced to confirm repair of the paternal allele and absence of indel 
mutations on the maternal allele. 
Viral expression of ESRP1 mutation in human cell culture  
Human ESRP1 full-length cDNA was cloned from the ORFeome Collection (RBP clone 
#290) using GATEWAY into a pIBX-cFFB-Emerald vector. The c.775C>G mutation was 
introduced into the ESRP1 cDNA by site directed mutagenesis. Wild type (WT) and 
mutant ESRP1 cDNAs were PCR amplified and cloned into pCRBlunt. The pMXs-cFF-B 
(IRESpuro) retroviral vector was cut with EcoRI, end-filled using Phusion, then cut with 
NotI. Wild type and mutant ESRP1 cDNAs were then subcloned from pCRBlunt using 
EcoRV and NotI. The resulting constructs include a Kozak, ESRP1 WT or c.775C>G 
mutant cDNA fused to a 2x FLAG tag at the carboxy terminus. Murine leukemia virus 
was generated using the viral packaging N16 cells were grown in DMEM, 10% FBS and 
transfected with the viral pMXs plasmids encoding WT or mutant ESRP1 in combination 
with VSV-G for pMXs EGFP, pMXs-cFF-B ESRP1 WT, and pMXs-cFF-B ESRP1 C>G 
(patient mutation). Virus was collected and applied in the indicated ratio with polybrene 
to triplicate wells of MDA-MB-231 cells grown in DMEM, 10% FBS, and 
Pennicillin/Streptomycin. Cells were collected into Trizol (Invitrogen) three days after 
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infection. Total RNA was extracted for RT-PCR evaluation of endogenous ESRP splicing 
targets.  Expression levels of WT and mutant ESRP1 C>G were confirmed by Western 
blot. 
RT-PCR  
Total RNA was extracted from purified cochlear epithelium and cultured cells (iPSCs, 
MDA-MB-231, mESCs) using Trizol-LS (Invitrogen), precipitated in the presence of 
glycogen and resuspended in 10mM Tris pH 8.0. For CRISPR corrected iPSCs and 
control lines, total RNA was extracted using an RNeasy mini kit (Qiagen). For synthesis 
of cDNA, 100ng of total RNA from cochlear epithelium or 1ug of total RNA from cell 
culture was used for random hexamer primed M-MLV reverse transcriptase (Promega) 
or Oligo(dT) primed Omniscript reverse transcriptase (Qiagen). Analysis of gene 
expression was performed using SYBR green master mix (AppliedBiosystems) and 
primer sequences listed in Table S4. Real-time RT-PCR analysis was performed using a 
7500 Fast Realtime machine (AppliedBiosystems). 
Semi-quantitative radioactive RT-PCR products were separated on 5% PAGE gels, dried 
and exposed on phosphor screens, scanned on a Typhoon FLA 9500, and quantified 
using ImageQuant TL, version 7.0. Splicing ratios are represented as Percent Spliced In 
(PSI) of the alternative exon for cassette exons and were normalized to RT-PCR product 
sizes. Quantification of exon IIIb and IIIc for Fgfr1, Fgfr2, and Fgfr3 required restriction 
enzyme digestion to discriminate the two isoforms. Fgfr2 PCR products were digested 
with AvaI (IIIb) or HincII (IIIc). Fgfr1 products were digested with BstXI (IIIb) and HincII 
(IIIc). Fgfr3 products were digested with StuI (IIIb) and PstI (IIIc) (all restriction digestions 
were performed according to NEB guidelines at 5U/digestion). Primer sequences are 
listed (Table S4).  
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Inner ear paint fill 
Paint fills were performed essentially as described (Martin and Swanson, 1993) with the 
use of White-Out Plus (Bic, Milford, CT,USA) as the contrast medium. Cochlear length 
and width measurements were made using ImageJ. 
In situ hybridization 
Embryos were collected from timed pregnant females (vaginal plug = E0.5). The inner 
ears were dissected from the head and fixed for 2 hours in 4% paraformaldehyde at 4°C, 
then washed in PBS. Inner ears were cryoprotected overnight in 30% sucrose/PBS then 
snap frozen in OCT embedding compound (Sakura Finetek Torrence, CA). Inner ears 
were serially sectioned along the transverse plane from anterior to posterior. The 
position of a given section through the cochlear duct was calculated based on its 
distance (µm) from the first and last section (#sections x thickness = position within 
cochlear duct along anterior-posterior axis). Mid-modiolar sections containing all three 
turns of the cochlear duct (base, mid-base, apex) were confirmed using the above 
calculation to ensure comparison of equivalent sections through control and mutant 
embryos. Sections were hybridized with digoxigenin-UTP-labeled riboprobes as 
previously described (Nissim et al., 2007). 
Whole mount cochlear preparations 
Inner ears were dissected and fixed in 4% paraformaldehyde for 2 hours at 4°C, then 
washed in PBS. Cochleae were microdissected in 0.1% PBST to expose the sensory 
epithelium, and incubated with a rabbit polyclonal anti-Myosin VIIa antibody (1:500; 
Proteus Biosciences Inc, 25-6790) and a Phalloidin conjugated Alexa488 probe (1:50; 
Molecular Probes, A12379), followed by a donkey anti-rabbit IgG secondary antibody 
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conjugated to Alexa594 (1:200). Hair cells were counted along the entire length of the 
cochlear duct, as well as per unit area (150µm) at base, mid and apical regions. 
Immunohistochemistry 
Inner ears were processed for immunohistochemistry in the same fashion as for in situ 
hybridization. Inner ear sections were stained with DAPI and antibodies found in Key 
Resources.  
Western Blot 
Total protein was extracted from patient derived and CRISPR corrected iPSCs in RIPA 
buffer. Lysate was separated on a Bis-Tris 4–12% gradient SDS-PAGE gel and 
transferred to nitrocellulose membrane. Membranes were blocked in 5% Non-fat Milk in 
0.1% PBST then incubated overnight at 4°C in primary antibody and loading control 
(anti-Beta Actin M2; 1:10,000). Membranes were incubated in secondary Sheep anti-
mIgG:HRP (1:2500; GE Healthcare) for one hour and protein detection was performed 
with ECL detection (Invitrogen) by chemiluminescence.  
RNA-seq analysis 
Cochlear epithelium from control and Esrp1-/- mouse embryos (n=3 pairs of biological 
replicates) were isolated at E16.5 exposed to collagenase P (0.1mg/ml) at 37oC for 15 
min to remove surrounding mesenchyme, and snap frozen in Trizol-LS (Invitrogen). RNA 
was extracted and precipitated in the presence of glycogen and resuspended in 10mM 
Tris pH 8.0. Total RNA (200ng) was used for poly A selected RNA-seq library 
preparation using the NEBNext® Ultra™ Directional RNA Library Prep Kit from Illumina® 
(mRNA) (New England Biolabs) (products: NEBNext® Poly(A) mRNA Magnetic Isolation 
Module (E7490S) and NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® 
(E7420S). Biological replicates were individually barcoded, pooled, and sequenced on 
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two lanes of a HiSeq 2000 platform for 100x2 bp paired-end RNA-seq at the Penn Next 
Generation Sequencing Core (NGSC) Facility. Alignment and expression values were 
determined using RUM (Grant et al., 2011).  
Characterization of alternative splicing switches 
RNA-Seq reads were mapped to the reference mouse genome (mm10) using STAR with 
the option --alignSJoverhangMin 8 (Dobin et al., 2013). Alternative splicing events were 
analyzed using MAJIQ and VOILA with the default parameters (Vaquero-Garcia et al., 
2016). Briefly, uniquely mapped, junction-spanning reads were used by MAJIQ to 
construct splice graphs for transcripts by using the Ensembl transcriptome annotation 
(release 82) supplemented with de-novo detected junctions. Here, de-novo refers to 
junctions that were not in the Ensembl transcriptome database, but had sufficient 
evidence in the RNA-Seq data (default: at least three reads mapping to at least two 
different start positions). The resulting gene splice graphs were analyzed for all identified 
local splice variations (LSVs), defined as splits in a splice graph to or from a given exon. 
Redundant LSVs were removed and each junction in the remaining LSVs was quantified 
for its expected percent spliced in (PSI) value in control and Esrp1-/- samples and 
expected change in PSI (ΔPSI) between WT and Esrp1-/- samples. PSI and ΔPSI 
correspond to the percent of isoforms and change in percent of isoforms, respectively, 
that use a specific junction compared to the other junctions in the given LSV. LSVs 
comprised of one or more junctions with an expected ΔPSI of at least 10% were then 
utilized by VOILA to produce gene and LSV splice graphs as well as violin plots 
representing PSI and ΔPSI quantifications (Table S1).  
Quantification and Statistical Analysis 
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Statistical analysis of cell counts and splicing assays were performed using GraphPad 
Prism 7 software. Relevant information for each experiment including n-values, statistical 
tests and reported p-values are found in the legend corresponding to each figure. In all 
cases P<0.05 is considered statistically significant. 
Cell counts were performed from equivalent sections through the cochlear duct using the 
cell counter feature in ImageJ. Cochlear length was measured from E14.5 paint fills and 
E18.5 and P0 cochlear epithelium preparations from the most basal to most apical turn 
of the cochlear duct using ImageJ. 
RNA-seq results were processed using edgeR (Robinson et al., 2010) to detect 
differentially expressed transcripts with fold change >0.4 (P<0.05). 
Data and Software Availability 
RNA sequencing data is accessible at NCBI Gene Expression Omnibus under accession 
number: GSE90821 
Interactive HTML output files for visualizing splicing variations between WT and Esrp1-/- 
samples are accessible at: http://majiq.biociphers.org/rohacek_2016/ and Table S1. 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies (dilution) 
mouse anti-Atp1A1 (1:250) Developmental Studies 
Hybridoma Bank 
A5 
mouse anti-β-Actin M2 (1:10000) Sigma AC-74 
rabbit anti-Barttin (1:1000) Thomas Jentsch 
(Leibniz-Institut für 
Molekulare 
Pharmakologie) 
N/A 
rat anti-CD44 (1:200) BD Parmingen 550538 
rabbit anti-Claudin-11 (1:100 +AR) Novex 364500 
mouse anti-Connexin-26/Gjb2 (1:200) Thermo Scientific 71-0500 
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mouse anti-E-cadherin (1:200 +AR) BD Transduction 
Laboratories 
610181 
mouse anti-Esrp1 (1:200) Russ Carstens 
(UPenn) 
N/A 
rabbit anti-Esrrβ/Nr3b2 (1:500 +AR) Jeremy Nathans 
(Johns Hopkins Univ.) 
N/A 
goat anti-Kcnq1 (1:300) Santa Cruz SC-10646 
rabbit anti-MyosinVIIa (1:500) Proteus Biosciences 25-6790 
mouse anti-Neurofilament (1:200) Developmental Studies 
Hybridoma Bank 
2H3 
rabbit anti-P27kip1 (1:400) Thermo Scientific PA5-27188 
mouse anti-Pou4F3/Brn-3c (1:200 +AR) Santa Cruz sc-81980 
rabbit anti-Prox1 (1:500) Chemicon Billerica AB5475 
rabbit anti-Otx2 (1:1000) Flora Vaccarino (Yale 
University) 
N/A 
Mouse anti-Sox2 (1:200 +AR) R&D Systems MAB2018 
donkey anti-mouse IGG Alexa488 (1:200) Molecular Probes A-21202 
donkey anti-rabbit IGG Alexa594 (1:200) Molecular Probes A-21207 
rabbit anti-goat IGG Alexa488 (1:200) Molecular Probes A-11078 
donkey anti-rat Alexa488 (1:200) Molecular Probes A-21208 
*AR, antigen retrieval – boil for 6 minutes in 10mM citric acid buffer (pH 6.0) 
Chemicals, Peptides, and Recombinant Proteins 
Phalloidin conjugated Alexa488 (1:50) Molecular Probes A-12379 
Critical Commercial Assays 
NEBNext® Poly(A) mRNA Magnetic Isolation 
Module 
New England 
Biosystems 
E7490S 
Directional RNA Library Prep Kit for Illumina® New England 
Biosystems 
E7420S 
Deposited Data 
RNA-seq raw and analyzed data This paper GSE90821 
MAJIQ splicing analysis This paper http://majiq.biocip
hers.org/rohacek
_2016/. 
Experimental Models: Cell Lines 
Human: patient derived IPSCs This paper N/A 
Human: MDA-MB-231 cells ATCC HTB-26 
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Mouse: Esrp1-/- embryonic stem cells Cieply et al. 2016 N/A 
Experimental Models: Organisms/Strains 
Mouse: Esrp1+/- Bebee et al. 2015 N/A 
Mouse: Fgf9+/- - B6N(Cg)-Fgf9tm1b(KOMP)Wtsi/J The Jackson 
Laboratories 
0224362 
Human: Family members screened for ESRP1 
mutations were enrolled under an IRB approved 
protocol of informed consent at the Children’s 
Hospital of Philadelphia (CHOP) 
This paper N/A 
Human: A cohort of 144 pediatric probands with 
bilateral SNHL were enrolled under an IRB 
approved protocol of informed consent at CHOP 
This paper N/A 
Recombinant DNA 
PMX-CFF-B Modified from Toshio 
Kitamura 
N/A 
Sequence-Based Reagents 
PCR Primers for human ESRP1 and ESRP2  
exons see Table S3 
This paper N/A 
Primers used to detect gene specific alternative 
splicing switches by RT-PCR.see Table S4 
This paper N/A 
sgRNA oligos for ESRP1 (c.665_683 del) CRISPR: 
F: caccGATGGAACTTATTGGGCACG 
R: aaacCGTGCCCAATAAGTTCCATC 
This paper N/A 
ESRP1 (c.665_683 del) repair template: 
TATTGAGTCCTTTGAAGAATCTTGCAATATCTTGA
TCTGAAGACTGCCATGGTAAACCTCGTGCCCTGA
CTACGGTGTTATCATCGATAAGTTCCATCTTGCT
GCTGTGGATGAAGCAAAACTTCAGGTTGCATGAT
AAA 
This paper N/A 
ESRP1 (c.665_683 del) repair PCR genotyping 
primers:  
F: CACAGGCAGCCATGTTTCTA 
R: TAGGCAGTTGTCTTGCAGGG 
This paper N/A 
Software and Algorithms 
RUM Grant et al. 2011 http://www.cbil.upe
nn.edu/RUM/ 
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edgeR Robinson et al. 2010 https://bioconducto
r.org/packages/rel
ease/bioc/html/edg
eR.html 
MAJIQ Vaquero-Garcia et al., 
2016 
http://majiq.biociph
ers.org/ 
STAR Dobin et al., 2013 https://github.com/
alexdobin/STAR 
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Table 2.1. Esrp1 dependent alternative splicing events in the cochlear epithelium. 
(see attached Excel file)  
 
Table 2.2 Expression values of selected genes from RNA-seq on E16.5 control and 
Esrp1-/- cochlear epithelium.  
Gene Control FPKM Esrp1-/- FPKM Fold Change P-Value 
Atoh1 3.46 ± 0.59 2.43 ± 0.38 -0.596 0.040 
Atp1a1 96.99 ± 19.03 81.56 ± 4.37 -0.334 0.089 
Bsnd 0.53 ± 0.14 0.01 ± 0.01 -5.029 8.513E-16 
Cd44 1.92 ± 0.18 1.37 ± 0.10 -0.570 0.014 
Cldn11 13.24 ± 4.30 13.12 ± 2.44 -0.161 0.546 
Esrrb 10.61 ± 2.38 0.72 ± 0.33 -4.012 3.959E-40 
Etv4 6.32 ± 1.14 9.17 ± 1.78 0.403 0.047 
Etv5 11.50 ± 1.01 11.81 ± 0.33 -0.048 0.758 
Fgfr1 17.18 ± 0.52 18.69 ± 0.65 0.029 0.954 
Fgfr2 15.10 ± 2.02 12.43 ± 1.30 -0.343 0.076 
Fgfr3 6.55 ± 1.22 3.91 ± .054 -0.796 2.055E-04 
Gjb2 55.99 ± 9.04 39.31 ± 7.70 -0.547 0.012 
Gli1 1.92 ± 0.17 1.58 ± 0.24 -0.341 0.188 
Hey1 15.66 ± 1.85 13.05 ± 1.59 -0.318 0.096 
Hey2 7.27 ± 0.41 8.51 ± 1.14 0.176 0.501 
Kcne1 1.52 ± 0.3 0.06 ± 0.03 -4.503 9.817E-24 
Kcnq1 1.72 ± 0.3 0.97 ± 0.38 -0.989 0.004 
Myo7a 2.29 ± 0.43 1.89 ± 0.76 -0.441 0.093 
Otx2 8.75 ± 2.75 18.29 ± 1.12 0.995 9.071E-05 
Pou4f3 5.89 ± 0.69 3.49 ± 1.11 -0.914 0.004 
Prox1 3.67 ± 0.18 2.02 ± 0.57 -0.876 0.001 
Ptch1 6.54 ± 0.68 6.18 ± 1.30 -0.128 0.492 
Sox2 19.14 ± 0.28 18.54 ± 2.95 -0.110 0.501 
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Table 2.3. PCR primers used to amplify human ESRP1 and ESRP2 exons. 
ESRP1 Primers 
Exon Forward primer 
(5’-3’) 
Reverse Primer 
(5’-3’) 
Size 
(bp) 
Exon 1 TAGCAGTAGCAAGGAAGGGG GGGTCCAGACTCACAAGTGG 396 
Exon 2 GAGAGCTTTGATTCTGCGTC ATGAAGAGAAGCAGCGACC 445 
Exon 3 AAGGGGAGCTACTTTGCAG AGAACAGAGAAACTTGAATAAACC 279 
Exon 4 TAGGTTCCTAATTGTGAGAGAAAC ATTTTGGATAGGCCAATTTTATC 450 
Exon 5-6 GTTGAATGACTGACTGATGGG ATTAGCCAGGTATGGTAGCG 662 
Exon 7-9 AACTAGGCAGTTGTCTTGCAG AAAACCATTCATGACCCTATTC 686 
Exon 10 CATTGGCAGGACTTTTATCAC TGAGCAATGTAGGACTATTTTCAG 469 
Exon 11 GTATCATGCTTTCCCTGCTG CTTAGTGTGTAACTGAGGATTACG 675 
Exon 12 TTGTCACTTTGCATGTTTTG AGGGGCACAGAAAGTTACG 369 
Exon 13 TGTGTAGATGGAACAGTGACTATG GAGCTCTTGCACTGGCTATC 334 
Exon 14 GCTCTGAGAAGTATAAGAAAGGTTG ATCTGTTTCTTTCCTGGCTG 360 
Exon 15 TCTAAATGTCCTATACTTTTGTTGG TCTAAATGCCTTCAGAATCTTG 286 
ESRP2 Primers 
Exon Forward primer 
(5’-3’) 
Reverse Primer 
(5’-3’) 
Size 
(bp) 
Exon 1-2 GTAACTCGCCTGGAGAGGG ACAAGAGCCCAGTCCTGC 844 
Exon 3-4 TTCCTCCTACCCTCACTTCC ATACTCAGACACATGTACCCACAG 475 
Exon 5 GGAGTAAACAGGATTAGTGCTTATG GAGCAATAGGCATTTGTCATC 217 
Exon 5 GTGTCTATGGAGGGGAGTTG TAGAGAAGGTCACAGTGGGG 265 
Exon 6-8 GCAGAACTTGGTGGGGAC TATACACCTGTGGGTACAGAGAGC 599 
Exon 6-8 TTTTGCAGAACTTGGTGG CACCTGTGGGTACAGAGAGC 599 
Exon 9-10 GGCCAATCTGAGTCAGGC GTAGGGCAGGGACACAGAG 612 
Exon 11 AGATGTACTGTTACTCCAGGGC TACCCCTAACACACACCCC 353 
Exon 12 GTGTGTGTTAGGGGTAAGGC TAGAAGGTAGGGGCTTACAACAG 331 
Exon 13 ATAGCGGGGACTCCTTTC TTCCCCAGATTGGGACAG 323 
Exon14-15 GGTCTCGGTCTAGGCCAC GTTGAGGGTGCTGGTCTTC 469 
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Table 2.4. Primers used to quantify changes in alternative splicing and gene 
expression by RT-PCR. 
Alternative Splicing Primers 
Gene Forward-Primer Reverse-primer 
Mouse 
Arhgef11 TCAAGCTCAGAACCAGCAGGAAGT TGCTCGATGGTGTGGAAGATCACA 
Col11a2 GGACGGCCCTCAGACTCAGAAG GCCAGGGGGTCCAGCTAATCCAG 
Col11a2 GCCGCCCTGTCCGCTTTCTC GGCCCTTGTCACCCCCACTACTG 
Csnk1d CTCACGGGCCGACAAGATACCT GAGCTCCCGGCGTTAACATTTCAG 
Ctnnd1 AACCTCGCTGGATTTGTCTTTC TGATCCTGGGGTCCGTTGAGTTTC 
Dgkd CTAAACGCAGCCGTAGTGGTAAA TTTGTTAGAGACAGGAAGCCCAAT 
Enah GCTGGGCGTGGGAATGGACCTCTT TTGCCAGCTCTTTTCTCATCTCAT 
Epb4.1 TTAACATCAACGGGCAAGTC ATATCGGCATCTCCTGTGA 
Eya4 GAGGTGCTTTCCCCATTG ATTTCATCCGTTAAGACCATT 
Eya4 TCCCCATTGAGAACATTTACAG AGAGGTCCGAGTGGCTTGATA 
Fgfr1 CCTGGGCAGCAATGTGGAGTT AAGGCCCCGGTGCAGTAGATA 
Fgfr2 CCCGGGTCTAGATTTATAGTGATGC
CCAGCC 
CCCGGGGAATTCACCACCATGCAGG
CGATTAA 
Fgfr3 TGCCGGCCAACCAGACAGC GCGCAGGCGGCAGAGTATCACA 
Flnb GGCGAGGAGGTGGGCTTTGTAG CCTGACGGCAAATGGAATCACCAA 
Ganab GCCCGGCTTTCTGTCTCTGGTC CATCCCTGGGTGTTTCCTCA 
Limch1 AGAGCCTGAAGCAACCCTGACG TCGCCGGCGCTCCTCTTCT 
Lsm14b CCTCGGCGACACAGCTCAATGGT ATCACAGCTGGGTCCTTCTCTTCC 
Map3k7 TTCCTGCCACAAACGACAC ATTCTGACACTAGGGCTGGATGAC 
Nf2 TGACTTCAAGGATACGGACAT CAAACAAGCCAGCCCTCTACT 
Ocrl TGAACTCCGGTGAAGATAAGATTG GAAGGGGTCGCTCACTGGTA 
Phactr4 TGGAAGCAGGGGACACAACAC GGGCTAGAGGACCTGGCACTG 
Ralgps2 ACCTGCTGGATGATAGTGTC CTTCAGAGATTTGGCGGCATAGTA 
Scrib ATCCGCAAAGACACGCCCCACTAC AGCCTTTTCCCCCTGCGATACTGA 
Sec22c CAGCCCTGGGTGTCCTCTC CCAGCATCAGCAGCACCTTCA 
Human 
ARHGEF11 GAAATTCTGGGATATGGGAGTC GCCTGTTGAGCTTGAGAGTGA 
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ENAH TGCTGGCCAGGAGGAGAAGA ACTGGGCTGTGATAAGGGTGT 
NF2 TGGCAGCAGCAAGCACA CCCGGTAGCAGGAGAAGT 
RALGPS AGACCTCATGGCCTGCTTTTG TGTAGGCTTTTTGCCTTCTTT 
SYBR Green Primers 
hβACTIN AGGCACCAGGGCGTGAT GCCCACATAGGAATCCTTCTGAC 
hESRP1 TGATCTTCGAAAAGAATTCAAGAAA CGAGAGACTGAACTACTCTTCTCAA
AA 
hESRP2 CCCTACATGCTCTGCACTGA GGAATTCTCTTCGGAGGTCA 
mB2M TCTCTCTTTCTGGCCTGGAG AATGTCGGATGGATGAAACC 
mAtoh1 ATGCACGGGCTGAACCA TCGTTGTTGAAGGACGGGATA 
mGli1 GGAAGTCCTATTCACGCCTTGA CAACCTTCTTGCTCACACATGTAA 
mHey1 CACTGCAGGAGGGAAAGGTTA CCCCAAACTCCGATAGTCCAT 
mHey2 AAGCGCCCTTGTGAGGAAA TCGCTCCCCACGTCGAT 
mPtch1 CTGGCTCTGATGACCGTTGA GCACTCAGCTTGATCCCAATG 
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Chapter 3: Gas2 is a Shh responsive gene required for hearing 
Introduction 
Hedgehog genes  
 Originally identified in a screen for developmental mutants in drosophila larvae, 
the Hedgehog (Hh) gene was named for the ectopic denticle phenotype seen in these 
animals which resemble the spikes on a hedgehog (Nüsslein-Volhard and Wieschaus, 
1980). Hh mutant larvae also display a complete failure in anterior-posterior patterning 
and do not form a segmented body plan. This, and similar patterning phenotypes, are 
common amongst Hh mutants as these proteins are some of the most well described 
morphogens, molecules that diffuse across a tissue and pattern responding cells in a 
time and concentration gradient manner. Since their initial discovery, Hh genes have 
been found to play roles not only in developmental patterning, but also in cell 
proliferation, survival, and differentiation. 
Orthologs to drosophila Hh are found in vertebrates (Echelard et al., 1993). Due 
to genome duplications in this clade, vertebrate Hh genes fall into three families: Desert 
Hedgehog (Dhh), Indian Hedgehog (Ihh), and Sonic Hedgehog (Shh). Dhh is expressed 
is a subset of gonadal cells and mutants for this gene present with infertility (Bitgood et 
al., 1996). Ihh transcripts are found in the primitive endoderm and chondrocytes of the 
bone growth plates (Colnot et al., 2005; Dyer et al., 2001; St-Jacques et al., 1999). 
Mouse mutants for Ihh display variable phenotypes with half of the embryos dying from 
vasculature defects in the yolk-sac and the remaining having abnormal bone 
development. Humans with Ihh mutations develop acrocapitofemoral dysplasia, a 
disorder characterized by short stature and skeletal defects (Hellemans et al., 2003).  
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Shh is the most widely, and dynamically, expressed of the vertebrate Hh 
orthologs. Early in embryogenesis, Shh is expressed from the floorplate and notochord 
and is responsible for left-right and dorsal-ventral (DV) patterning (Echelard et al., 1993). 
This expression is maintained through mid to late gestation and functions to pattern the 
central nervous system and placodal derived structures such as the eye and inner ear 
(Chiang et al., 1996; Riccomagno et al., 2002). In the limb-bud, Shh is expressed in the 
zone of polarizing activity and is required for distal patterning of the limbs (Chiang et al., 
1996; Echelard et al., 1993). As development progresses, Shh signaling is also active 
and plays roles in the organogenesis of nearly all epithelial tissues and organs. Mouse 
knockouts for Shh are profoundly dysmorphic and lack any defined anterior structures, 
such as the head, limbs and many internal organs (Chiang et al., 1996). Humans and 
other animals with defects in Hh signaling often present with holoprosencephaly and 
cyclopia, a failure to separate the eye fields and cerebral hemispheres, which results in 
late prenatal or early postnatal lethality (Belloni et al., 1996; Roessler et al., 1996). 
Hedgehog signaling 
  While the core components of the Hedgehog signaling pathway are conserved 
between invertebrates and vertebrates, the latter contain additional factors that add to its 
complexity, thus the vertebrate system will be discussed here. Within the secreting cell, 
Hh protein is proteolytically cleaved into N- (N-Hh) and C-terminal (C-Hh) fragments 
(Bumcrot et al., 1995). The C-Hh acts as a posttranslational intermediary, transferring 
cholesterol to the N-Hh fragment which is thought to direct it to the secretory machinery 
(Kelley et al., 1996; Roessler et al., 1997). The N-Hh is secreted from the expressing cell 
and binds its cognate receptors on the receiving cells. 
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 The Hh responsive cell expresses a host of specialized proteins required for 
signal transduction: the receptor, a 12-pass transmembrane receptor Patched (Ptch); co-
receptors, Cell Adhesion Associated, Oncogene Regulated (Cdo), Brother of Cdo (Boc) 
and Growth arrest specific 1 (Gas1); the obligate transducer, a G-protein-coupled 
receptor-like seven-pass transmembrane protein Smoothened (Smo); and the Glioma-
associated transcription factors (Gli1, Gli2, and Gli3) (Allen et al., 2007; Goodrich et al., 
1997; van den Heuvel and Ingham, 1996; Hui et al., 1994; Kinzler et al., 1988; Lee et al., 
1997; Marigo et al., 1996; Tenzen et al., 2006; Zhang and Jetten, 2001). Interestingly, in 
vertebrates the primary cilium (PC) is required for Hh signaling and many pathway 
components are localized there during signal response, though the exact reasons for 
this remain uncertain (Huangfu and Anderson, 2005; Huangfu et al., 2003; Liu et al., 
2005). 
 In the absence of Hh ligand, Ptch is localized to the PC and prevents the 
accumulation of Smo therein, forcibly repressing the pathway (Rohatgi et al., 2007; Strutt 
et al., 2001; Taipale et al., 2002; Fig. 3.1A). Gli2 and 3 are bound by Suppressor of 
fused (Sufu) and sequestered into the cytoplasm where they are phosphorylated (Ding 
et al., 1999; Kogerman et al., 1999; Liu et al., 2005; Svärd et al., 2006). The 
phosphorylated Gli2/3 are then proteolytically cleaved (Haycraft et al., 2005; Pan et al., 
2006; Wang et al., 2000). Gli2 is a transcriptional activator while Gli3 contains an N-
terminal repressor domain and a C-terminal activator domain. Phosphorylation and 
cleavage marks the C-terminus for degradation, destroying Gli2 and allowing the N-
terminus of Gli3 to translocate to the nucleus and act as a transcriptional repressor.  
Binding of Ptch by Hh ligand internalizes much of the receptor-ligand complex, 
and allows Smo to translocate to the PC (Chen and Struhl, 1998; Corbit et al., 2005; 
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Martín et al., 2001; Murone et al., 1999; Fig. 3.1B). The exact mechanisms by which 
Smo localization are controlled are still under investigation, however, recent evidence 
has found that phosphorylation and cholesterol modifications accumulate on Smo during 
pathway activation and are prevented by Ptch localization within the cilia (Li et al., 2016; 
Martín et al., 2001; Xiao et al., 2017). Interestingly, this data corroborates findings that 
chemical Smo agonists cyclopamine, sonidegib, and vismodegib all bear structural 
similarity to cholesterol (Chen et al., 2002; Incardona et al., 1998). Activated Smo re-
localizes the Sufu-Gli complex to the cilia, relieving the repression of Gli by Sufu (Ding et 
al., 1999; Kogerman et al., 1999; Liu et al., 2005; Svärd et al., 2006). Gli2/3 then remain 
in their full-length isoforms and translocate to the nucleus to act as transcriptional 
activators of Hh target genes, such as Gli1 (Haycraft et al., 2005; Lee et al., 1997; Pan 
et al., 2006; Wang et al., 2000). Interestingly, an additional Hh target gene is its receptor 
Ptch, which acts as a negative regulator of the pathway, likely to dampen and prevent 
overactive signaling (Chen and Struhl, 1996; Goodrich et al., 1997). 
 
Growth Arrest Specific 2 
 The Growth Arrest Specific (Gas) genes were initially identified as transcripts 
with increased expression in mouse fibroblasts that had been serum starved into cell 
cycle arrest (Schneider et al., 1988). Growth arrest specific 2 (Gas2) was the second 
such identified transcript and is now known to encode for a cytoplasmic protein that 
interacts with the cytoskeleton (Brancolini and Schneider, 1994; Brancolini et al., 1992, 
1992, 1995; Zhang et al., 2011). The N-terminus of the Gas2 protein contains an actin 
binding Calponin homology (CH) domain while the C-terminus encodes for a microtubule 
binding Gas2 domain (Brancolini et al., 1992b, 1995; Zhang et al., 2011a; Fig. 3.6A). 
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Gas2 itself is conserved only through vertebrates with orthologs found in zebrafish and 
lamprey, but is also part of a larger gene family known as the Gas2-like genes 
(Goriounov et al., 2003; Stroud et al., 2011, 2014; Zhang et al., 2011). Gas2-like proteins 
contain the same basic domain structure but also contain additional extensions of the C-
terminal tail. Members of the Gas2-like family are conserved through flies and include 
the cytoskeletal linker Pickled Eggs (Pigs) (Girdler et al., 2016; Pines et al., 2010). 
 Gas2 and the Gas2-like proteins have been shown to interact with the 
cytoskeleton. In mouse and human cell lines, Gas2 colocalizes with actin and 
microtubules by immunofluorescence and in co-sedimentation and western blot assays 
(Brancolini et al., 1992; Girdler et al., 2016; Goriounov et al., 2003; Stroud et al., 2011). 
Structure function analyses have demonstrated that the CH and Gas2 domains interact 
with actin and microtubules respectively and that many Gas2-like proteins, including 
Pigs, have been shown to act as cross linkers between these two fibers. Interestingly, 
the Gas2-like proteins have also been shown to stabilize microtubules by interacting with 
end binding (EB) proteins that coat the tubule plus end (Goriounov et al., 2003; Stroud et 
al., 2014; Girdler et al., 2016). This interaction relies on the extended C-terminal 
domains found in Gas2-like proteins that is absent in Gas2 itself, leaving open the 
question of whether this function is conserved in the Gas2 protein. Gas2 has also been 
shown to be a target for caspase mediate cleavage, generating short CH containing and 
Gas2 domain containing fragments (Benetti et al., 2001; Brancolini et al., 1995; Lee et 
al., 1999; Sgorbissa et al., 1999; Zhang et al., 2011). The Gas2 domain fragment, as 
well as full length Gas2, has been shown to localize to microtubules during apoptosis 
and to prevent cell cycle progression in cell culture and Xenopus embryos. 
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 The expression of Gas2 has been described in only a few circumstances and its 
function in many of these tissues remains unclear. In culture, Gas2 is detected at the cell 
border and along actin based stress fibers and its expression is greatly increased under 
mitotic arrest conditions and during apoptosis (Benetti et al., 2001; Brancolini and 
Schneider, 1994; Brancolini et al., 1995; Lee et al., 1999). Overexpression of Gas2 in 
cell culture induces membrane ruffling and can prevent mitosis, suggestive of a critical 
role for Gas2 in regulating cell cycle progression and cell death. In the mouse embryo, 
Gas2 expression was found to be dynamic between E11.5 and E14.5 in the developing 
axial skeleton and myogenic regions of the limbs (Lee et al., 1999). Gas2 is first 
expressed in and around sites of chondrocyte recruitment that will form the bone 
scaffolds, then becomes localized to regions of apoptotic cells in the interdigital tissues 
and surrounding mesenchyme. At E16.5, Gas2 is also found in the somatic cells of the 
developing female gonad (York et al., 2016). This expression is maintained into 
adulthood and is restricted to the stromal tissue that surrounds the ovarian follicles. Few 
other studies have analyzed Gas2 and so the full extent of expression remains to be 
determined. 
 Mouse knockouts for Gas2 have recently been described, though with a narrow 
phenotypic focus (York et al., 2016). Broadly, Gas2-null mice are born in normal 
Mendelian ratios and exhibit no overt morphological or behavioral deficits. Female Gas2 
mutants were found to be infertile due to defects in oocyte cyst breakdown, follicle 
growth, and basal lamina organization. This phenotype correlated with an increase in 
Notch1 expression and subsequent decreases in Notch signaling within the ovary. 
Interestingly, a similar phenomenon can be seen in Pigs deficient Drosophila, which 
demonstrate fusion of the egg chambers associated with alterations in Notch signaling 
94 
 
(Girdler et al., 2016; Pines et al., 2010). How Gas2 regulates aspects of Notch signaling, 
as well as the potential for additional roles of Gas2 in vertebrate development are areas 
in need of further investigation.  
Rationale 
 While numerous genes have been implicated as playing key roles in the 
development of the cochlear duct and sense of hearing, many facets of this structure's 
origins, cell types, function and maturation still lack genetic and/or mechanistic 
components. Shh signaling has been shown to be crucial for the proper development of 
the cochlear duct (Bok et al., 2007; Brown and Epstein, 2011; Riccomagno et al., 2002). 
Mouse embryos with an inner ear specific deletion of smoothened (Smoecko) display a 
complete failure of cochlear outgrowth and morphogenesis as well as a loss of ventral 
otic identity (Brown and Epstein, 2011). We sought to utilize these embryos to discover 
new inner ear specific Hh targets as well as genes that might play novel roles in cochlear 
development and hearing. 
 In this study, we performed an RNA-seq experiment comparing control and 
Smoecko mutants at E11.5, a time point where the first outgrowth of the cochlear duct can 
be observed, and identified genes with the potential to be Hh targets and have novel 
functions in the inner ear. The expression of a number of these genes was examined by 
in situ hybridization and Shh signaling responsiveness validated on two different mutant 
backgrounds. Of the validated genes, Gas2 was selected for further study based on its 
expression domain and potential to act as a regulator of cochlear morphogenesis. Gas2 
mutant mice were generated and examined for defects in cochlear development and 
function. While no defects were seen embryonically, adult Gas2 mutants presented with 
severe hearing impairment in the absence of morphological defects of the cochlear duct. 
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Gas2 was found to be expressed in the supporting pillar and Deiter's cells of the organ of 
Corti and Gas2-null animals had progressive defects in microtubule organization within 
these cells that correlate with the onset of hearing. These findings implicate Gas2 as a 
Shh responsive gene that is critical for the maintenance of the pillar cell cytoskeleton 
and sense of hearing. 
 
Results 
RNA-seq reveals novel Shh targets in the developing cochlea 
 To identify novel Shh targets, as well as discover genes with novel functions in 
cochlear development, we performed RNA-sequencing to compare the expression 
profiles of E11.5 control (FoxG1Cre;SmoLoxp/+) and Smoothened ear conditional 
knockout (FoxG1Cre;SmoΔ/Loxp, referred to as Smoecko) otic vesicles. Smoecko mutants 
lack ventral otic tissues, including the cochlear duct, but retain the dorsal vestibular 
structures allowing us to enrich for genes expressed in the presumptive cochlear duct 
upon comparison with controls. We found 1,222 differentially expressed genes 
(FDR<0.05, RPKM>1) with 630 downregulated and 592 upregulated transcripts in 
Smoecko otic vesicles compared to controls (Fig. 3.2A). Genes found to be downregulated 
were enriched within gene ontology terms associated with inner ear morphogenesis, 
positive regulation of transcription, and sensory perception of sound as revealed by the 
DAVID 6.8 analysis tool (Fig. 3.2B). Genes that were upregulated did not fall into any 
inner ear specific categories (GO terms: positive regulation of epithelial to mesenchymal 
transition, positive regulation of cell migration, cell adhesion) and were not included for 
further analysis (Data not shown). Amongst the most differentially expressed 
downregulated genes several with known cochlear duct expression and roles in inner 
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ear development are found including Otx2, Rspo2, Emx2, Pax2, Hey1 and 2, Eya1, 
Gata3, Sox2 and FoxG1. Further, Gata3, Otx2, and Pax2 have previously been 
described as Shh responsive genes in the otocyst, providing evidence that our screen 
had identified cochlear enriched genes that may be Shh targets (Brown and Epstein, 
2011; Fig. 3.2C).  
 To validate potential novel cochlear enriched genes we performed in situ 
hybridization and fluorescent antibody staining on E11.5 WT otic vesicles (Fig. 3.2D-AB; 
Fig. 3.5A,D). In addition to 4 previously described Shh responsive targets (Gata3, Gli1, 
Otx2 and Pax2) the expression of 21 downregulated genes was examined. We found 
that all examined genes are expressed in the ventral otic epithelium, confirming that the 
RNA-seq experiment had enriched for cochlear transcripts. Interestingly, these genes 
were expressed in one of four discrete territories that overlapped the patterns of Gata3, 
Gli1, Otx2 and Pax2. Gli1 is broadly expressed throughout the ventral otic epithelium 
and marks the region responsive to Shh signaling (Fig. 3.2D). Six of the tested genes 
(Dsp, Emx2, Eya1, Eya4, Mpzl2, and Pchdh11x) showed a similar pattern of expression 
in the ventral otic vesicle (Fig. 3.2E-J). The ventral medial wall is marked by Pax2 
expression at this stage and additionally expresses 7 validated genes (Brip1, Car13, 
Gas2, Fam107a, Fat3, Pls1 and Six1) (Fig. 3.2K-Q). The presumptive sensory 
epithelium at the ventral most tip of the otic vesicle expresses Gata3 as well as 7 genes 
(Ano1, Fst, Jag1, Lin28b, Slc39a8, Sox2, and Thrβ) from our dataset (Fig. 3.2R-Y; Fig. 
3.5A). Otx2 is expressed along the lateral wall of the otic vesicle along with two 
additional genes (Capn6 and Rspo2) (Fig. 3.2Z-AB). In addition to these 21 
downregulated genes, we also interrogated the expression of Jag1 as a known regulator 
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of sensory cell fate that showed the potential to be a Shh target gene though it did not 
meet statistical significance in this experiment (FDR=0.156) (Fig. 3.2V; Fig. 3.5D). 
 We next sought to determine if the genes identified in our RNA-seq data set were 
regulated by Shh signaling. Given that the ventral otic tissue is absent in Smoecko 
mutants, transcripts could be identified as downregulated in this experiment because 
they require Shh signaling for their expression or because the tissue in which they are 
expressed is missing. To address this question, we examined expression of the 
identified genes by in situ hybridization or immunofluorescence on Smoecko otic vesicles 
at E10.5 (Fig. 3.3A-Q; Fig. 3.5G-J). At this stage the Smoecko mutant vesicle is 
morphologically similar to controls and thus any loss of expression would be presumed 
to originate directly from lack of Shh responsiveness. We were able to analyze the 
expression of 18 potential target genes in control and Smoecko mutants, 3 additional 
genes (Fst, Pcdh11x, and Thrβ) did not show expression in control tissue at this stage 
(data not shown). We found that expression of the majority of the analyzed genes 
(13/18) is completely abrogated in the Smoecko otic vesicle, suggesting that Shh signaling 
is required for their expression (Fig. 3.3A,B,E-J,L,N-Q). 
The remaining 5 genes (Eya1, Eya4, Jag1, Six1, and Sox2) demonstrated a 
more complex response to loss of Shh signaling. Eya1 and Eya4 are expressed in a 
broad ventral pattern in controls of which the lateral domain is preserved in Smoecko 
mutants while the medial expression is lost (Fig. 3.3C,D). Jag1, Six1, and Sox2 are 
restricted to a ventral medial domain in controls which is lost in the Smoecko. Interestingly, 
these genes also show a gain of ectopic expression on the lateral wall of the otic vesicle, 
which is maintained for Jag1 and Sox2 at E11.5 (Fig. 3.3K,M; Fig. 3.5C,F,G-J). These 
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data suggest that Shh signaling may be part of a more complex regulatory logic that 
governs the expression of this subset of genes. 
 Finally, we wanted to determine if Shh signaling was sufficient to drive the 
expression of genes identified by our experiment. To accomplish this, we performed in 
situ hybridization on E11.5 otic vesicles from a mouse line that ectopically expresses 
Shh ligand in the dorsal otocyst (ShhP1) (Fig. 3.4A). The majority (21/24) of the tested 
genes showed responsiveness to the ectopic Shh source and demonstrated altered 
expression domains (Fig. 3.4B-V). Many genes (Ano1, Brip1, Exm2, Fam107a, Fst, 
Gas2, Gata3, Hey1, Jag1, Lin28b, Pax2, Pls1, Six1, and Sox2) demonstrated induction 
of an ectopic, dorsal, expression domain that, at least partially, overlaps the region of 
Shh expression (Fig 3.4B,C,H,I,K-T; Fig. 3.5B,E). The expression domains of a subset of 
genes (Car13, Slc39a8, and Thrβ) were expanded laterally (Fig. 3.4J,U,V) while Dsp, 
Eya1, Eya4, Mpzl2, and Pchd11x became expressed throughout the entire otic vesicle 
(Fig. 3.4B,D-G). As the expression of these genes were also altered in the Smoecko 
mutants we conclude that Shh signaling is both necessary and sufficient for their 
expression. Interestingly, the genes expressed along the ventral-lateral wall of the otic 
vesicle (Capn6, Otx2, and Rspo2) did not show any alterations in their expression 
patterns in the ShhP1 embryos (Fig. 3.4W-Y). We thus conclude that Shh signaling is 
required for the expression of these genes, however, it alone is not sufficient to induce it. 
Gas2 is dynamically expressed in the developing and mature cochlear duct 
 From our list of Shh responsive genes we next set out to identify potential novel 
regulators of cochlear development. We chose to pursue Growth Arrest Specific 2 
(Gas2) based on its expression in the ventral otic vesicle at E11.5 and its previously 
described functions as a cytoskeletal binding protein which, we hypothesized, made it a 
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good candidate regulator of cochlear morphology and/or function (Fig. 3.6A,D). Previous 
studies have found that Gas2 is expressed in the developing axial skeleton as early as 
E11.5, an observation we confirm by in situ hybridization, and maintained at least 
through E14.5 in the condensing mesenchyme and chondrocytes of the long bones (Fig. 
3.6B). No previous data existed describing the expression of Gas2 during inner ear 
development so we performed a time course of in situ hybridization to address when and 
where this gene is expressed in the cochlear duct. Gas2 expression is detected in the 
ventral tip and medial wall of the otic vesicle starting around E10.5 and is maintained at 
E11.5 (Fig. 3.6C,D). At E14.5 Gas2 transcript is detected in the presumptive sensory 
epithelium in the medial cochlear duct, although at a lower level than seen at E10.5 and 
11.5, and low-level expression can be seen on the lateral wall (Fig. 3.6E). Through the 
remainder of prenatal development (E16.5-E18.5) expression is undetectable in the 
region of the developing organ of Corti but is maintained and upregulated on the lateral 
wall, particularly in the developing stria vascularis (Fig. 3.6F,G). Postnatally, Gas2 is 
expressed in multiple cochlear regions including Reissner’s membrane, the stria 
vascularis, the outer sulcus and the organ of Corti (Fig. 3.6H,I). 
 To better characterize the complex postnatal expression of Gas2 we stained 
sectioned cochleae with a Gas2 specific antibody. At E11.5 the Gas2 antibody labels 
cells along the ventral medial wall of the otic vesicle in an identical pattern to Gas2 
transcript expression as detected by in situ hybridization, suggesting that the antibody is 
appropriately detecting endogenous Gas2 (Fig. 3.6J). Postnatal analysis at P14 confirms 
Gas2 expression in the stria vascularis, spiral ligament, and the organ of Corti. 
Interestingly, within the organ of Corti, Gas2 is detected within the supporting pillar and 
Deiters’ cells and is excluded from the sensory hair cells (Fig. 3.6K,L).  
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Generation of a Gas2 knockout mouse line 
 To interrogate the function of Gas2 in inner ear development, we generated a 
Gas2 deficient mouse line utilizing ES-cells from the European Conditional Mouse 
Mutagenesis Program (EUCOMM) as part of the International Knockout Mouse 
Consortium (IKMC). ES-cells generated by the IKMC are a C57B/6N-Tac background 
and are heterozygous for a targeted Knockout first allele (tm1a) (Fig. 3.7A). This allele 
replaces an endogenous exon with one flanked by loxp sites and knocks-in a LacZ 
reporter and neomycin resistance cassette into the upstream intronic sequence. Exon 5 
of the Gas2 genomic sequence was targeted as it encodes for residues of both the actin 
and microtubule binding domains (Fig. 3.6A). The targeted allele is expected to produce 
a loss of function transcript due to a frameshift resulting in an early stop codon in exon 5 
that would be a likely target for nonsense mediated decay. 
 ES-Cells containing the Gas2 targeted allele (Gas2tm1a/+) were injected into albino 
C57B/6N-tac blastocysts and chimeric mice obtained. High percentage chimeras (>90% 
black/agouti coat) were bred to albino C57B/6N-tac mice and the resulting pups were 
screened for the Gas2-tm1a allele by coat color and PCR genotyping (See methods and 
Table 3.1 for details). Gas2tm1a/+ mice were intercrossed to generate homozygous 
animals. Gas2tm1a/tm1a mice are born at expected Mendelian ratios and display no defects 
in gross anatomy or behavior, similar to a previously described knockout line (York et al., 
2016; Fig. 3.7C and data not shown). Loss of Gas2 expression was confirmed by 
western blot on E14.5 limbs, as well as immunofluorescence and in situ hybridization on 
cochlear tissue at multiple stages (Fig. 3.7B,D-K). No Gas2 protein is detected in these 
samples and expression by in situ is profoundly reduced though not completely absent, 
a finding we attribute to the homology of the in situ probe to the 5’ UTR of Gas2, thus 
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allowing it to detect newly transcribed mRNA that has yet to be degraded (Fig. 3.7D-K). 
An additional advantage of the EUCOMM Knockout first system is the ability to generate 
additional floxed and null alleles from the same construct. Experiments are underway to 
generate conditional (Gas2-tm1c) and null (Gas2-tm1d) alleles that can be utilized for 
additional experiments. 
The development of the cochlea is unaffected by loss of Gas2 
  We examined Gas2 mutants for defects in inner ear morphology at E14.5 using 
the paint fill technique (Fig. 3.8A,B). Gas2 mutant inner ears did not present with any 
defects in gross morphology and all structures of the vestibular apparatus and cochlear 
duct appeared normal. We next stained sections through control and Gas2 mutant ears 
at E11.5 and E18.5 with E-cadherin to look for any defects in early cochlear outgrowth or 
later maturation (Fig. 3.8C-F). At E11.5, the initiation of cochlear outgrowth is 
unperturbed by loss of Gas2 and no detectable differences in morphology are seen at 
E18.5 between control and mutant samples. We further interrogated the development of 
the organ of Corti on control and mutant sections at E18.5 for hair (Myosin VIIa) and 
support (Sox2) cells as well as innervation (Neurofilament) and found that all were 
unaffected in Gas2 mutants (Fig. 3.8.G-J). Examination of cochlear hair cells at E18.5 on 
whole mounted sensory epithelium revealed a normal compliment of these cells in the 
Gas2 mutant embryos (Fig. 3.8K-M). We thus conclude that Gas2 is not required for 
cochlear morphogenesis or for the development of the cell types within the cochlear duct 
during embryogenesis. 
Gas2 mutant mice have severe hearing impairment 
 Given the lack of an embryonic inner ear phenotype and that the cell types of the 
cochlea appeared unaffected in Gas2 mutants, we next sought to test these animals for 
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hearing deficits to potentially reveal a function for Gas2. Hearing was measured by 
auditory brainstem response (ABR) testing, utilizing both click and tone stimuli, in control 
and mutant animals at P42 and P70. Surprisingly, Gas2 mutant animals displayed a 
failure to respond to click stimuli resulting in an abnormal ABR waveform, indicative of a 
defect in sensation at the level of the cochlea (Fig. 3.9A). When exposed to tone stimuli 
of varying frequencies, Gas2 mutants showed an increased ABR threshold compared to 
controls (Fig. 3.9B). This defect was more pronounced at higher frequencies, with a 
~50db upward shift between 20 and 56kHz, than lower frequencies which displayed a 
~15db shift at 5kHz and a ~20db shift at 10kHz. These results were confirmed with an 
independent ABR cohort at P70 (data not shown). 
 We next sought a mechanism for the hearing loss detected in the Gas2 mutant 
animals. Our previous observation that Gas2 is expressed in the stria vascularis inspired 
us to ask if this tissue was functioning properly in these mutants. We stained control and 
Gas2 mutant cochlea for markers of the multiple cell layers of the stria vascularis. The 
morphology of the stria vascularis appeared unchanged (Actin) and normal patterns of 
staining were observed for marginal (Kcnq1 and Atp1A1), intermediate (CD44), and 
basal (Claudin 11 and Connexin 26) cells in the Gas2 mutants, indicating that these cells 
are both present and expressing the channel and junction proteins required for their 
function (Fig. 3.9C-N). To address the functionality of the stria vascularis we measured 
endocholear potential, a readout of ionic concentration within the cochlear duct, from 
control and Gas2 mutant inner ears (Fig. 3.9O). No difference was found in the 
endocochlear potential of Gas2 mutants when compared to controls suggesting that the 
stria vascularis is functioning as expected and that loss of Gas2 in these cells in unlikely 
to be the cause of hearing loss in these animals. 
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 To further interrogate hearing function in the Gas2 mutants we measured 
distortion product otoacoustic emissions (DPOAEs). DPOAEs are reflective of outer hair 
cell amplifier function and basilar membrane mechanics. Interestingly, Gas2 mutants 
displayed a lower DPOAE output than controls (Fig. 3.9P). Analysis of P42 sensory 
epithelium revealed a significant loss of outer hair cells, particularly in rows 2 and 3, in 
Gas2 mutants compared to controls, however, inner hair cells and total hair cell numbers 
were unaffected (Fig. 3.9Q-T). In spite of these findings, the loss of a relatively small 
percentage of outer hair cells is unlikely to cause the altered DPOAEs or severe hearing 
deficit seen in Gas2 mutants. While further analysis will be required to directly test outer 
hair cell functionality, our previous observations that Gas2 is not expressed in these cells 
leads us to conclude that another mechanism is likely responsible for the altered DPOAE 
and ABR responses of Gas2 mutants.  
The pillar cell cytoskeleton is disrupted in Gas2 mutant mice 
 In continuing to search for an explanation for the hearing deficits seen in Gas2 
mutant mice, we began to investigate a role for Gas2 in support cells. Pillar cells have 
previously been described as containing dense networks of actin and modified 
microtubules to act as a structural support for the organ of Corti during hearing response 
(Arima et al., 1986; Chan and Hudspeth, 2005; Nam and Fettiplace, 2010, 2010; 
Slepecky et al., 1995; Tannenbaum and Slepecky, 1997; Tolomeo and Holley, 1997). 
Gas2 is a putative cytoskeletal interacting protein, binding microtubules and actin 
filaments, and is expressed in pillar cells. Based on this information, we examined the 
cytoskeletal networks of control and Gas2 mutant pillar cells at P25. We confirm earlier 
reports that the pillar cells are enriched for post-translationally modified (acetylated and 
detyrosinated) microtubules as well as actin filaments (Fig. 3.10A,C,E,G). These 
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microtubule arrays are particularly evident in the pillar cell heads and phalangeal 
processes that extend between the rows of inner and outer hair cells. Surprisingly, we 
found that the pillar cells of Gas2 mutants displayed severe defects in their microtubule 
network. The inner pillar cell head appears depleted of microtubules at the outer hair cell 
connection and only short, disordered, bundles remain at the inner hair cell connection 
(Fig. 3.10B,D,F). Staining for actin revealed a normal localization pattern and analysis of 
cellular morphology of the pillar cells showed no alterations in Gas2 mutants compared 
to controls, suggesting that these cells are intact and that microtubules are uniquely 
affected by the loss of Gas2 (Fig. 3.10G-K). 
 We next set out to understand if the defects seen in Gas2 mutant pillar cells was 
due to a failure to establish or to maintain the microtubule network. We analyzed control 
and Gas2 mutants over a postnatal time course for detyrosinated tubulin, a marker of 
highly stable microtubules (Fig. 3.10L-W). Analysis of control and Gas2 mutant pillar 
cells at P5, a time point when the cytoskeletal network is established, revealed strong 
staining for detyrosinated microtubules in both genotypes, suggesting that Gas2 is 
dispensable for establishing the initial microtubule network in these cells (Fig. 3.10L-N). 
At P12 highly regular arrays of microtubule bundles are detected in control inner and 
outer pillar cell heads extending across the tunnel of Corti. Gas2 mutants at this stage 
begin to display defects in microtubule organization with small gaps in the cytoskeletal 
network at the center of the inner pillar cell head, however, the total amount of 
microtubules is not affected (Fig. 3.10O-Q). At P16, shortly after the onset of hearing, 
Gas2 mutant inner pillar cells display a marked reduction in tubulin, primarily at the 
center of the pillar cell head when compared to controls (Fig. 3.10R-T). These defects 
progress in the Gas2 mutant such that by P25 nearly 75% of the microtubules have 
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been depleted from the inner pillar cell head compared to controls (Fig. 3.10O-Q). 
Interestingly, the outer pillar cell phalangeal process appears less affected in the Gas2 
mutants although occasional cells present with tubulin deficiencies or aberrant 
morphology (Fig. 3.10B,D,F,S,T,V,W). 
 To gain insight into the microtubule organization in the pillar cell body, we 
analyzed control and Gas2 mutant sensory epithelia by transmission electron 
microscopy at P25. The body of control pillar cells display a dense meshwork of 
microtubules that occupy the majority of the cytoplasmic space (Fig. 3.11A,F). These 
microtubules are arrayed in regularly aligned rows and are tethered by crosslinking actin 
filaments (Fig. 3.11B,G). In Gas2 mutants, we found that the microtubule network of the 
pillar cell body was disrupted when compared to controls (Fig. 3.11C,D,H,I). The bodies 
of Gas2 mutant inner pillar cells show a trend for increased size and contained a more 
distributed network of microtubules when compared to controls (Fig. 3.11A-E). A small 
increase in cell size was found in Gas2 mutant outer pillar cells along with alterations in 
microtubule distribution (Fig. 3.11F-J). The central region of Gas2 mutant outer pillar 
cells contain irregularly spaced, single, microtubules with no apparent actin connections 
while small “islands” of interconnected microtubules remain at the periphery near the cell 
membrane. Close inspection of the disorganized microtubules of Gas2 mutants revealed 
that these tubules appear to lack the actin crosslinks seen in controls that are required to 
maintain the cytoskeletal network (Fig. 3.11B,D,G,I). Combined with our 
immunofluorescence analysis, these data suggest that Gas2 is required for maintaining 
the microtubule cytoskeletal network in pillar cells. 
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Discussion 
 We utilized RNA sequencing to compare the transcriptomes of control and 
Smoecko otic vesicles and discovered a cohort of cochlear enriched transcripts. Our 
analysis of 21 of these genes by in situ hybridization on control inner ears at E11.5 
revealed that they are expressed in four partially overlapping domains of the cochlear 
duct: broad ventral, medially restricted, ventral tip restricted, and lateral wall restricted. 
These domains are of particular note as they coincide with the expression patters of 
known Shh responsive transcription factors Gli1, Pax2, Gata3, and Otx2 (Brown and 
Epstein, 2011). Based on these expression domains it is appealing to hypothesize that 
these transcription factors function downstream of, or in concert with, Shh signaling to 
regulate the activity of the examined genes. Analysis of the promoter regions and 
potential enhancers near genes in our dataset should be carried out to determine if 
binding sites for the transcription factors Gli1, Pax2, Gata3, and Otx2 are enriched for in 
these regions and followed by ChIP studies to confirm these observations. 
 While our experiments do not address the regulatory logic of the analyzed genes, 
we are able to confirm that the majority of these show responsiveness to Shh signaling 
with in situ hybridization experiments on embryos with a loss of Shh signaling 
responsiveness (Smoecko) and with a gain of Shh in the dorsal otocyst (ShhP1). Further 
experiments will be required to test if these genes are direct targets of Shh signaling, 
however, two observations deserve attention. First, our results corroborate evidence for 
Shh responsiveness of a subset of analyzed genes. Previous experiments with an ear 
specific Smom2 mouse line, which results in overactive Shh signaling response, and 
cochlear explants treated with Shh ligand found activation of Hey1 and 2 (Benito-
Gonzalez and Doetzlhofer, 2014; Tateya et al., 2013). We similarly find that Hey1 shows 
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responsiveness to Shh signaling in our gain and loss of function studies, providing 
corroboration of these observations. Fst and Bmp4 were described as being regulated 
by Shh signaling in an ear specific Smom2 mouse line (Son et al., 2012, 2015). These 
genes were previously found to be expressed in an apical to basal gradient that 
correlates with auditory tonotopy, the ability of different regions of the cochlea to respond 
to different sound cues, and that an increase in Fst and decrease of Bmp4 is observed in 
the Smom2 inner ear. Here, we provide an additional example of Fst upregulation in 
response to ectopic Shh and that its expression is lost when Shh signaling is abrogated. 
While we did not examine Bmp4 expression we note that it was identified as putatively 
upregulated in our RNA-seq dataset, suggesting a similar regulation by Shh. These data 
add support to the hypothesis that Shh signaling may be a factor in establishing, or 
maintaining, tonotopy in the cochlea.  
Of interest, our expression analysis also contradicts a previous report that Six1 is 
not regulated by Shh in the inner ear. In Shh null embryos Six1 expression was found to 
be unaffected while we report alterations of Six1 in the Smoecko and ShhP1 lines (Ozaki 
et al., 2004). The discrepancies between these findings may be due, at least in part, to 
the alterations in Wnt signaling and gene expression patterns in the Shh null otocyst as 
well as a complex regulatory mechanism governing Six1 expression. These findings are 
of particular interest as Shh and Six1 null embryos share a similar inner ear phenotype, 
suggestive of cooperation between these factors.  Further experiments will be required 
to address the responsiveness and cooperativity between Shh signaling and Six1 
expression and to reconcile these two reports. 
 An additional finding from our Shh signaling analysis is that the gene expression 
along the cochlear lateral wall is defined by a complex regulatory logic. Genes normally 
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restricted laterally at E11.5, Otx2, Capn6, and Rspo2, require Shh for their expression 
but are not activated in response to ectopic signaling. This suggests that additional 
regulators are required for their expression beyond Shh. Intriguingly, the loss of these 
factors coincides with the gain and/or maintenance of lateral expression for Eya1, Eya4, 
Jag1, Six1, and Sox2 while their medial expression is lost. Previous reports of an inner 
ear specific deletion of Otx2 found that the cochlear lateral wall of these mutants was re-
specified into a sensory cell fate and ectopically expresses Jag1 and Sox2 (Vendrell et 
al., 2015). These data suggest that Otx2 is downstream of Shh signaling and acts as a 
repressor of cell fate on the cochlear lateral wall. Further interrogation of the regulatory 
sequences of these genes along with other differentially expressed transcripts in the 
Smoecko mutant may reveal novel control mechanisms for sensory and lateral cell fates of 
the cochlear duct.  
 The goal of our RNA-seq experiment was to uncover novel regulators of cochlear 
development and function that are Shh responsive. We chose to pursue Gas2 as a 
strong candidate gene given its previously described functions as a cytoskeletal binding 
protein. Gas2 is expressed early in cochlear development at the ventral tip and along the 
medial wall and demonstrates responsiveness to alterations in Hh signaling in the ear. 
Later in development and postnatally, Gas2 is enriched in the stria vascularis and 
support cells, particularly the pillar and Deiters’ cells. We developed a Gas2 knockout 
mouse line and found that cochlear morphogenesis and cell fate specification are 
unperturbed by the loss of this gene. In spite of these findings, Gas2 mutant mice 
display profound hearing deficits. Another group has described that female Gas2 
deficient mice also present with ovarian dysfunction and low fertility (York et al., 2016). 
Interestingly, Perrault syndrome is a disorder characterized by hearing impairment and 
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female infertility due to ovarian failure caused by mutations in genes that function in the 
mitochondria: CLPP, HARS2, HSD17B4, LARS2, and TWNK (Gispert et al., 2013; 
Jenkinson et al., 2013; Lerat et al., 2016). The microtubule cytoskeleton is required for 
the proper localization of mitochondria and disruptions of this network, as seen in Gas2 
mutant mice, could lead to mislocalization and dysfunction of these organelles (Frederick 
and Shaw, 2007; Melkov and Abdu, 2018). This is particularly interesting as Clpp is also 
expressed in pillar and Deiters’ cells at a similar timepoint as Gas2 (Gispert et al., 2013). 
Experiments will need to be performed to address the localization and function of 
mitochondria within the Gas2 mutant pillar cells. Additionally, while Perrault syndrome 
has yet to be linked to disruptions in GAS2, we recommend that these and other cases 
where low fertility is comorbid with hearing loss be screened for mutations in GAS2. 
 Previous studies of Gas2 mutant mice and Pigs deficient drosophila found an 
aberrant increase in Notch signaling that correlated with aspects of the ovarian 
phenotype in these models (Pines et al., 2010; York et al., 2016). Notch signaling is 
critically required in inner ear development for the specification of the proper numbers of 
hair and support cells (Brooker et al., 2006; Hao et al., 2012; Kiernan et al., 2006; 
Petrovic et al., 2014; Takebayashi et al., 2007; Tateya et al., 2011). Inner ear specific 
activation of Notch signaling, either embryonically or postnatally, leads to defects in 
sensory development with ectopic support cells, transformations of sensory cells, and 
dysmorphology of the cochlear duct (Campbell et al., 2016; Liu et al., 2012a, 2012b; Pan 
et al., 2013; Savoy-Burke et al., 2014; Tateya et al., 2015). As we did not observe any of 
these phenotypes in Gas2 mutant cochlea we were not encouraged to investigate Notch 
signaling in these animals. While we do not anticipate observing an upregulation in 
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Notch signaling in Gas2 cochlea it will be important for further studies to examine this 
pathway and rule out any potential contribution to the phenotypes seen in these mice. 
 Our findings that Gas2 mutants exhibited hearing loss prompted us to examine 
the cell types in which this gene is expressed for signs of dysfunction. Mutations in 
genes affecting the function of the stria vascularis are known to cause hearing loss, thus, 
we examined the development and function of these cells (Chen and Nathans, 2007; 
Collin et al., 2008; Lee et al., 2000; Neyroud et al., 1997; Rickheit et al., 2008; 
Schlingmann et al., 2004). We found that the major cell types of the stria vascularis are 
intact in Gas2 mutants and that endocochlear potential was generated normally. These 
data strongly suggest that the stria vascularis is not affected by the loss of Gas2. This 
leaves open the question of why Gas2 is expressed in these cells and what its function 
therein may be. Little is understood about the cytoskeleton of the stria vascularis, 
however, it is known that adherens and tight junctions, protein structures often coupled 
to actin and microtubules, are required for its function (Chausovsky et al., 2000; 
Stehbens et al., 2006). A basal cell knockout of E-cadherin revealed that proper 
adherens junctions are required for generation of endocochlear potential, likely by 
preventing outward flow of ions from the endolymph (Trowe et al., 2011). In addition, 
mice deficient in Claudin-11, a critical component of tight junctions, display severe 
hearing loss coupled to decreased endocochlear potential in the absence of 
morphological defects (Kitajiri et al., 2004). While we found no evidence for a defect in 
the stria vascularis of Gas2 mutants, it is intriguing to speculate on a potential link 
between Gas2 and E-cadherin or Claudin-11, or alternative roles for this gene in the stria 
vascularis that will need to be addressed in future studies.   
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 The pillar cells of the organ of Corti possess a dense network of modified 
microtubules (Slepecky et al., 1995; Henderson et al., 1994; Tolomeo and Holley, 1997; 
Tannenbaum and Slepecky, 1997). Our observations of acetylated and detyrosinated 
microtubules in these cells are in agreement with previous findings and supports the 
idea that these cells contain a highly stable cytoskeletal network (Slepecky et al., 1995; 
Tannenbaum and Slepecky, 1997). We discovered that, in Gas2 mutants the pillar cells 
microtubule network forms but is not maintained, such that around the onset of hearing 
these cells rapidly become depleted of tubulin. This suggests that Gas2 is likely 
dispensable for building the cytoskeleton of the pillar cells but is required to maintain the 
microtubule network once hearing begins. Measurements of pillar cell stiffness by atomic 
force microscopy has found that this cellular property requires an intact microtubule 
network (Szarama et al., 2012a). Similar measurements on Gas2 null pillar cells would 
corroborate these findings and lend additional insight into the defects seen in these 
mutants. Transmission electron micrographs of Gas2 pillar cells revealed that the 
microtubules are disordered and lack many of the actin crosslinks required for their 
organization, indicative of a putative function for Gas2 as an actin/microtubule cross 
linker. Pillar cells that have been treated with Triton-X to disrupt actin-microtubule 
interactions also display a disorganization of the cytoskeleton, however, no in vivo 
experiment has yet tested the requirement for these crosslinks, or the pillar cell 
cytoskeleton in general, in hearing function (Tolomeo and Holley, 1997). These findings 
are particularly interesting as the morphology of the organ of Corti, including the pillar 
cells, appears largely unaffected by the loss of Gas2. 
 During the course of our experiments, we observed a dynamic loss of 
microtubules from the Gas2 mutant pillar cell that appeared to begin near the central 
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region of these cells. This observation is of interest because it suggests that 
microtubules at the center of the cell are either more dynamic or more susceptible to 
catastrophe than those at the cell membrane. Adherens junctions, such as E-cadherin, 
are enriched at the cell-cell contacts of epithelial cells and recruit and stabilize the 
microtubule and actin cytoskeleton (Bellett et al., 2009; Chausovsky et al., 2000; Ligon 
et al., 2001; Stehbens et al., 2006; Waterman-Storer et al., 2000). It is likely that these 
interactions stabilize the microtubule networks in pillar cells and prevent catastrophe of 
these filaments longer than their more centrally localized counterparts. It is also possible 
that the central region of the pillar cell experiences quantitatively different forces during 
auditory evoked movements than the junctional regions which could increase strain on 
and destabilize microtubules (Chan and Hudspeth, 2005; Karavitaki and Mountain, 2007; 
Nam and Fettiplace, 2010). Further studies will be required to address the potentially 
stabilizing nature of adherens junctions in pillar cells and the stresses put on these cells 
during auditory responses. 
The observed defects in the microtubule network of pillar cells coupled with the 
lack of phenotypes in other sites of Gas2 expression lead us to conclude that pillar cell 
dysfunction is the root cause of the hearing deficits seen in these animals. While we 
found that Gas2 mutant animals displayed loss of ~10% of outer hair cells this is unlikely 
to result in the level of hearing impairment or decrease in DPOAE response found in 
these mice. Additionally, Gas2 is not found to be expressed in the sensory hair cells and 
their development and morphology appear unperturbed in these mutants. While 
additional work will be required to fully exclude any contribution of hair cell dysfunction to 
hearing loss in Gas2 mutants, our findings suggest that these perturbation of these cells 
does not contribute to the phenotype. Our experiments have also determined that loss of 
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Gas2 expression from the stria vascularis is not contributing to hearing dysfunction. 
Previous work has described the requirement for pillar cells for the proper response to 
sound stimuli (Mansour et al., 2009, 2013; Mellado Lagarde et al., 2013; Shim et al., 
2005). Furthermore, the microtubule cytoskeleton is likely required for the force bearing 
properties of these cells during hearing response (Chan and Hudspeth, 2005; Kraus and 
Aulbach-Kraus, 1981; Nam and Fettiplace, 2010; Slepecky et al., 1995; Szarama et al., 
2012c; Tannenbaum and Slepecky, 1997; Tolomeo and Holley, 1997; Zetes et al., 
2012). Of interest, we observed that the hearing loss in Gas2 mutants was more severe 
at higher frequencies, corresponding to defects at the more basal regions of the cochlea. 
It has been observed that pillar cells at the cochlear base have a higher stiffness and 
greater numbers of microtubule than those at the apex, properties which are inversely 
correlated with basilar membrane stiffness (Dallos, 1996; Emadi and Richter, 2008; 
Kikuchi et al., 1991; Zetes et al., 2012). These intrinsic properties of the pillar cells and 
basilar membrane suggest that pillar cells at the base are reliant on their stiffness than 
those at the apex. This may explain the discrepancies in hearing impairment between 
high and low frequencies in the Gas2 mutants. Based on these findings, we propose that 
the Gas2 null mouse line may reveal, and provide an excellent model for testing, aspects 
of pillar cell functions that are required for hearing. 
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Figures 
 
Figure 3.1. The Hedgehog signaling pathway. (A) In the absence of Hh ligand, Ptch is 
localized to the primary cilium and prevents the accumulation of Smo. Gli2 and 3 are 
bound by Suppressor of fused and sequestered into the cytoplasm where they are 
phosphorylated and proteolytically cleaved. Gli2 is degraded while N-terminal Gli3 can 
translocate to the nucleus and act as a transcriptional repressor. (B) Binding of Ptch by 
Hh ligand allows Smo to translocate to the primary cilium. Activated Smo re-localizes the 
Sufu-Gli complex to the cilia, relieving the repression of Gli by Sufu. Gli2/3 then remain 
in their full-length isoforms and translocate to the nucleus to act as transcriptional 
activators of Hh target genes such as the additional activator, Gli1. 
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Figure 3.2. RNA-seq on Smoecko mutants reveals cochlear enriched transcripts. (A) 
Plot of differentially expressed genes between wild type and Smoecko otic vesicles at 
E11.5 (n=4 replicates). (B) Gene Ontology term enrichment for differentially expressed 
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genes between wild type and Smoecko otic vesicles. (C) Heatmap of differentially 
expressed genes. (D-AB) Transverse sections through E11.5 wild type otic vesicles 
showing expression of genes identified by RNA-seq. (AC) Schematic displaying WT 
expression patterns at E11.5 for comparison. Scale bar = 100µm.  
119 
 
 
Figure 3.3. Loss of cochlear expressed genes in Smoecko mutants. (A-Q) Transverse 
sections through E10.5 Control and Smoecko otic vesicles showing differential expression 
of genes identified by RNA-seq (N≥3 for all panels). (R) Schematic displaying WT 
expression patterns at E11.5 for comparison. Scale bar = 100µm.  
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Figure 3.4. ShhP1 mutants reveal Shh regulated genes. (A-Y) Transverse sections 
through E11.5 ShhP1 otic vesicles showing differential expression of genes identified by 
RNA-seq (N≥3 for all panels). Black arrowheads indicate ectopic expression. (Z) 
Schematic displaying WT expression patterns at E11.5 for comparison. Scale bar = 
100µm. 
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Figure 3.5 Sox2 and Jag1 respond to altered Shh signaling. (A-J) Transverse 
sections through E11.5 (A-F) Control, ShhP1, and Smoecko and E10.5 (G-J) Control and 
Smoecko otic vesicles showing ectopic localization of Sox2 and Jag1 (N=4 for all panels). 
Scale bar = 100µm. 
  
122 
 
 
Figure 3.6. Gas2 is expressed in the developing and postnatal cochlea. (A) 
Schematic of Gas2 locus in the mouse genome and encoded protein. (B) E11.5 embryo 
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showing Gas2 expression in limbs and somitic mesoderm. (C-I) Transverse sections 
through wild type otic vesicles (C,D) and cochlear ducts (E-I) over several 
developmental stages showing dynamic Gas2 expression. (J-L) Transverse sections 
through wild type otic vesicle (J) and cochlear duct (K,L) showing Gas2 protein 
localization. Scale bar = 400µm (B), 100µm (C,D,J), 50µm (E-I, K) and 10µm (L). 
Abbreviations: Claudius Cells (CCs), cochlear duct (cd), Deiters’ Cells (DCs), dorsal (D), 
endolymphatic duct (ed), Inner Hair Cell (IHC), lateral (L), lateral cochlear epithelium 
(lce), medial (M), prosensory domain (psd), organ of Corti (oC), otic vesicle (ov), Outer 
Hair Cells (OHCs), outer sulcus (os), Pillar Cells (PCs), Reissner’s membrane (Rm), 
stria vascularis (sv), ventral (V), vestibular outpouch (vo). 
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Figure 3.7. Generation of a Gas2 null mouse line. (A) Schematic of Knockout first 
(tm1a) targeted Gas2 locus. (B) Western blot showing loss of Gas2 protein from E14.5 
limb tissue in Control, heterozygous (+/-) and homozygous (-/-) tm1a embryos (N=3). (C) 
Table displaying statistically normal Mendelian ratios of Gas2-tm1a mice generated from 
heterozygous intercrosses. (D-K) Transverse sections through Control and Gas2 mutant 
otic vesicles (D-G) and cochlear ducts (H-K) showing loss of Gas2 transcript and protein 
(N=3). Scale bar = 100µm (D-G) and 50µm (H-K). 
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Figure 3.8. Inner ear development is unaffected by loss of Gas2. (A-B) Inner ear 
paint fills of control and Gas2 mutant embryos at E14.5. (C-F) Transverse sections 
through control and Gas2 mutant E11.5 otic vesicles (C,D) and E18.5 cochlear ducts 
(E,F) stained for E-cadherin to highlight morphology. (G-J) Transverse sections through 
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E18.5 control and mutant cochlea reveal normal (G,H) hair cell (Myo7a) morphology, 
innervation (Neurofil = neurofilament) and (I,J) support cell compliment (Sox2). (K,L) 
E18.5 whole mount preparations of control and Gas2 mutant cochlear sensory 
epithelium stained with markers of hair cells (Myo7a) and actin/stereocilia (Phalloidin) 
with quantification (M) of total hair cells represented as mean ±SD (student's T-test, ns = 
not significant). N = 3 (A-J) and 5 (K-M). Scale bar = 100µm, (A,B), 50µm (C-F), and 
10µm (G-L) 
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Figure 3.9. Gas2 mutants exhibit severe hearing impairment. (A) Representative 
waveforms obtained from ABR click response from Control and Gas2 mutants at P70 
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(N=8). (B) ABR thresholds from P56 Control (N=6) and Gas2 mutants (N=5) 
(***P<0.001, multiple T-test with Holm-Sidak method). (C-N) Transverse sections 
through P25 Control and Gas2 mutant cochlea stained for markers of the stria vascularis 
(N=3). (O) Graph of endocochlear potential readings from P56 Control (N=6) and Gas2 
mutant (N=5) animals (ns=not significant, T-test). (P) Graph of DPOAE recordings from 
P56 Control (N=6) and Gas2 mutants (N=5), gray shading indicates significant difference 
(P<0.05, multiple T-test with Holm-Sidak method). (Q-R) Whole mount preparations of 
control and Gas2 mutant cochlear sensory epithelium stained with markers of hair cells 
(Myosin VIIa) at P42, white arrowheads indicate missing hair cells. (S-T) Quantification 
of (S) total and (T) missing hair cells from control and Gas2 mutants at P42 (N=3) 
presented as mean ±SD (ns=not significant, **P<0.01, ***P<0.001, T-test). Scale bar = 
(C-K, O-P) 25µm and (M-N) 50µm. 
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Figure 3.10. Gas2 mutants display progressive loss of microtubules from the inner 
pillar cell head. (A-H) Whole mount preparations of P25 control and Gas2 mutant 
cochlear sensory epithelium stained with markers of the microtubule (A-F) and actin 
(G,H) cytoskeleton (N=3). (I-K) Graphs of measurements from P25 control and mutant (I) 
inner to outer hair cell distance, (J) inner pillar cell head width, and (K) outer pillar cell 
head length presented as mean ±SE (N=5; ns=not significant, T-test). (L,M,O,P,R,S,U,V) 
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Whole mount preparations of control and Gas2 mutant cochlear sensory epithelium at 
(L,M) P5 (N=4), (O,P) P12 (N=3), (R,S) P16 (N=3) and (U,V) P25 (N=5) stained for 
detyrosinated-tubulin showing progressive loss of microtubules in Gas2 mutants. 
(N,Q,T,W) Quantification of detyrosinated-tubulin fluorescent pixels at (N) P5, (Q) P12, 
(T) P16, and (W) P25 presented as mean ±SE (ns=not significant, * P,0.05, ***P<0.001, 
T-test). Scale bar = (A-H,O,P,U,V) 5µm, (R,S) 8µm, and (L,M) 10µm. Abbreviations: 
Deiters’ cells (DCs), Inner Pillar Cell (IPC), Inner hair cell To Outer hair cell distance 
(ITO), and Outer Pillar Cell (OPC).   
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Figure 3.11. Electron microscopy reveals disorganization of the pillar cell 
microtubule network in Gas2 mutants. Transmission electron micrographs of P25 
(A,B,F,G) control and (C,D,H,I) Gas2 mutant (A-D) inner (red outline) and (F-I) outer 
pillar cells showing microtubule disorganization with (B,D,G,I) higher magnification of 
representative areas (N=3). (E,J) Graphs of (E) inner and (J) outer pillar cell size 
presented as mean ± SE (N=3, average of 3 cells per sample; T-test). Scale bar = 
(A,C,F,H) 500nm and (B,D,G,I) 100nm. 
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Materials and Methods 
Mouse lines 
Generation of FoxG1Cre/+, ShhP1, Smo+/-, and Smoloxp/loxp mouse lines are described 
elsewhere (Hébert and McConnell, 2000; Long et al., 2001; Riccomagno et al., 2002; 
Zhang et al., 2001). 
 
The Gas2tm1a/+ mouse line was generated from ES-cells obtained from the European 
Conditional Mouse Mutagenesis Program (EUCOMM) containing a targeted Knockout 
first allele in Gas2 (Cone: HEPD0681_7_F03). Targeted ES-Cells were screened for 
proper targeting by PCR amplification of the 5’ and 3’ homology arms with one primer 
anchored in the genomic locus and the second within the targeting construct (5`F-
GAAGTTCCTATTCCGAAGTTCCT, 5`R-CTGCCTGTGTTGAATGTTCTCAT, 7076bp 
amplicon; 3`F- CCTGCTTGCCGAATATCATGG, 3`R- ACTTCTGTGGAGTCTCAGCTC, 
6493bp amplicon).  ES-Cells containing the Gas2 targeted allele (Gas2tm1a/+) were 
injected into albino C57B/6N-tac blastocysts at the UPenn Transgenic and Chimeric 
Mouse Facility and chimeric mice obtained.  
High percentage chimeras (>90% black/agouti coat) were bred to albino C57B/6N-tac 
mice and the resulting pups were screened for the Gas2-tm1a allele by coat color and 
PCR genotyping. Genotyping primers were designed to flank the floxed Gas2 exon 5 
and generate bands of differing size for the targeted and WT allele (F-
TTGGATCATATGGAGAGAGCCAT, R-GGGCATATCACAGGCCCATA, Products: 
223bp – WT; 257bp – Loxp/Tm1a) using the following thermocycler program:  
95ºC for 5 min, 95ºC for 30 sec, 58ºC for 30 sec, 72ºC for 18 sec, Repeat 2-4 for 31x, 
72ºC for 10 min (*this program is utilized for all subsequently described primer sets). 
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Resulting Gas2tm1a/+ mice were backcrossed to WT C57B/6N-tac for 10 generations and 
maintained by heterozygous intercrosses. 
Conditional Gas2-tm1c mice were generated by crossing Gas2tm1a/+ to a constitutively 
active Flp recombinase (B6.129S4-Gt(ROSA) 26Sortm2(FLP*)Sor/J [FLPo]) to remove the 
Lacz-Neomycin cassette. Recombination and loss of the cassette was confirmed by 
PCR genotyping (F-GGCGCATAACGATACCACGA, R-TATAAGCCGCCTACTGCGAC) 
which amplifies a 208bp fragment from the recombined region (*this will not detect a WT 
allele from the endogenous locus due to the placement of primers within the extended 
homology arms). Additional primer sets that amplify across the Lacz (F-
AGAACAAGCAACATGCGCTC, R-GACCTTGGGACCACCTCATC, 611bp amplicon) 
and Neomycin (F-CTCCCCCTGAACCTGAAACATA, R-
TTATATAAGCCGCCTACTGCGA, 360bp amplicon) inserts were also included as 
negative controls. Resulting FLPo;Gas2tm1c/+ were backcrossed to WT C57B/6N-tac to 
remove the FLPo allele then intercrossed and maintained as homozygous Gas2tm1c/tm1c. 
The Gas2-tm1d allele was generated by crossing homozygous Gas2tm1c/tm1c to a 
germline expressed Cre recombinase (B6.FVB-Tg(EIIa-cre) C5379Lmgd/J [E2a-Cre]). 
Recombination and deletion of Gas2 exon 5 was confirmed by PCR genotyping (F-
GGCGCATAACGATACCACGA, R-GGGCATATCACAGGCCCATA, 225bp amplicon) as 
well as previously described primer sets as negative controls. Resulting E2a-
Cre;Gas2tm1d/+ animals were backcrossed to WT C57B/6N-tac to remove the E2a-Cre 
allele then intercrossed and maintained as Gas2tm1d/+. 
RNA sequencing 
Otic vesicles from control (FoxG1Cre/+; Smoloxp/+) and Smoecko mouse embryos (n=4 pairs 
of biological replicates) were isolated at E11.5, exposed to collagenase P (1mg/ml) at 
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37oC for 20 min to remove surrounding mesenchyme, and transferred into chilled 
RNAlater™ Stabilization Solution (Invitrogen). RNA was extracted using an RNeasy 
Micro RNA extraction kit (Qiagen) according to standard protocols. Total RNA (200ng) 
was used for poly A selected RNA-seq library preparation using the NEBNext® Ultra™ 
Directional RNA Library Prep Kit from Illumina® (mRNA) (New England Biolabs) 
(products: NEBNext® Poly(A) mRNA Magnetic Isolation Module (E7490S) and 
NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (E7420S). Biological 
replicates were individually barcoded, pooled, and sequenced on one lane of a HiSeq 
400 platform with a read depth of 45 million per library at the Penn Next Generation 
Sequencing Core (NGSC) Facility. Alignment and expression values were determined 
using RUM (Grant et al. 2011).  
Inner ear paint fill 
Paint fills were performed essentially as described (Martin and Swanson, 1993) with the 
use of White-Out Plus (Bic, Milford, CT, USA) as the contrast medium.  
In situ hybridization 
Embryos were collected from timed pregnant females (vaginal plug = E0.5). Postnatal 
mice were euthanized with CO2 and the inner ears were dissected from the head and 
fixed for 2 hours in 4% paraformaldehyde at 4°C, then washed in PBS. Inner ears were 
cryoprotected overnight in 30% sucrose/PBS then snap frozen in OCT embedding 
compound (Sakura Finetek Torrence, CA). Inner ears were serially sectioned along the 
transverse plane from anterior to posterior. Sections were hybridized with digoxigenin-
UTP-labeled riboprobes as previously described (Nissim et al., 2007). 
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Whole mount cochlear preparations 
Inner ears were dissected and fixed in 4% paraformaldehyde for 2 hours at 4°C, then 
washed in PBS. Cochleae were microdissected in 0.1% PBST to expose the sensory 
epithelium, and incubated with antibodies found in Key Resources. Hair cells were 
counted along the entire length of the cochlear duct. 
Immunohistochemistry 
Inner ears were processed for immunohistochemistry in the same fashion as for in situ 
hybridization. Inner ear sections were stained with DAPI and antibodies found in Key 
Resources.  
Western blots 
E14.5 embryonic limbs were collected in RIPA buffer and protein extracted by manual 
homogenization. Total protein lysate was separated on 4-12% Mini-PROTEAN® TGX™ 
Precast Gels at 120V for 1 hour and transferred to PVDF membranes for 1 hour at 
250mA. Membranes were blocked for 1 hour in Odyssey® Blocking Buffer (LI-COR) at 
RT and incubated overnight at 4ºC in primary antibodies found in Key Resources. 
Membranes were washed 4x 10 minutes with .1% Tween-PBS then incubated for 1 hour 
at RT with IRDye® 680LT Goat anti-Mouse IgG (1:20000) and IRDye® 800CW Goat 
anti-Rabbit IgG (1:20000) in Odyssey® Blocking Buffer. The membranes were washed 
4x 10 minutes with .1% Tween-PBS then imaged on an Odyssey® CLx Imaging System 
(LI-COR). 
Auditory Brainstem Response 
All recordings were from the left ear. ABR recording was carried out using Tucker-Davis 
Technologies (TDT) System II hardware and software. Animals were anesthetized using 
ketamine and xylazine (80/15 mg/kg, intraperitoneal injection) and positioned dorsally in 
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a custom head holder. Subdermal platinum needle electrodes (Grass) were placed in the 
mid-back (ground), behind the right pinna (reference), and at the vertex (active). Body 
temperature was monitored throughout testing using a rectal probe, and maintained at 
37.5 ± 1.0°C using a DC current-based isothermal pad (FHC). A TDT ES-1 speaker was 
placed 7 cm along the interaural axis. Stimuli were 5 ms tone bursts (1000 repetitions, 
20/s, 1.0 ms rise/fall time) at frequencies of 5, 10, 20, 28.3, 40 and 56.6 kHz. Responses 
were amplified x100,000 and filtered at 100-10,000 Hz. Thresholds were taken to be the 
lowest sound level for which Wave I could be identified, using a 5dB minimum step size.   
 
Mice were anesthetized with isoflurane (1–2.5%) and electrodes were inserted 
subdermally (recording electrode—posterior to the pinna of the exposed ear; reference 
electrode—anterior cranial midline; ground electrode—posterior cranial midline). 
Thresholds were obtained for tones at 8, 12, 16, 22, 28 kHz (5ms duration with 0.1ms 
ramp for 1200 repetitions) presented from 10–80 dB SPL in 10dB steps. ABR signals 
were amplified, filtered (band passed 300 Hz-2000 Hz), and averaged using Neuralynx 
(Cheetah software). Data was analyzed with MATLAB (The MathWorks, Inc.). 
Distortion product otoacoustic emissions 
DPOAE recordings were obtained in a separate session from ABR recordings, but the 
animals were prepared similarly as for ABRs. DPOAE iso-input (DP-gram) responses 
were obtained using EMAV (S. Neely, Z. Liu, BTNRH) in conjunction with TDT and 
custom hardware using f2 frequencies ranging from 5-40 kHz. F1 frequencies were 
given by f2/1.2.  L1 and L2 levels were set at 75 and 65 dB SPL, respectively.  Stimuli 
were delivered to the ear using a custom coupler inserted using an operating scope. 
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Each channel was output to a TDT EC-1 speaker. DPOAE responses were recorded 
using a Knowles FC-23652-P16 microphone calibrated to 40 kHz. 
Endocochlear potential recording 
After ABR and DPOAE recording, animals underwent a single terminal EP measurement 
from the cochlear lower basal turn of the left ear. Animals were anesthetized (60 mg/kg 
sodium pentobarbital, IP) and positioned ventrally in a custom head holder. Core 
temperature was maintained at 37.5 ± 1.0 oC using a thermostatically-controlled heating 
pad in conjunction with a rectal probe (Yellow Springs Instruments Model 73A). An 
incision was made along the midline of the neck and soft tissues were blunt dissected 
and displaced laterally to expose the trachea and left bulla. A tracheostomy was then 
made and the musculature over the bulla was cut posteriorly to expose the bone 
overlying the round window. Using a fine drill, a hole was made in the left cochlear 
capsule directly over scala media of the lower basal turn. Glass capillary pipettes (40-80 
M) filled with 0.15 M KCl were mounted on a hydraulic microdrive (Frederick Haer) and 
advanced until a stable positive potential was observed that did not change with 
increased electrode depth. The signal from the recording electrode was led to an AM 
Systems Model 1600 intracellular amplifier. A silver/silver chloride ball inserted into the 
neck muscles served as ground. 
Transmission electron microscopy 
Inner ears were dissected from postnatal animals after euthanasia with CO2. The apical 
turn was opened by cutting a hole in the otic capsule and the cochlea was perfused 
through the round window every 15 minutes with a mixture of 2% glutaraldehyde and 1% 
tannic acid in PBS for 90 minutes. The inner ear was then decalcified in 0.5M EDTA 
overnight at 4ºC. After decalcification the otic capsule, spiral ganglia and stria vascularis 
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were removed to expose the sensory epithelium. The sensory epithelium was then 
postfixed in 1% OsO4 for 90 minutes, dehydrated in ethanol, permeated in propylene 
oxide, and embedded in Epon resin. Sections were taken on a diamond wafer blade, 
stained with uranyl acetate and lead citrate and imaged on Jeol-1010 Transmission 
electron microscope. 
Quantification and Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 7 software. Relevant 
information for each experiment including n-values, statistical tests and reported p-
values are found in the legend corresponding to each figure. In all cases P<0.05 is 
considered statistically significant. 
Quantification of pillar cell size was performed on phalloidin and tubulin stained whole 
mount images using ImageJ. A total of 6 inner and 6 outer pillar cells were measured 
from each sample at approximately the mid-basal turn of the cochlea.  
Quantification of detyrosinated tubulin fluorescence was performed on binary 
thresholded images and total white (positive) pixels per unit area was calculated using 
ImageJ. A total of 6 inner and 6 outer pillar cells were measured from each sample at 
approximately the mid-basal turn of the cochlea. 
RNA-seq results were processed using edgeR (Robinson et al., 2010) to detect 
differentially expressed transcripts with FDR<0.05 and RPKM>1. 
Data and Software Availability 
RNA sequencing data will be made accessible at the NCBI Gene Expression Omnibus. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies (dilution) 
mouse anti-Acetylated-tubulin (1:200) Sigma T 6793 
mouse anti-Alpha-tubulin (1:200) Cell Signaling 3873 
mouse anti-Atp1A1 (1:250) Developmental Studies 
Hybridoma Bank 
A5 
rat anti-CD44 (1:200) BD Parmingen 550538 
rabbit anti-Claudin-11 (1:100 +AR) Novex 364500 
mouse anti-Connexin-26/Gjb2 (1:200) Thermo Scientific 71-0500 
rabbit anti Detyrosinated-tubulin (1:200) abcam ab48389 
mouse anti-E-cadherin (1:200 +AR) BD Transduction 
Laboratories 
610181 
mouse anti-Gas2 (IF-1:200; WB-1:2000) Santa Cruz SC-101241 
rabbit anti-Gas2 (1:500) Abcam ab109762 
rabbit anti-Jag1 (1:200 +AR) Santa Cruz SC-8303 
goat anti-Kcnq1 (1:300) Santa Cruz SC-10646 
rabbit anti-MyosinVIIa (1:500) Proteus Biosciences 25-6790 
mouse anti-Neurofilament (1:200) Developmental Studies 
Hybridoma Bank 
2H3 
Mouse anti-Sox2 (1:200 +AR) R&D Systems MAB2018 
donkey anti-mouse IGG Alexa488 (1:200) Molecular Probes A-21202 
donkey anti-rabbit IGG Alexa594 (1:200) Molecular Probes A-21207 
rabbit anti-goat IGG Alexa488 (1:200) Molecular Probes A-11078 
donkey anti-rat Alexa488 (1:200) Molecular Probes A-21208 
IRDye® 680LT Goat anti-Mouse IgG (1:20000)  LI-COR 925-68020 
IRDye® 800CW Goat anti-Rabbit IgG (1:20000) LI-COR 925-32211 
*AR, antigen retrieval – boil for 6 minutes in 10mM citric acid buffer (pH 6.0) 
 
Chemicals, Peptides, and Recombinant Proteins 
Phalloidin conjugated Alexa488 (1:50) Molecular Probes A-12379 
Odyssey® Blocking Buffer LI-COR 927-40000 
Critical Commercial Assays 
NEBNext® Poly(A) mRNA Magnetic Isolation 
Module 
New England 
Biosystems 
E7490S 
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Directional RNA Library Prep Kit for Illumina® New England 
Biosystems 
E7420S 
Deposited Data 
RNA-seq raw and analyzed data This paper  
Experimental Models: Cell Lines 
Mouse: Gas2tm1a(EUCOMM)Hmgu https://www.eummcr.or
g 
HEPD0681_7_F03 
Experimental Models: Organisms/Strains 
Mouse: FoxG1Cre/+ Hebert and 
McConnell, 2000 
N/A 
Mouse: ShhP1 Riccomagno et al. 2002 NA 
Mouse: Smo+/- Zhang et al. 2001 N/A 
Mouse: Smoloxp/loxp Long et al. 2001 N/A 
Mouse: Gas2tm1a/+ This paper N/A 
Mouse: B6.129S4-Gt(ROSA) 26Sortm2(FLP*)Sor/J 
[FLPo (B6 ROSA26Flpo)] 
The Jackson Labs 012930 
Mouse: B6.FVB-Tg(EIIa-cre) C5379Lmgd/J 
(E2a-Cre) 
The Jackson Labs 003724 
Mouse: Gas2tm1c/tm1c This paper N/A 
Mouse: Gas2tm1d/+ This paper N/A 
Sequence-Based Reagents 
Genotyping primers for Gas2 alleles – see table 
3.1 
  
Software and Algorithms 
RUM Grant et al. 2011 http://www.cbil.upe
nn.edu/RUM/ 
edgeR Robinson et al. 2010 https://bioconducto
r.org/packages/rel
ease/bioc/html/edg
eR.html 
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Table 3.1 Primer sets for Gas2 allele genotyping. 
 
 
  
Gas2 Genotyping Primers 
Target Forward primer (5’-3’) Reverse Primer (5’-3’) Size (bp) 
5’ arm GAAGTTCCTATTCCGAAGTTCCT CTGCCTGTGTTGAATGTTCTCAT 7076 
3’ arm CCTGCTTGCCGAATATCATGG ACTTCTGTGGAGTCTCAGCTC 6493 
Tm1a/Loxp TTGGATCATATGGAGAGAGCCA
T 
GGGCATATCACAGGCCCATA WT-223 
Tm1a-257 
Tm1c GGCGCATAACGATACCACGA TATAAGCCGCCTACTGCGAC 208 
Gas2-LacZ AGAACAAGCAACATGCGCTC GACCTTGGGACCACCTCATC 611 
Gas2-Neo CTCCCCCTGAACCTGAAACATA TTATATAAGCCGCCTACTGCGA 360 
Tm1d GGCGCATAACGATACCACGA GGGCATATCACAGGCCCATA 225 
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Chapter 4: Conclusions and Future Directions 
The development and function of the inner ear rely on a host of signaling 
pathways, post transcriptional processes, complex cell types, and mechanical 
interactions. Taken together, these properties of the inner ear provide us with an 
excellent model organ for understanding basic biology and for asking questions 
regarding the development of complex systems. Beyond that, the prevalence of hearing 
disorders amongst the human population lends medical relevance to the study of the 
development of the cochlear duct and its functional properties. 
Hearing impairment and repair 
As hearing loss and deafness represent the most common forms of sensory 
deficit in the developed world considerable effort has been spent attempting to repair all 
forms of hearing impairment. Current options for patients with hearing impairment are 
limited to imperfect mechanical devices, such as hearing aids and cochlear implants, 
that only partially relieve symptoms and are not available to cases with certain forms of 
hearing loss (Casazza and Meier, 2017; Cunningham and Tucci, 2017). In recent years, 
a number of cellular and gene therapy approaches have been undertaken to address 
these concerns including regenerating sensory hair cells and repairing of genetic 
lesions. Many groups have focused on the regeneration of sensory hair cells utilizing 
manipulations of the remaining cells within the cochlea. Manipulating Notch signaling 
and ectopically expressing Atoh1 have proven able to convert supporting cells into hair 
cells, however, this comes at the expense of normal cochlear architecture and is unlikely 
to provide full hearing restoration (Mizutari et al., 2013; Richardson and Atkinson, 2015; 
White et al., 2006; Yang et al., 2012). It has been discovered that a small subset of 
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support cells express the factor Lgr5, a marker for stem cells, and that these Lgr5+ cells 
exhibit the capacity to replicate in culture and be differentiated into hair cells (Bramhall et 
al., 2014; Shi et al., 2012, 2013). If these cells could be reintroduced into the cochlea or 
endogenous cells programmed to replicate and differentiate to the same efficacy it could 
provide a potential therapy for age related hearing loss and some forms of congenital 
deafness. 
In cases of congenital hearing impairment, however, additional factors must be 
considered apart from cell replacement therapy. The nature of many hearing loss 
mutations renders hair cell replacement problematic as these genes either affect other 
aspects of hearing, such as stria vascularis function, or affect the hair cells themselves, 
making it impossible to utilize cells from the patient that contain the mutation in question 
(Atik et al., 2015; Casazza and Meier, 2017; Kazmierczak and Müller, 2012; Raviv et al., 
2010; Shearer et al., 1993; Venkatesh et al., 2015; Weil et al., 1995). Recent work with 
CRISPR-Cas9 and gene therapy approaches have shown that the ear is a potential 
target for genetic editing and replacement, however, much work is required before these 
methods are ready for the clinic (Akil et al., 2012; Gao et al., 2017; Gomes et al., 2016; 
György et al., 2017; Iizuka et al., 2015; Landegger et al., 2017; Tao et al., 2018). Of 
interest, we propose that the Gas2 mutant mouse line developed in our work may 
provide an excellent platform for testing gene therapy approaches to hearing loss. An 
issue with many deafness phenotypes is that they result in the degeneration of cochlear 
cells or morphological defects that preclude postnatal repair. We have shown that Gas2 
mutants present with severe hearing impairment in the absence of gross morphological 
perturbation. Thus, the Gas2 mutant may be an excellent model to test the efficacy and 
longevity of genetic repair strategies in a mammalian system 
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Alternative splicing  
Our analysis of Esrp1 mutant cochlea revealed a number of differentially spliced 
transcripts with unknown significance to inner ear development. We were able to 
establish that aberrant splicing of Fgfr2 was responsible for defects in stria vascularis 
development of these embryos, however, that case was greatly abetted by the near 
100% isoform switch of Fgfr2. Most other genes in this and in other studies do not 
exhibit such isoform exclusivity, making interrogation of these transcripts much more 
cumbersome. The ability to examine the contribution of shifts in 10-50% isoform usage 
has been a major hurdle in the field of alternative splicing research. The Tetracycline 
inducible rtTA-tetO system may provide a utility to begin interrogating isoform specific 
contributions to phenotypes (Gossen and Bujard, 1992; Gossen et al., 1995). By driving 
specific isoforms of a transcript under control of a tetO element it may be possible to 
generate dosage dependent expression. Experiments such as this will be required to 
move forward and understand how isoform dosage impacts cellular and developmental 
phenotypes. 
Roles for Esrps in vestibular morphogenesis 
 We uncovered mutations in ESRP1 by exome sequencing in patients with SNHL 
and dysgenesis of the lateral semicircular canal (SSC) of the vestibular apparatus. 
Analysis of Esrp1 deficient mouse embryos revealed defects in cochlear duct 
development that are likely causative for hearing loss and a dysmorphia of the vestibular 
apparatus similar to those seen in the human patients. This vestibular phenotype 
presents as an apparent failure to resorb and refine the epithelial labyrinth of the 
common cruz and lateral SSC, leading to an expansion of these structures. 
Fascinatingly, a recent publication examining the loss of esrp1 and esrp2 in zebrafish 
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also described a horizonal SSC defect in double mutant fish (Burguera et al., 2017). 
These results demonstrate that Esrps play a critical and conserved role in SSC 
morphogenesis.  
The mechanism by which this phenotype arises, however, remains to be 
explored. Our work and that of many others have demonstrated that many Esrp directed 
splicing events are cell-type specific, thus, a comparative analysis of the gene 
expression and alternative splicing events between control and Esrp mutant vestibular 
epithelia is required to gain insight into this phenotype. Several factors, however, stand 
out as potential contributors to the SSC phenotype in Esrp mutants. Ntn1 instructs dorsal 
otic cells to undergo apoptosis and sculpt the SSCs (Nishitani et al., 2017; Salminen et 
al., 2000) and is regulated by Lrig3 in the lateral SCC (Abraira et al., 2008). Additionally, 
regulation of canonical Wnt signaling has also been shown to impact SSC 
morphogenesis (Rakowiecki and Epstein, 2013). While these genes and pathways have 
yet to be shown to be targets of Esrp1, their contributions to SSC formation warrant 
investigation in these mutants. Of interest, mouse mutants for Fgf9 also display a failure 
to resorb phenotype and Fgf receptors are known targets for Esrp directed splicing 
(Bebee et al., 2015; Burguera et al., 2017; Pirvola et al., 2004; Warzecha et al., 2009a). 
It has been shown, however, that Fgf9 directs SSC morphogenesis through 
mesenchymal interactions, and thus any contribution of this factor to the phenotype seen 
in Esrp mutants must be indirect. While much work is needed to understand the 
mechanism behind the SSC dysgenesis seen in various Esrp mutants, the interrogation 
of these phenotypes may reveal novel regulators of vestibular development that are 
conserved across evolutionary time. 
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Establishing roles for early otic expression patterns 
We performed a comparative expression experiment in control and Shh signaling 
deficient inner ears and discovered a cohort of cochlear enriched genes. Several of the 
identified transcripts encode for transcription factors and regulators of early cochlear 
patterning and development, such as Gata3, Pax2, and Otx2. Many genes have, as of 
yet, undescribed functions in cochlear development, and provide intriguing potential 
candidates for follow-up studies. Interestingly, several genes uncovered in our analysis 
(Col11a2, Myo7a, Pls1, Rspo2, and Thrβ) have been described in mouse knockouts to 
display hearing loss due to defects in hair cell development and sensory function (Krey 
et al., 2016; Mulvaney et al., 2013; Ng et al., 2015; Shpargel et al., 2004; Taylor et al., 
2015; Vikkula et al., 1995; Weil et al., 1995). None have been described as having a 
function as early as E11.5 and most have not been described as expressed prior to hair 
cell development. Given the relative expression levels of these transcripts they cannot 
simply be ignored as statistical errors in our analysis and, thus, their expression at this 
stage deserves further interrogation. It is possible that these transcripts are the result of 
a pre-patterning mechanism, the establishment of a gene expression profile for sensory 
cells many days before the cells differentiate. Another possibility is that these genes do 
have a function at this early timepoint but it is masked in knockout animals by functional 
redundancy with additional factors. As little evidence exists to corroborate either of these 
hypotheses, further interrogation and experimentation will be required to draw 
conclusions about the expression of these genes. 
Another interesting candidate from our screen, Gas2, also fits this category of its 
expression having unknown significance at E11.5. Our experiments in Gas2 deficient 
mice revealed a hearing loss phenotype that is attributed to defects that arise postnatally 
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in the supporting pillar cells. As no abnormalities were observed embryonically we were 
unable to address any function that the early expression of Gas2 has on cochlear 
development. It is possible that a morphogenetic function for Gas2 is masked by the 
presence of potentially redundant cytoskeletal binding proteins, such as Pls1 and Dsp, 
and that combinatorial knockouts would be required to drive a cochlear outgrowth 
phenotype.  
Pillar cells and the sense of hearing 
Perhaps the most fascinating finding from our investigation of Gas2 null mice 
was the link between hearing loss and defects in the pillar cell cytoskeleton. It has been 
long appreciated that the pillar cells are defined by a highly stable, microtubule rich, 
cytoskeleton and that these cells are required for hearing function. The few syndromes 
that affect pillar cells and result in hearing loss are tied to fate specification of these 
cells, making a direct assay of their normal function impossible from these studies 
(Jacques et al., 2007b; Mansour et al., 2009; Mellado Lagarde et al., 2013; Mueller et 
al., 2002; Shim et al., 2005; Szarama et al., 2012b). Of interest, recent work has found 
that deletion of Gjb2, a gene encoding a gap junction protein that has previously been 
described as required for stria vascularis function, also affects the development of the 
pillar cell cytoskeleton (Chen et al., 2018). In Gjb2 conditional knockouts the microtubule 
network of the pillar cells is disrupted and the tunnel of Corti fails to open, leading to 
hearing deficits. Microtubules have previously been shown to be important for proper 
membrane localization of gap junctions, suggesting there may be an intersection 
between the Gjb2 and Gas2 mutant phenotypes (Guo et al., 2003; Thomas et al., 2001). 
Future experiments will need to address the localization of connexin-26 (Gjb2) in Gas2 
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mutants and vice-versa as well the mechanism by which loss of Gjb2 affects pillar cell 
development. 
In Gas2 mutants, the pillar cells are specified and appear to develop normally 
thus providing a unique model system in which to assay postnatal cellular dysfunction 
that is linked to hearing loss. Experiments are already planned and underway to 
generate a support cell specific deletion of Gas2 utilizing the mouse lines we have 
derived and a Sox2CreERt2, which is expressed in the pillar and Deiters’ cells late in 
embryonic and throughout postnatal development (Gu et al., 2016). These mice would 
allow us to perform not only a cell type but also time specific deletion of Gas2 utilizing 
tamoxifen administration. We can thus address the requirement for Gas2 directly in pillar 
cells and at what times this gene is essential for hearing function. 
We observed that the microtubule network of Gas2 mutant pillar cells is disrupted 
and quickly lost shortly after the onset of hearing. That the microtubules appeared to 
form and extend initially, and that the morphology of mutant pillar cells was unaffected, 
we concluded that Gas2 is likely required for the maintenance of the microtubule 
network in these cells. Experiments are planned to test this hypothesis utilizing the 
Sox2CreERt2 mouse line to delete Gas2 postnatally after hearing has begun. We would 
expect to observe a depletion of microtubules from Gas2 mutant pillar cells after 
tamoxifen administration, similar to that seen in the Gas2 null line at P16. This data 
would provide strong evidence that Gas2 is required for maintenance of the microtubule 
network of pillar cells. If we do not observe a loss of microtubules it will argue instead for 
a role of Gas2 in establishment of the microtubule network prior to hearing and that the 
timing of the phenotype in the Gas2 null line is simply coincident due to the prolonged 
nature of pillar cell development. 
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An additional possibility is that the breakdown of microtubules in the absence of 
Gas2 is caused or exacerbated by hearing itself. This hypothesis relies on the current 
prevailing model that the pillar cells act as a “hinge”, the point of deflection during basilar 
membrane movements caused by sound waves traveling along the cochlear duct. We 
propose that this movement causes strain on the pillar cells, requiring them to be highly 
rigid and stable to provide structural support for the organ of Corti. This idea is supported 
by the presence of detyrosinated microtubules in the pillar cells, a modification that has 
been shown to increase cellular stiffness and increase compression-resistance in 
cardiomyocytes, as well as data collected from gerbil cochlear explants and finite 
element models (Chan and Hudspeth, 2005; Nam and Fettiplace, 2010; Ni et al., 2016; 
Robison et al., 2016; Slepecky et al., 1995). This model also posits that the observed 
decrease in DPOAEs and loss of outer hair cells in the Gas2 mutants are a secondary 
consequences of altered pillar cell function and excessive movement of the organ of 
Corti. In essence, the loss of microtubules in the pillar cells results in decreased stiffness 
and increased movement of the organ of Corti during acoustic stimulation. This would 
cause the outer hair cells to contact the tectorial membrane with increased force, 
subsequently damaging these cells and altering the DPOAE response. This model could 
be tested by altering the noise exposure of Gas2 deficient animals. Induction of 
conductive hearing loss by surgically removing the middle ear bones before the onset of 
hearing would be predicted to alleviate mechanical stress on the pillar cells and rescue 
the loss of microtubules and outer hair cells (Chhan et al., 2017; Qin et al., 2010). 
Alternatively, exposure to loud noise would have the opposite effect. The increased 
movement of the basilar membrane would put additional stress on the organ of Corti 
leading to a more rapid depletion of the microtubule network in pillar cells and greater 
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loss of outer hair cells. These experiments would provide some of the first in vivo 
evidence for the requirement of pillar cell rigidity for the sense of hearing. 
Recent genetic mouse models have also been developed that could prove useful 
in testing the requirements of the microtubule network of pillar cells in hearing function. 
Spastin is a microtubule severing protein that, when overexpressed, severely disrupts 
cytoskeletal organization (Errico et al., 2002; Trotta et al., 2004). A mouse line in which a 
highly active form of Spastin was placed under control of a tetO response element has 
recently been described (Muroyama and Lechler, 2017). This allows for cell type specific 
activation of Spastin when combined with an rtTA driver and Doxycycline administration. 
Utilizing this system, it would be possible to disrupt the microtubule network of pillar 
cells, effectively mimicking the Gas2 null phenotype, and test for hearing response in the 
resulting animals. In addition, it was recently discovered that vasohibin-1 (VASH1) in 
complex the small vasohibin binding protein (SVBP) act to detyrosinated microtubules 
(Aillaud et al., 2017; Nieuwenhuis et al., 2017). By knocking out this complex in pillar 
cells it is possible to inhibit the detyrosination of microtubules, potentially rendering them 
less stable and susceptible to mechanical perturbation during hearing. Data from these 
experiments could support or refute the hypothesis that a rigid microtubule cytoskeleton 
is required in pillar cells for the sense of hearing. 
Conclusions 
In conclusion, we have identified Esrp1 and Gas2 as novel hearing loss genes, 
adding to the list of previously established regulators of cochlear function. Our analysis 
of Esrp1 mutants uncovered roles for an alternative splicing regulator in the development 
of the cochlear duct. Loss of Esrp1 results in a shortened cochlear duct, delay in hair cell 
differentiation and maturation, and loss of the stria vascularis due to inappropriate Fgf 
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ligand usage in these cells. These findings provide strong evidence for Esrp1 as a 
critical factor in inner ear development and opens the possibilities for studying additional 
alternative splicing events that may play a role in hearing and cochlear development. We 
utilized a genetic screen to identify hundreds of cochlear enriched transcripts that may 
be targets of Shh signaling in the inner ear. In validating these targets, we uncovered 
repeated use of similar expression domains that may be indicative of the regulatory logic 
governing cochlear duct patterning. Our analysis of Gas2 as a putative Shh target gene 
in the cochlear duct revealed that it is required for auditory function. Loss of Gas2 results 
in defects in the pillar cell cytoskeleton that may be linked to hearing dysfunction. These 
studies provide a unique model for studying pillar cell function and may be utilized as a 
test platform for genetic rescue of hearing loss. 
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